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SUMMARY 
 
 
 This thesis deals with 3-membered carbocycles; their use as ligands for the 
asymmetric Heck reaction (AHR), the development of novel methods and reactions 
for their synthesis and use.  It is broken into three chapters, each one devoted to 
different aspects of the chemistry of these uniquely interesting small carbocycles. 
 The first chapter discusses the development of a novel class of chiral, non-
racemic, phosphorous containing, cyclopropyl oxazolidinones and their use as ligands 
in the asymmetric Heck reaction.  It gives a brief overview of the Heck reaction and 
describes how these ligands influence the outcome of the reaction.  This is then 
followed with a discussion of the synthetic methodology used in developing the 
PHOX ligands and ultimately their application to the asymmetric Heck reaction. 
 Chapter two covers the development of a high throughput screening method 
for the hydroformylation of olefins.  The method described makes use of a multi-
reactor array and rapid analysis via GCMS which allowed for the screening of a 
library of approximately fifty chiral phosphine ligands in the hydroformylation of 
styrenes as well as the development of solvent and temperature screening 
optimization protocols.   
 Chapter three can be broken down into three parts.  The first deals with the 
improvement on a 1,2-elimination procedure for the synthesis of cyclopropenes 
which has been known since the 1960’s.  Through careful optimization of the reaction 
conditions it was possible to improve the method and correspondingly increase the  
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SUMMARY (Continued) 
 
 
yield of the cyclopropenes.  Part two divulges a novel methodology for the synthesis 
of cyclopropenes which replaces DMSO with THF as the solvent in the base assisted  
1,2-elimination step.  It also shows how this change ultimately allowed for an overall 
improvement in yield especially for cyclopropenes bearing a hydrophilic amido 
moiety.  The final portion of chapter three discusses the application of the high-
throughput screening method shown in chapter one to cyclopropenes.  While 
hydroformylation of cyclopropenes is a precedented process, until recently this was 
done with the assistance of a stoichiometric amount of a transition metal.  The 
method divulged herein is the first catalytic hydroformylation which has been done 
on strained, small carbocycles both in a racemic and asymmetric fashion.   
  
1 
Chapter 1.  Development of Chiral, non-racemic cyclopropyl PHOX ligands 
 
1.1.  Introduction 
 
The asymmetric Heck reaction is one of the most powerful and versatile 
processes for the enantioselective construction of new carbon-carbon bonds.  
Intramolecular versions of this reaction catalyzed by palladium complexes with 
BINAP and related diphosphine ligands1 allow for efficient installation of tertiary and 
quaternary chiral centers leading to a rapid increase of molecular complexity.2 To 
date, various modes of this transformation are being successfully employed in the 
synthesis of complex organic molecules.3  Considerable achievements have also been 
made towards the application of BINAP type ligands in the intermolecular 
asymmetric Heck reaction. 4   This reaction was pioneered by Hayashi, 5  who 
demonstrated the arylation of dihydrofuran 1 with phenyl triflate 2a (Scheme 1) in the 
presence of (R)-BINAP5,6 produced isomeric dihydrofurans 3a and 4a, with the latter 
being the major product, due to substantial isomerization of the double bond. 
Depending on the reaction conditions, moderate to good selectivities toward 
formation of 4a were observed.  Remarkably, the obtained products, “normal” 3a and 
“isomerized” 4a, had the opposite absolute configurations of the stereogenic center at 
C2.  Moreover, it was found that the enantioselectivity improved during the reaction 
course.  The mechanistic rationale proposed by Hayashi5 fully accounts for the 
observed stereoselectivity change (Scheme 2).   
 
  
2 
Scheme 1. 
 
 
 
The catalytic cycle begins with the oxidative addition of Pd(0) species 5 into 
the aryl triflate 2 resulting in the formation of cationic complex 6.  The latter can 
coordinate to either of the prochiral faces of dihydrofuran (1) affording 
diastereomeric 2η-complexes 7 and 10.  Subsequent carbopalladation, followed by β-
hydride elimination, produces species 9 and 12, respectively. It was proposed that the 
diastereomeric complex 12 has a higher propensity toward further hydropalladation 
than 9.  Accordingly, the latter species releases the (S)-enantiomer of 2,5-
dihydrofuran 3 (Path I), while the former undergoes a series of reversible hydropalla-
dations and β-hydride eliminations, resulting in the formation of a thermodynamically 
more favored 2η-complex 14, which ultimately produces (R)-enantiomer of the 
isomeric product 4.   
Later, a number of research groups pursued the design of alternative 
diphosphine ligands to achieve better regio- and enantioselectivity in the 
intramolecular Heck reaction.  Several derivatives of BINAP 7  and other chiral 
diphosphines8,9 including TMBTP,10 BIPHEP,11 BITIANP12 (Scheme 3) were tested, 
some of which provided improved selectivity.  Nevertheless, in all cases predominant 
or exclusive formation of the isomerized product 4 was observed. 
 
  
3 
Scheme 2. 
 
 
 
 
Scheme 3. 
 
 
 
 
At the same time, several mixed heteroatom ligands of the P-S,13 P-O,14 and 
N-N15 type have also been explored in the intermolecular Heck arylation; however, 
they demonstrated only marginal regio- and enantioselectivities.  On the other hand, 
  
4 
superior results were obtained using chiral ligands of the P,N-type.16 Particularly, 
excellent enantioselectivities were achieved using different variations of phosphanyl-
oxazoline (PHOX) ligands, 17  originally introduced by Pfaltz (Scheme 4). 18   The 
remarkable, yet not fully understood feature of PHOX ligands is their low tendency to 
promote C=C bond isomerization.17  In contrast to the diphosphines, PHOX ligands 
produced dihydrofuran 3 with very high selectivity.  Structural modification of the 
flat ortho-phenylene tether in the Pfaltz ligand through the incorporation of additional 
chirality elements into the ligand backbone allowed for significant improvement of 
the enantioselectivity.  Thus, ferrocene-based ligands introduced by Dai and Hou,19 
and Guiry20 (Scheme 4) were employed in the asymmetric Heck reaction of different 
cyclic olefins. Furthermore, Gilbertson demonstrated PHOX ligands featuring 
apobornene backbone (Scheme 4) exhibit outstanding activities and selectivities in 
the arylation and alkenylation of different cyclic substrates. 21  Recently, a highly 
efficient asymmetric arylation in the presence of sugar-derived phosphite-oxazoline 
ligands was reported by Diéguez and Pàmies.17c,d  
 
Scheme 4. 
 
 
   
 
  
5 
PHOX ligands are very appealing due to their high catalytic potential and 
modular design, which permits easy preparation of a series of analogs via the same 
synthetic route.  To date; however, the general approach to the ligand design has been 
largely empirical due to a poor understanding of the factors affecting the activity and 
selectivity of the corresponding catalytic systems.   
1.2.  Results and Discussion 
 
 
Our approach to the PHOX ligands with a chiral cyclopropyl backbone is 
presented in Scheme 5.  The synthesis began from optically active 1-methyl-2,2-
dibromocyclopropanecarboxylic acid (15)22  readily available in both enantiomeric 
forms.  The S-enantiomer of acid 15 was converted into acyl chloride (S)-16. 
Subsequent acylation of (R)-phenyl glycinol with (S)-16 afforded amide 17, which 
was subjected to cyclization in the presence of mesyl chloride and a base providing 
dihydrooxazole 18.  Diastereoselective partial reduction of the dibromocyclopropane 
moiety with zinc dust in glacial acetic acid produced a 1:4 mixture of trans- and cis-
bromocyclopropanes 19, which were separated by column chromatography.  Lithium 
to halogen exchange followed by trapping of the resulting cyclopropyllithium species 
with chlorophosphine produced ligand L1 (Scheme 5). 
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Scheme 5. 
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Ligand L1 once obtained, was tested in the asymmetric arylation reaction of 
2,3-dihydrofuran under various reaction conditions (Table 1).  It was found that the 
reaction proceeded efficiently, yet with only moderate enantioselectivity, in the 
presence of palladium acetate and Hünig’s base (Table 1, entry 3).  Interestingly, the 
employment of proton sponge as a base resulted in significant isomerization of 
product 3a into more thermodynamically stable dihydrofurans 4a and 20a. Close 
monitoring of the reaction by chiral GC revealed the reaction begins with formation 
of “normal” product 3a (Table 1, entry 4); however, at the time of complete 
consumption of the starting material 1, the entire amount of 3a produced was 
converted into 4a (Table 1, entry 5).  Remarkably, all through the reaction course, the 
absolute configuration of the stereogenic center at C2 remained the same; 
furthermore, the optical purity of both products 3a and 4a did not change significantly 
(Table 1, entries 4,5).  This feature makes this isomerization mechanistically distinct 
from the one reported by Hayashi (vide supra).  
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Table 1. Selected Results on Optimization of the Reaction Conditions for 
Asymmetric Heck Arylation Using L1 
 
 
 
# Pd-cat. Base Solvent Time/Temp 3a:4a ee, % conv, %a 
1 Pd2dba3. 
CHCl3 
EtNiPr2 benzene 3 days/70 oC 19:1 90 (A) 15 
2 Pd2dba3. 
CHCl3 
EtNiPr2 THF 20 hrs/85 oC 10:1 85 (A) 60 
3 Pd(OAc)2 EtNiPr2 THF 20 hrs/85 oC 11:1 83 (A) 99 
4 Pd(OAc)2 Proton  
sponge 
THF 20 hrs/60 oC 10:1 88 (A) 45 
5 Pd(OAc)2 Proton  
sponge 
THF 70 hrs/60 oC >1:50b 85 (B) 99 
6 Pd(OAc)2 Proton  
sponge 
THF 20 hrs/90 oC >1:50b 82 (B) 99 
a
 Conversion by GC. b Formation of small amounts of dihydrofuran 20a was observed. 
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To better understand the factors affecting the selectivity and efficiency of the 
asymmetric arylation, we have prepared two more analogs of L1: ligand L2, 
possessing a diphenylphosphanyl group; and ligand L3 derived from tert-leucinol 
(Scheme 6).25   
 
Scheme 6. 
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Not surprisingly, installation of the less hindered phosphorus moiety in L2 
negatively affected the asymmetric induction the corresponding product 3a was 
obtained in only 78-79 % ee (Table 2, entries 3,4). However, in contrast to L1 (Table 
2, entries 1,2) the selectivity toward 3a in the reaction using L2 remained high 
regardless of the base used.   
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Table 2. Screening of L1-L3 in the Asymmetric Heck Arylation of Dihydrofuran 1 
 
 
 
# Ligand Base 3a:4a ee, %b conv, %c 
1 L1a EtNiPr2 11:1 83 99 
2 L1a Proton sponge >1:50 82 99 
3 L2 EtNiPr2 20:1 79 99 
4 L2 Proton sponge 15:1 78 99 
5 L3 EtNiPr2 7:1 87 35 
6 L3 Proton sponge 1.4:1 84d 80 
a
 Results from Table 1. b Enantioselectivity of a major product. c Conversions by GC. 
d
 Enantioselectivity of product (R)-4a was 80 %.  
 
 
Modification of the dihydrooxazole moiety by installation of a bulky tert-
butyl group was pursued in attempt to improve the enantioinduction of our catalytic 
system. Indeed, a number of previously reported PHOX ligands derived from tert-
leucinol were shown to provide superior enantioselectivities compared to their 
analogs obtained from less bulky amino alcohols.18b,20,21  However, the arylation 
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carried out in the presence of L3 proceeded much more sluggishly (Table 2, entries 
5,6), and allowed for only insignificant improvement in enantioselectivity (84-87 % 
ee).  Most remarkably, the same (R)-enantiomer of product 3 was obtained, despite 
the opposite absolute configuration of L3 with respect to L1 (Scheme 6).  In other 
words, switching from Ph to a tBu substituent in the dihydrooxazole ring of the ligand 
resulted in a reversal of enantioselectivity.   
Such an unexpected change in the catalyst selectivity motivated us to perform 
structural analysis of the key intermediate complexes invoked in the catalytic cycle of 
the Heck arylation.  First, we assessed the possibility of conformational equilibrium 
for the six-membered arylpalladium species bearing L1 (Scheme 7).  The non-planar 
six-membered palladacycle23 can potentially adopt one of two conformations: I1, in 
which the syn-tert-Bu-substituent at phosphorus assumes a pseudo-equatorial 
position, whereas the anti-tert-Bu-substituent is pseudo-axial; and I2, where this 
relationship is reversed (Scheme 7).  Analysis of these two conformations suggests 
steric repulsions between the axial syn-substituent and the methylene group in 
cyclopropane makes conformation I2 thermodynamically disfavored compared to I1.  
This hypothesis was also supported by a single crystal X-ray analysis of (L1)PdCl2 
complex (Figure 1).  The resolved crystal structure clearly shows the syn- (C14) and 
anti-substituent (C18) at phosphorus adopt a pseudo-equatorial and a pseudo-axial 
position, respectively.  It would be reasonable to assume the strained and rigid 
cyclopropyl backbone renders the six-membered palladacycle particularly inflexible, 
thus significantly suppressing conformational fluctuations throughout the catalytic 
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cycle.  Furthermore, coordination of the soft pi-ligand dihydrofuran should take place 
predominantly trans- to a soft phosphorus atom24 (Scheme 8.).  In this case, the re-
face approach (I4) is encumbered by a large pseudo-axial tert-butyl group, while the 
si-face approach (I3) is also somewhat hindered by a pseudo-axial syn-phenyl 
substituent in dihydrooxazole ring.  As a result, the (R)-enantiomer of the product was 
predominantly formed, albeit with moderate enantioselectivity.  Analogously, in the 
intermediate I5 derived from chiral ligand L2, the less bulky pseudo-axial phenyl 
substituent at phosphorus blocks the re-face approach even less efficiently, which 
ultimately results in a further decrease of enantioselectivity (Scheme 8.). 
 
Scheme 7.  Conformational equilibrium in cationic arylpalladium(II) complexes with 
chiral ligand L1. 
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Figure 1.  
 
Overlay of X-ray structures of complexes (L1)PdCl2 (solid lines) and (L4)PdCl2 
(dashed lines, molecule A). The 18 conformationally-similar non-hydrogen atoms 
[Pd, Cl(1), Cl(2), P, N, C(1)→C(4), C(13)→C(21)] in the two isomers can be 
superimposed with a rms deviation of 0.12 Å and a maximum deviation of 0.22 Å for 
any pair of these atoms. 
 
Similar considerations were used to account for the observed reversal of 
enantioselectivity in the reaction carried out in the presence of L3 (Table 2, entries 
5,6, Scheme 9).  Thus, the increased sterics created by a bulky tert-butyl group in the 
dihydrooxazole ring does not allow for the si-face approach resulting in the reaction 
proceeding predominantly from the re-face, providing the (S)-enantiomer of 3 
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(Scheme 9).  The fact that in both intermediates I7 and I8 dihydrofuran experiences 
certain impediment on approach to palladium may also be responsible for the 
observed decrease in the reaction rate.  
 
Scheme 8. 
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Scheme 9. 
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 Based on this analysis, we rationalized that the “wrong” relative configuration 
of the stereogenic centers in ligands L1, L2, L3 could be responsible for the observed 
marginal enantioselectivity of the corresponding catalytic systems.  We envisioned 
inverting the absolute configuration of the asymmetric center at C4 in the 
dihydrooxazole ring may potentially help improve enantioselectivity of the arylation 
reaction. Indeed, it is reasonable to propose inversion of the stereogenic center in the 
dihydrooxazole ring should not significantly affect the thermodynamic equilibrium of 
the corresponding palladacycle conformations I9 and I10 (Scheme 10), as compared 
to I1 and I2 (Scheme 7).  Thus, the cationic palladacycle with (S,S,S)-ligand L4 
would still predominantly adopt conformation I9 to avoid the unfavorable steric 
interaction between the pseudo-axial syn-tert-butyl group and the methylene group of 
the cyclopropane (Scheme 10).  Accordingly, the axial P-tBu group and a bulky 
substituent at C4 in dihydrooxazolyl moiety in the alternative, (S,S,S)-configuration 
of the ligand would now act synergistically to provide efficient blocking of both 
bottom quadrants thereby completely preventing the re-face attack (I12, Scheme 11).  
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On the other hand, the si-face attack should become more favorable after the removal 
of a bulky group obstructing the top right quadrant (I11, Scheme 11 vs. I3, Scheme 
8). Ultimately, if the above assumptions are correct, this change should result in 
enhanced enantioselectivity of the asymmetric arylation in the presence of ligand L4 
in favor of the (R)-enantiomer of the product 3. 
 
Scheme 10. 
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Scheme 11. 
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With this idea in mind, we prepared a new series of ligands with the (S,S,S) 
absolute configuration using the synthetic approach described above (Scheme 5), 
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starting from acid chloride (S)-16 and (S)-phenyl glycinol.25  Additional 
diversification of the ligand structure was achieved by varying the chlorophosphine 
source.  Thus, employment of di-tert-butylchlorophosphine, chlorodicyclo-
hexylphosphine, and chlorodiphenylphosphine at the last step of the sequence 
provided ligands L4, L5, and L6, respectively (Scheme 6).25  Crystallographic data 
obtained for the (L4)PdCl2 complex (Figure 1) completely confirmed the preference 
of conformation I9 vs. I10 (Scheme 10).26,27  Remarkably, X-ray analysis has also 
demonstrated that the phenyl substituent at C4 of dihydrooxazole ring adopts a 
pseudo-axial position thereby completely blocking any potential re-face attack 
(Scheme 11).  Ligands L4, L5, L6 once obtained were tested in the asymmetric 
arylation of dihydrofuran 1 (Table 3). Gratifyingly, right along with our expectations, 
the entire series of (S,S,S) ligands L4-L6 not only provided a significant improvement 
in enantioselectivity, but also helped suppress the unwanted isomerization of 3 into 4, 
as compared to the diastereomeric ligand series (L1-L3, Table 2).  Remarkably, 
changing the absolute configuration of the stereocenter in the dihydrooxazole ring did 
not cause the change of the absolute configuration of the product.  This is in contrast 
to the reactions performed using most known PHOX ligands, in which configuration 
of the oxazoline moiety usually determines the stereochemical outcome of the 
reaction.28 Thus, employment of L4 and L5 afforded dihydrofuran (R)-3 with very 
high enantioselectivity regardless of the base used (entries 1-6); however, the 
reactions proceeded more sluggishly in the presence of Hünig’s base (Table 3, entries 
2,5).  Making use of  a proton sponge helped boost the reaction rate in the arylation 
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catalyzed by both L4 and L5 (Table 3, entries 3,6) yet, significant isomerization of 3 
into 4 was observed with this base when the reaction catalyzed by Pd/L4 complex 
was allowed to run for an additional 20 hrs (Table 3, note c).  Employment of the 
diphenylphosphanyl ligand L6 provided lower enantioselectivity (Table 3, entries 
7,8), which can be attributed to decreased steric demands created by phenyl groups at 
phosphorus as compared to the tert-butyl (L4) and cyclohexyl (L5) substituents.  
The different tendencies of Pd/L1 and Pd/L4 catalyst systems to promote 
isomerization of product 3 into 4 can be rationalized as follows:  as discussed above 
(Scheme 2), the isomerization process involves reversible hydropalladation of the 
double bond of product 3.  The migration of the double bond can be realized only 
when hydropalladation of 3 occurs with addition of palladium to C4 (Scheme 12, path 
A), whereas the opposite regioselectivity of hydropalladation would ultimately lead, 
after the subsequent β-hydride elimination, back to compound 3 (Scheme 12, path B).   
The diastereoselectivity of the hydropalladation of 3 by Pd/L1 hydride species I13 is 
controlled as shown in Scheme 13.  Thus, the si-face approach of palladium hydride 
species I13 to the double bond of 3 cannot be realized due to severe steric clashes 
between the di(tert-butyl)phospanyl group of the ligand and the aryl substituent in 3 
on one side, and between the phenyl substituent in dihydrooxazole ring and C5-
methylene of dihydrofuran 3 on the other (I15, Scheme 13).  However, the alternative 
re-face approach is not associated with any steric hindrance, making this mechanistic 
channel available for isomerization (I14, Scheme 13).  
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Table 3. Screening of L4-L6 in the Asymmetric Heck Arylation Reaction 
 
 
 
 
 
# Ligand Base 3a:4a ee (3a), % Conv, %a 
1 L4 EtNiPr2 >50:1 98 53 
2 L4 EtNiPr2 16:1 98 97b 
3 L4 Proton sponge >50:1c 98 74 
4 L5 EtNiPr2 >50:1 94 71 
5 L5 EtNiPr2 40:1 94 90b 
6 L5 Proton sponge 29:1 95 99 
7 L6 EtNiPr2 16:1 88 76 
8 L6 Proton sponge >50:1 86 83 
a
 Conversions by GC. b Conversion after 2 days at 85 °C. c When the reaction was allowed to stir for an 
additional 20 hrs, the product ratio changed to 2:1. The enantioselectivities of products (R)-3a and 
(R)-4a in this case were found to be 98 % and 97 %, respectively. 
 
 
Two potential pathways for hydropalladation of 3 by the diastereomeric Pd/L4 
hydride species I16 are shown in Scheme 14.  In conjunction with L1-derived 
complex I15 (Scheme 13), complex I18 produced via the si-face approach should be 
highly disfavored (Scheme 14).  In this case; however, an alternative complex I17 
  
19 
resulting from the re-face attack should also experience steric repulsion between the 
C5-methylene of dihydrofuran 3 and a pseudo-equatorial phenyl substituent in 
dihydrooxazole ring (Scheme 14).  Accordingly, complex I17 should be much more 
unfavorable compared to L1-derived complex I14, where such interaction does not 
occur (Scheme 13). As a result, both mechanistic channels for isomerization of 
compound 3 into 4 should be suppressed in this case. It should be mentioned; 
however, that electronic density at the phosphine moiety of the ligand also notably 
affects the propensity of the corresponding catalyst to promote the isomerization. 
 
Scheme 12. 
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Our experiments indicate in the series of di(tert-butyl)-, dicyclohexyl-, and 
diphenylphosphanyl-containing ligands (L4→L6), the former has the highest 
tendency to induce isomerization while the latter has the lowest (Table 3).  A similar 
electronic effect was previously observed in the asymmetric Heck arylation in the 
presence of diphosphine-oxazoline ferrocenyl ligands.19a 
 
Scheme 14. 
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Next, the most efficient ligands L4 and L5 were tested in the asymmetric 
arylation of dihydrofuran 1 against various aryl triflates (Table 4).  It was found that 
all reactions catalyzed by Pd/L4 provided excellent enantioselectivities (98-99 % ee) 
regardless of the nature of the aryl triflate (Table 4, entries 1-5). However, the 
reactions carried out in the presence of L4/Hünig’s base combination proceeded 
much more sluggishly; as a result, the selectivity toward formation of 3 was slightly 
lower in these cases. Reactions performed in the presence of Pd/L5 catalyst and 
proton sponge proceeded much faster, albeit providing somewhat lower ee’s (Table 4, 
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entries 6-10).  In contrast to the Pd/L4 catalyzed reactions, enantioselectivities in this 
case varied slightly depending on the aryl triflate used, with the highest value 
obtained from 1-naphthyl triflate (96 % ee, entry 9) and the lowest from 2-naphthyl 
triflate (87 % ee, entry 10). Interestingly, the electronic nature of the aryl triflate had a 
pronounced effect on the reaction rate, which is best seen in the Pd/L5 series of 
catalyzed reactions. Thus, electron-rich aryl triflates (entries 6,7,9) reacted much 
faster than the electron-poor analog 2d (entry 8).  Furthermore, a remarkable 
difference between the reactivity of 1- and 2-naphthyl triflates was also observed, 
suggesting the reaction is also sensitive to sterics (entries 9 and 10).  
We also tested all new ligands L1-L6 in the asymmetric Heck arylation of 
cyclopentene (Table 5). Initial experiments conducted under the conditions optimized 
for arylation of dihydrofuran 1 (Table 4) provided no reaction with cyclopentene 19.  
Additional optimization revealed reasonable reaction rates can be achieved only in 
the presence of Pd(dba)2 catalyst and proton sponge (Table 6). 29  Generally, the 
enantioselectivities obtained in this transformation (Table 5) were somewhat lower 
than those obtained in the arylation of dihydrofuran (Tables 2,3) for all ligands tested 
except L4. Notably, similarly to the arylation of dihydrofuran (Tables 2,3), the 
isomerization rates (22→23) in this transformation were significantly lower in the 
reactions carried out in the presence of ligands with the (S,S,S) absolute configuration 
(L4-L6, Table 5, entries 4-6), as compared to the ligands in the diastereomeric series 
(L1-L3, Table 5, entries 1-3).   
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Table 4. Asymmetric Arylation of Dihydrofuran with Aryl Triflates 
 
 
 
 
# Aryl Ligand/Base Time, h 3:4 ee (3), % Conv, %a 
1 p-Me-C6H4 2b L4/Hünig’s base 48  16:1 99 96 
2 p-MeO-C6H4 2c L4/Hünig’s base 20 17:1 98 98 
3 p-CF3-C6H4 2d L4/Hünig’s base 48 >50:1 98 58 
4 1-Naphthyl 2e L4/Hünig’s base 48 18:1 98 70b 
5 2-Naphthyl 2f L4/Hünig’s base 20 >50:1 98 32b 
6 p-Me-C6H4 2b L5/Proton sponge 6 39:1 95 93 
7 p-MeO-C6H4 2c L5/Proton sponge 6 35:1 92 99 
8 p-CF3-C6H4 2d L5/Proton sponge 20 42:1 91 95 
9 1-Naphthyl 2e L5/Proton sponge 6 31:1 96 94b 
10 2-Naphthyl 2f L5/Proton sponge 20 17:1 87 100c 
a
 Conversion by GC. b Formation of ca.10 % of naphthalene was observed. c Formation of ca.20 % of 
naphthalene was observed. 
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Table 5. Evaluation of Ligands L1-L6 in the Intermolecular Asymmetric Heck 
Reaction of Phenyl Triflate (2a) with Cyclopentene (21) 
 
 
 
# Ligand 22:23 ee (22), % Conv, %a 
1 L1 12:1 81 99 
2 L2 15:1 86 95 
3 L3 13:1 82 15 
4 L4 27:1 92 32 
5 L5 44:1 89 96 
6 L6 40:1 80 60 
a
 Conversion by GC. 
 
1.3.  Conclusions 
 
In conclusion, a series of novel PHOX ligands featuring a chiral cyclopropyl 
backbone have been synthesized and examined in the intermolecular asymmetric 
Heck arylation of cyclic olefins. By lowering degrees of freedom in the catalyst 
structure through the introduction of additional conformation constraints, we have 
created a model catalytic system with predictable, tunable and easily adjustable 
properties.  Structure-activity relationship studies allowed for identifying the key 
topological and stereochemical features of the ligands, responsible for achieving high 
enantioselectivity and for suppressing product isomerization.  This has resulted in the 
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development of efficient catalytic systems demonstrating excellent 
enantioselectivities in the asymmetric arylation of dihydrofuran with various aryl 
triflates.  It was also shown that product isomerization in the presence of these ligands 
has a different nature from that reported previously using chiral diphosphine ligands. 
Furthermore, a number of factors were shown to affect the isomerization rate 
including the absolute configuration of the ligand, its electronic properties, and the 
base employed. 
 
1.4.  Experimental 
 
1.4.1.  General Information 
 
NMR spectra were recorded on a Bruker Avance DPX-400 instrument, 
equipped with a quadruple-band gradient probe (H/C/P/F QNP) or a Bruker Avance 
DRX-500 with a dual carbon/proton cryoprobe (CPDUL).  13C and 31P NMR spectra 
were registered with broad-band decoupling.  The (+) and (-) designations represent 
positive and negative intensities of signals in 13C DEPT-135 experiments.    
GC/MS analyses were performed on a Shimadzu GC-2010 gas chromatograph 
interfaced to a Shimadzu GCMS 2010S mass selective detector and equipped with an 
AOC-20i auto-injector and an AOC-20S auto-sampler tray (150 vials).  30 m x 0.25 
mm x 0.25 µm capillary column, SHR5XLB, polydimethylsiloxane, 5 % Ph was 
employed.  Helium (99.96 %), additionally purified by passing consecutively through 
a CRS oxygen/moisture/hydrocarbon trap (#202839) and VICI oxygen/moisture trap 
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(P100-1), was used as a carrier gas.  The same model of gas chromatograph, equipped 
with the same auto-injector, FID detector, and J&W CyclosilB column (30 m x 0.25 
mm x 0.25 µm) or J&W CyclodexB column (30 m x 0.25 mm x 0.25 µm) was 
employed for chiral GC analyses.  Hydrogen gas was used as both carrier gas and FID 
fuel; zero-grade air and zero-grade nitrogen were used as an oxidant and make-up 
gas, respectively, for the FID.  All these gases were purified by passing through CRS 
#202839 traps.   
Glassware employed in moisture-free syntheses was flame-dried in vacuum 
prior to use.  Water was purified by dual stage deionization, followed by dual stage 
reverse osmosis.  Anhydrous hexane, dichloromethane, and tetrahydrofuran were 
obtained by passing degassed HPLC-grade commercially available solvents 
consecutively through two columns filled with activated alumina (Innovative 
Technology).  Anhydrous triethylamine was obtained by distillation of ACS-grade 
commercially available materials over calcium hydride in a nitrogen atmosphere.  
Glacial acetic acid was purchased from Acros Organics and used as received.  
Palladium complexes were obtained from Strem Chemicals.  Racemic 
2,2-dibromocyclpopanecarboxylic acid (rac-15) was obtained according to the 
literature procedure.30   All other reagents were purchased from Sigma-Aldrich or 
Acros Organics. 
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1.4.2.  Preparation of the Homochiral Dibromocyclopropylcarboxylic Acid: 
Scale up Procedure 
 
 
Resolution of racemic 2,2-dibromo-1-methylcyclopropanecarboxylic acid 
(rac-15) with (+)-dehydroabiethylamine was performed using previously published 
protocol.31  Our modifications allowed for preparation of large quantities of optically 
active material. (Scheme 15) 
 
Scheme 15. Chiral Resolution of Racemic Dibromoacid 15 
 
 
 
 
Commercially available technical grade (60 % essay) 32  (+)-
dehydroabiethylamine (500 g) was stirred in toluene (2500 mL) at 0 °C, and a 
solution of glacial acetic acid (121 mL) in toluene (1000 mL) was added over 1 hr.  
The solution was stirred for 2.5 hrs at 0 °C and the resulting precipitate was collected 
by suction filtration.  The filter cake was washed with ice-cold toluene (2 x 250 mL) 
and then was air dried.  The waxy off-white solid was re-crystallized from refluxing 
toluene (2000 mL) to obtain acetate as fine colorless needles (yield 429 g, 57 %).  To 
this material dissolved in distilled water (1300 mL) was slowly added a 10 % aqueous 
solution of NaOH (1100 mL).  The resulting solution was stirred for 1 hr in water/ice 
bath, after which the free amine was extracted with ether (3 x 700 mL).  Combined 
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ethereal phases were washed with brine (500 mL), dried with anhydrous K2CO3, 
filtered, and concentrated in vacuum.  After removal of residual solvent in high 
vacuum (<20 µm Hg), pure (+)-dehydroabiethylamine (340 g) was obtained as a 
highly viscous yellow oil, which slowly crystallized upon standing.  This material 
was used in further operations. 
To a stirred hot solution of 2,2-dibromo-1-methylcyclopropanecarboxylic acid 
(rac-15) (317 g, 1.23 mol) in aqueous methanol (water, 310 mL + methanol, 1240 
mL) was added a hot solution of (+)-dehydroabiethylamine (88.8 g, 310 mmol) in 
methanol (1500 mL).  The mixture was stirred for 1 min, until crystals began to 
precipitate.  Then stirring was stopped, the flask was closed and covered with 
insulating blanket to allow slow crystallization (over ca. 8 hrs).  The resulting 
crystalline precipitate was collected by suction filtration; the mother liquor was saved 
for further isolation of the (R)-enantiomer of cyclopropylcarboxylic acid.  The filter 
cake was washed with ice cold methanol (2 x 100 mL) and air dried to provide 207 g 
of salt as white needles.  A second re-crystallization from 90 % aqueous methanol 
(2000 mL) afforded 141 g of crystalline salt, m.p. 209-210 °C.  This material was 
partitioned between 20 % aqueous NaOH (1500 mL) and dichloromethane (500 mL).  
Organic phase was separated; aqueous layer was extracted with dichloromethane (2 x 
500 mL).  Combined organic phases were evaporated to regenerate (+)-dehydro-
abiethylamine, which can be re-used as is without additional purification.  The 
aqueous phase was acidified with 30 % aqueous sulfuric acid and extracted with 
dichloromethane (3 x 500 mL).  The combined organic phases were washed with 
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brine (500 mL), dried with MgSO4, filtered, and concentrated to afford (S)-2,2-
dibromo-1-methylcyclopropanecarboxylic acid ((S)-15) (91 g, 353 mmol, 57 %), m.p. 
62-62.5 °C, ee > 99 % (determined by chiral GC of the corresponding methyl ester). 
The combined mother liquors obtained in the described above crystallizations 
were evaporated.  (+)-Dehydroabiethylamine amine and the acid enriched with the 
(R)-enantiomer was regenerated from the obtained crystalline mass by acid/base 
extraction, analogous to the procedure described above.  The crude acid was slowly 
re-crystallized from hot n-hexane.  The flask was closed and allowed to cool down to 
room temperature.  Crystallization (over ca. 15 hrs at 5 °C) produced a precipitate of 
a nearly racemic acid, which was filtered off.  Evaporation of the mother liquor 
afforded enantiomerically pure (R)-2,2-dibromo-1-methylcyclopropanecarboxylic 
acid ((R)-15) as a yellowish oil, which solidified upon standing.  Yield 87 g, 337 
mmol, 55 %; ee > 99 % (determined by chiral GC of the corresponding methyl ester).   
 
1.4.3.  Installation of the Chiral Dihydrooxazole Moiety 
 
  
(S)-2,2-Dibromo-1-methylcyclopropylcarbonyl chloride, (S)-16: (S)-2,2-
dibromo-1-methylcyclopropanecarboxylic acid ((S)-15) (49.8 g, 193 mmol) and 
freshly distilled thionyl chloride (50 mL) were stirred at room temperature overnight. 
Excess thionyl chloride was distilled off at ambient pressure.  The residue was 
distilled in vacuum, b.p. 57-60 °C (1.7 mm Hg).  Yield 49.9 g (180.5 mmol, 94 %). 
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 (R)-2,2-dibromo-1-methylcyclopropylcarbonyl chloride, (R)-16: was obtained 
using the procedure described above, starting from (R)-2,2-dibromo-1-methyl-
cyclopropanecarboxylic acid ((R)-15).  
 
18: To a stirred solution of (S)-2,2-dibromo-1-methylcyclopropyl-
carbonyl chloride (7.760 g, 28 mmol) in anhydrous methylene 
chloride (75 mL) was added at 0 oC a solution of (R)-
phenylglycinol (3.848 g, 28 mmol) in dry methylene chloride (15 mL), to obtain a 
thick suspension.  Then triethylamine (7.8 mL, 56.1 mmol) was added dropwise at 
0 oC, and the resulting clear solution was warmed to room temperature and stirred for 
3 hrs.  Solvent was removed in vacuum and the residue was partitioned between 
water and EtOAc.  Combined organic extracts were washed consecutively with water 
and brine, dried with MgSO4, filtered, and concentrated to give (1S)-2,2-dibromo-
N[(1R)-2-hydroxy-1-phenylethyl]-1-methylcyclopropanecarboxamide (17) as a white 
crystalline solid (> 95 % pure by NMR).33  This material was dissolved in anhydrous 
dichloromethane (200 mL) and dry triethylamine (6 mL) was added, followed by 
aminomethylpyridine (114 µL).  Mesyl chloride (3.25 mL, 42 mmol) was added 
dropwise at 0 oC, and the remaining dry triethylamine (36 mL) was added in one 
portion.  The mixture was warmed up to room temperature and stirred for 20 hrs, until 
TLC analysis showed complete conversion.  The reaction mixture was quenched with 
10 % aqueous HCl, the organic phase was separated, and the aqueous layer was 
extracted with dichloromethane.  Combined organic extracts were washed 
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consecutively with water and brine, dried with MgSO4, filtered, and concentrated.  
The oily residue was purified by short column chromatography on Silica gel, eluting 
hexane/EtOAc (4:1).  The titled compound 18 was obtained as yellowish oil. Yield 
8.896 g (25.8 mmol, 88 %).  
 
1H NMR (400.13 MHz, CDCl3) δ 7.40-7.37 (m, 2H), 7.33-7.28 (m, 3H), 5.24 (ps.-t, 
J = 10.1 Hz, 9.1 Hz, 1H); 4.75 (dd, J = 10.1 Hz, 8.3 Hz, 1H), 4.18 (ps.t, J = 9.1 Hz, 
8.3 Hz, 1H), 2.54 (d, J = 7.8 Hz, 1H), 1.73 (s, 3H), 1.72 (d, J = 7.8 Hz, 1H);  
13C NMR (100.67 MHz, CDCl3) δ 167.1, 141.5, 128.7 (+, 2C), 127.7 (+), 126.8 
(+, 2C), 75.3 (-), 69.7 (+), 33.3 (-), 31.7, 29.5, 21.3 (+). 
 
 24: Was prepared in a similar manner from 5.62 g (20.3 mmol) 
of (R)-2,2-dibromo-1-methylcyclopropylcarbonyl chloride 
((R)-16) and 2.38 g (20.3 mmol) of (S)-tert-leucinol.  However, 
the cyclization step required heating overnight at 40 oC for complete conversion. 
Purification of final product by preparative column chromatography was performed 
using hexane/EtOAc (4.5:1) as an eluent.  Yield 3.67 g (10.8 mmol, 54 %). 
 
1H NMR (400.13 MHz, CDCl3) δ 4.27 (dd, J = 9.9 Hz, 8.8 Hz, 1H), 4.13 (ps.-t, J = 
8.8 Hz, 8.6 Hz, 1H), 3.87 (dd, J = 9.9 Hz, 8.6 Hz, 1H), 2.43 (d, J = 7.8 Hz, 1H), 1.64 
(d, J = 7.8 Hz, 1H), 1.61 (s, 3H), 0.92 (s, 9H);  13C NMR (100.67 MHz, CDCl3) δ 
165.4, 75.6 (+), 69.2 (-), 33.3 (-), 31.8, 29.7, 25.9 (+, 3C), 21.3 (+). 
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 25:  Was prepared in a similar manner from 4.65 g (16.8 mmol) 
of (S)-2,2-dibromo-1-methylcyclopropylcarbonyl chloride ((S)-
16) and 2.92 g (16.8 mmol) of (R)-phenylglycinol.  Purification of 
final product by preparative column chromatography was performed using 
hexane/EtOAc (2.5:1) as an eluent.  Yield 4.14 g (11.5 mmol, 69 %). 
 
1H NMR (400.13 MHz, CDCl3) δ 7.40-7.26 (m, 5H), 5.25 (dd, J = 10.4 Hz, 9.1 Hz, 
1H), 4.76 (dd, J = 10.4 Hz, 8.6 Hz, 1H), 4.20 (ps.-t, J = 9.1 Hz, 8.6 Hz, 1H), 2.52 (d, 
J = 7.8 Hz, 1H), 1.71 (d, J = 7.8 Hz, 1H), 1.70 (s, 3H);  13C NMR (100.67 MHz, 
CDCl3) δ 167.1, 141.4, 128.5 (+, 2C), 127.5 (+), 126.8 (+, 2C), 75.4 (-), 69.6 (+), 33.0 
(-), 31.6, 29.5, 21.2 (+). 
 
1.4.4.  Diastereoselective Partial Reduction of Dibromocyclopropane 
 
 
Various reducing agents for partial reduction of dibromocyclopropanes into 
bromocyclopropanes were tested.  Depending on the nature of the reducing agent and 
the substitution pattern of the substrate, the reaction can be controlled by steric or 
directing effects, which greatly affects the diastereoselectivity of the reaction.  A 
number of reports demonstrated employment of different alkyllithium reagents,34 
which normally results in predominant formation of trans-bromocyclopropanes35  in 
the case where a suitable directing group is present in the substrate.  In our case, 
employment of tert-BuLi produced the trans- product with very good selectivity 
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(Table 6, entry 1).  Radical hydrodebromination with tin hydride36 (entry 2), as well 
as the titanium-catalyzed reduction with Grignard reagent 37  (entry 3) produced 
equimolar mixtures of isomeric products.  Employment of a more sterically hindered 
hydride source, tris(trimethylsilyl)silane, 38  in the presence of 1,1'-
azobis(cyanocyclohexane) (V-40) as a radical initiator allowed for a significant 
improvement of the diastereoselectivity in favor of the desired cis-product (entry 4).   
Reductions with zinc dust activated by aqueous HCl in ethanol 39  or by glacial 
AcOH 40  were also explored.  While the former protocol produced the required 
monobromide in moderate yield and poor diastereoselectivity (entry 5), the latter 
procedure provided satisfactory results (entry 6).  It was found that reaction 
temperature significantly affected the selectivity, providing the best cis/trans ratio at 
ca. + 5 oC.  Accordingly, this protocol was employed in the ligand synthesis as the 
most selective and cost-efficient method. 
 
Optimization protocol: An oven dried 3 mL Wheaton vial was charged with (4S)-2-
[(1S)-2,2-dibromo-1-methylcyclopropyl]-4-phenyl-4,5-dihydro-1,3-oxazole (25) (100 
mg, 0.28 mmol), followed by an appropriate solvent.  The reducing agent was added 
(see Table 1), and the reaction was stirred for a time indicated in Table 1, until 
GC/MS showed complete conversion of the starting material.  The 
diastereoselectivities were determined by 1H NMR. 
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Table 6. Optimization of the Reaction Conditions for Partial Reduction of 
Dibromocyclopropanes 
 
# Reducing agent Solvent Temperature Time, hrs cis/trans Yield, % 
1 
tBuLi        (1.05 
equiv) 
Et2O -85 - 90 oC 1 1:13 N/D 
2 
Bu3SnH      
(1.01 equiv) 
none r.t. 1 1:1 N/D 
3 
EtMgBr        
(1.1 equiv) 
Ti(OPri)4         
(5 mol %) 
Et2O r.t 1 1:1 N/D 
4 
V-40 (20 mol%) 
TMS3SiH        
(3 equiv) 
pyridine r.t 3 5.3:1 N/D 
5 
Zn (2.5 equiv) 
HCl (10 mol%) 
EtOH r.t. 2 2:1 54 
6 Zn (2.5 equiv) AcOH +5 oC 2 5.3:1 70 
 
 
Diastereomeric (4R)-2-[(1S)-2-bromo-1-methylcyclopropyl]-4-phenyl-4,5-dihydro-
1,3-oxazoles (19 and 19’):  To a stirred at +5 oC solution of (4R)-2-[(1S)-2,2-
dibromo-1-methylcyclopropyl]-4-phenyl-4,5-dihydro-1,3-oxazole (18) (8.90 g, 25.8 
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mmol) in glacial acetic acid (100 mL) was added zinc dust (4.2 g, 64.5 mmol, 2.5 
equiv) in small portions.  The mixture was stirred for 1.5 hr, while the temperature 
was slowly raised to 20 oC. When judged complete by GC/MS, the mixture was 
filtered and concentrated in vacuum.  The residue was dissolved in EtOAc (150 mL), 
washed consecutively with water (2x100 mL) and brine (100 mL), dried with MgSO4, 
filtered, and concentrated.  Preparative column chromatography of the residue on 
Silica gel (eluent hexane/EtOAc 5:1  2:1) afforded two fractions. 
 
19’ minor: Yield 1.13 g (4.0 mmol, 16 %); Rf = 0.37 (hexane-
EtOAc, 4:1); 1H NMR (400.13 MHz, CDCl3) δ 7.39-7.35 (m, 
2H), 7.32-7.28 (m, 1H), 7.26-7.23 (m, 2H), 5.18 (dd, J = 10.1 Hz, 
8.3 Hz, 1H), 4.61 (dd, J = 10.1 Hz, 8.6 Hz, 1H), 4.07 (ps.-t, J = 8.6 Hz, 8.3 Hz, 1H), 
3.62 (dd, J = 8.1 Hz, 5.3 Hz, 1H), 1.91 (dd, J = 8.1 Hz, 6.1 Hz, 1H), 1.63 (s, 3H), 1.10 
(ps.-t, J = 6.1 Hz, 5.3 Hz, 1H);  13C NMR (100.67 MHz, CDCl3) δ 169.1, 142.1, 
128.7 (+, 2C), 127.6 (+), 126.5 (+, 2C), 75.1 (-), 69.7 (+), 28.2 (+), 24.2 (-), 19.5, 18.1 
(+). 
 
19 major: Yield 3.76 g (13.4 mmol, 52 %); Rf = 0.27 (hexane-
EtOAc, 4:1);  1H NMR (400.13 MHz, CDCl3) δ 7.40-7.33 (m, 
4H), 7.32-7.28 (m, 1H), 5.26 (ps.-t, J = 10.1 Hz, 9.1 Hz, 1H), 4.70 
(dd, J = 10.1 Hz, 8.3 Hz, 1H), 4.12 (ps.-t, J = 9.1 Hz, 8.3 Hz, 1H), 3.02 (dd, J = 7.6 
Hz, 5.1 Hz, 1H), 1.88 (dd, J = 6.8 Hz, 5.1 Hz, 1H), 1.51 (s, 3H), 1.33 (dd, J = 7.6 Hz, 
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6.8 Hz, 1H);  13C NMR (100.67 MHz, CDCl3) δ 167.9, 142.0, 128.6 (+, 2C), 127.5 
(+), 126.9 (+, 2C), 74.9 (-), 69.9 (+), 26.0 (+), 21.9 (-), 21.9, 20.8 (+). 
 
26:  Was prepared in a similar manner from 3.67 g (10.8 mmol) 
of (4S)-4-tert-butyl-2-[(1R)-2,2-dibromo-1-methylcyclopropyl]-
4,5-dihydro-1,3-oxazole (24).  Purification of the final product 
by preparative column chromatography was performed using hexane/EtOAc (4:1) as 
eluent.  Yield 1.05 g (4.03 mmol, 37 %). 
 
1H NMR (400.13 MHz, CDCl3) δ 4.23 (dd, J = 10.1 Hz, 8.6 Hz, 1H), 4.08 (ps.-t, J = 
8.6 Hz, 8.3 Hz, 1H), 3.91 (dd, J = 10.1 Hz, 8.3 Hz, 1H), 2.92 (dd, J = 7.6 Hz, 5.1 Hz, 
1H), 1.74 (dd, J = 6.6 Hz, 5.1 Hz, 1H), 1.41 (s, 3H), 1.25 (dd, J = 7.6 Hz, 6.6 Hz, 
1H), 0.92 (s, 9H);  13C NMR (100.67 MHz, CDCl3) δ 166.1, 75.8 (+), 68.3 (-), 33.1, 
25.9 (+, 3C), 22.0, 21.7 (-), 21.0 (+). 
 
27: Was prepared in a similar manner from 4.14 g (11.5 mmol) of 
(4S)-2-[(1S)-2,2-dibromo-1-methylcyclopropyl]-4-phenyl-4,5-
dihydro-1,3-oxazole (26).  Purification of the final product by 
preparative column chromatography was performed using hexane/EtOAc (3:1) as an 
eluent.  Yield 1.92 g (6.86 mmol, 59 %). 
 
1H NMR (400.13 MHz, CDCl3) δ 7.40-7.25 (m, 5H), 5.26 (dd, J = 10.4 Hz, 8.6 Hz, 
1H), 4.71 (dd, J = 10.4 Hz, 8.3 Hz, 1H), 4.17 (ps.t, J = 8.6 Hz, 8.3 Hz, 1H), 3.01 (dd, 
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J = 7.6 Hz, 5.1 Hz, 1H), 1.87 (dd, J = 6.8 Hz, 5.1 Hz, 1H), 1.49 (s, 3H), 1.33 (dd, J = 
7.6 Hz, 6.8 Hz, 1H); 13C NMR (100.67 MHz, CDCl3) δ 167.9, 142.1, 128.5 (+, 2C), 
127.4 (+), 126.8 (+, 2C), 75.2 (-), 70.0 (+), 26.0 (+), 21.9, 21.8 (-), 20.7 (+). 
 
1.4.5.  Installation of the Phosphine Moiety 
 
 
L1:  To a stirred at -80 oC solution of (4R)-2-[(1S,2S)-2-
bromo-1-methylcyclopropyl]-4-phenyl-4,5-dihydro-1,3-
oxazole (19) (2.67 g, 9.52 mmol) in anhydrous THF (25 
mL) was added dropwise a solution of n-BuLi in hexane (2.5M, 4.2 mL, 10.5 mmol).  
The mixture was allowed to warm up to -30 oC (within 0.5 hr), after which di-tert-
butylchlorophosphine (2 mL, 10.53 mmol) was added dropwise, and the resulting 
mixture was stirred for 30 min at room temperature.  The mixture was quenched with 
saturated aqueous solution of NH4Cl (100 mL), and extracted with ether (3 x 50 mL).  
The combined ethereal phases were washed with brine, dried with MgSO4 and 
concentrated.41  Preparative column chromatography was performed in a nitrogen-
filled glove box, using degassed Silica gel and degassed dry solvents 
(hexane/EtOAc/CH2Cl2 10:1:1).  Yield 1.41 g (4.1 mmol, 43 %).   
 
1H NMR (400.13 MHz, C6D6) δ 7.43-7.41 (m, 2H), 7.30-7.27 (m, 2H), 7.21-7.17 (m, 
1H), 5.18 (ps.-t, J = 10.1 Hz, 9.6 Hz, 1H), 4.29 (dd, J = 10.1 Hz, 8.2 Hz, 1H), 3.96 
(dd, J = 9.6 Hz, 8.2 Hz, 1H), 2.02-1.99 (m, 1H), 1.59 (d, 4JPH = 1.8 Hz, 3H), 1.32 (d, 
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3JPH = 4.3 Hz, 9H), 1.29 (d, 3JPH = 4.3 Hz, 9H), 1.01-0.92 (m, 2H);  13C NMR (100.67 
MHz, C6D6) δ 169.8 (d, 3JCP = 2.2 Hz), 143.8, 129.0 (+, 2C), 127.8 (+, 2C), 127.7 (+), 
74.4 (-), 70.8 (+), 32.7 (d, 1JCP = 22.7 Hz), 31.4 (d, 1JCP = 20.5 Hz), 30.7 (d, 2JCP = 
13.2 Hz, +, 3C), 30.4 (d, 2JCP = 13.9 Hz, +, 3C), 23.3, 23.2 (d, 1JCP = 27.1 Hz, +), 
21.2 (d, 2JCP = 8.8 Hz, -), 19.4 (d, 3JCP = 4.4 Hz, +);  31P NMR (161.98 MHz, C6D6) δ 
22.4; αD25 +56.7o (c 1.15, CH2Cl2);  HRMS (TOF ES) Calculated for C21H33NOP 
(M+H) 346.2300, Found 346.2283 (4.9 ppm). 
 
L2: was prepared in a similar manner from 733 mg (2.62 
mmol) of (4R)-2-[(1S,2S)-2-bromo-1-methylcyclopropyl]-4-
phenyl-4,5-dihydro-1,3-oxazole (19).  Purification of the final 
product by preparative column chromatography was performed in a nitrogen-filled 
glove box using degassed Silica gel and CH2Cl2/EtOAc (40:1) as an eluent.  Yield 
200 mg (0.52 mmol, 20 %). 
 
1H NMR (400.13 MHz, C6D6) δ 7.72-7.68 (m, 2H), 7.67-7.63 (m, 2H), 7.29-7.15 (m, 
11H), 5.15 (t, J = 8.3 Hz, 1H), 4.23 (dd, J = 10.1 Hz, 8.3 Hz, 1H), 3.86 (dd, J = 9.6 
Hz, 8.3 Hz, 1H), 1.99 (ddd, 2JPH = 13.1 Hz, J = 7.1 Hz, 4.5 Hz, 1H), 1.62 (d, 4JPH = 
1.5 Hz), 1.48 (ddd, 3JPH = 6.3 Hz, J = 9.1 Hz, 7.1 Hz, 1H), 0.94 (ddd, 3JPH = 7.3 Hz, 
J = 9.1 Hz, 4.5 Hz, 1H);  13C NMR (100.67 MHz, C6D6) δ 169.0 (d, 3JCP = 3.7 Hz), 
143.2, 140.8 (d, 1JCP = 12.5 Hz), 140.3 (d, 1JCP = 13.2 Hz), 133.6 (d, 2JCP = 19.8 Hz, 
+, 2C), 132.2 (d, 2JCP = 17.6 Hz, +, 2C), 128.8 (d, 3JCP = 9.5 Hz, +, 2C), 128.70 (+), 
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128.65 (+), 128.6 (+, 2C), 128.1 (d, 3JCP = 9.5 Hz, +, 2C), 127.3 (+), 127.2 (+, 2C), 
74.5 (-), 70.4 (+), 26.9 (d, 1JCP = 12.4 Hz, +), 23.0 (d, 3JCP = 1.5 Hz, +), 22.3 (d, 
2JCP = 6.6 Hz), 19.1 (d, 2JCP = 11.0 Hz, -); 31P NMR (161.98 MHz, C6D6) δ -9.23;  
αD
25
 -84.7o (c 1.15, CH2Cl2); HRMS (TOF ES) Calculated for C25H24NOPNa 
(M+Na) 408.1493, Found 408.1483 (2.5 ppm). 
 
L3:  was prepared in a similar manner from 840 mg (3.22 
mmol) of (4S)-2-[(1R,2R)-2-bromo-1-methylcyclopropyl]-4-
tert-butyl-4,5-dihydro-1,3-oxazole (26).  Purification of the 
final product by preparative column chromatography was performed in a nitrogen-
filled glove box using degassed Silica gel and hexane/EtOAc (9:1) as an eluent.  
Yield 204 mg (0.63 mmol, 19 %); αD25 -84.0o (c 0.55, CH2Cl2). 
 
1H NMR (400.13 MHz, C6D6) δ 4.02-3.82 (m, 3H), 1.96 (m, 1H), 1.55 (d, 4JPH = 1.5 
Hz, 3H), 1.33 (d, 3JPH = 10.4 Hz, 9H), 1.30 (d, 3JPH = 10.4 Hz, 9H), 1.00 (s, 9H), 
0.97-0.89 (m, 2H); 13C NMR (100.67 MHz, C6D6) δ 168.5, 76.7 (+), 68.5 (-), 33.8, 
32.7 (d, 1JCP = 22.7 Hz), 31.4 (d, 1JCP = 20.5 Hz), 30.7 (d, 2JCP = 13.9 Hz, +, 3C), 30.5 
(d, 2JCP = 14.6 Hz, +, 3C), 26.9 (s, +, 3C), 23.3, 23.0 (d, 1JCP = 27.8 Hz, +), 21.2 (d, 
2JCP = 8.8 Hz, -), 19.2 (d, 3JCP = 3.7 Hz, +); HRMS (TOF ES) Calculated for 
C19H37NOP (M+H) 326.2613, Found 326.2603 (3.1 ppm). 
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L4:  Was prepared in a similar manner from 564 mg (2.0 
mmol) of (4S)-2-[(1S,2S)-2-bromo-1-methylcyclopropyl]-4-
phenyl-4,5-dihydro-1,3-oxazole (27).  Purification of the final 
product by preparative column chromatography was performed in a nitrogen-filled 
glove box using degassed Silica gel and hexane/EtOAc/CH2Cl2 (10:1:1) as an eluent.  
Yield 370 mg (1.07 mmol, 54 %). 
 
 
1H NMR (400.13 MHz, C6D6) δ 7.47-7.45 (m, 2H), 7.32-7.28 (m, 2H), 7.21-7.18 (m, 
1H), 5.14 (dd, J = 10.1 Hz. 8.2 Hz, 1H), 4.35 (dd, J = 10.2 Hz, 8.2 Hz, 1H), 3.90 
(ps.-t, J = 8.2 Hz, 8.0 Hz, 1H), 2.02-1.98 (m, 1H), 1.59 (d, 4JPH = 1.5 Hz, 3H), 1.33 
(d, 3JPH = 8.7 Hz, 9H), 1.31 (d, 3JPH = 8.7 Hz, 9H), 0.99-0.96 (m, 2H);  13C NMR 
(100.67 MHz, C6D6) δ 169.5, 143.7, 128.4 (+, 2C), 127.12 (+), 127.08 (+, 2C), 74.3 
(-), 70.2 (+), 32.2 (d, 1JCP = 22.0 Hz), 30.9 (d, 1JCP = 20.8 Hz), 30.1 (d, 2JCP = 13.3 
Hz, +, 3C), 29.8 (d, 2JCP = 14.4 Hz, +, 3C), 22.8, 22.5 (d, 1JCP = 27.6 Hz, +), 20.5 (d, 
2JCP = 7.6 Hz, -), 19.0 (d, 3JCP = 5.2 Hz, +);  31P NMR (161.98 MHz, C6D6) δ 22.7;  
αD
25
 -80.2o (c 1.15, CH2Cl2); HRMS (TOF ES) Calculated for C21H32NOPNa 
(M+Na) 368.2119, Found 368.2109 (2.7 ppm). 
 
L5: was prepared in a similar manner from 590 mg (2.10 
mmol) of (4S)-2-[(1S,2S)-2-bromo-1-methylcyclopropyl]-4-
phenyl-4,5-dihydro-1,3-oxazole (27) and 539 mg (2.32 mmol, 
1.1 equiv) of dicyclohexylchlorophosphine.  Purification of final product by 
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preparative column chromatography was performed in a nitrogen-filled glove box 
using degassed Silica gel and CH2Cl2/EtOAc (100:1) as an eluent.  Yield 228 mg 
(0.57 mmol, 27 %). 
 
1H NMR (400.13 MHz, C6D6) δ 7.49 (d, J = 7.3 Hz, 2H), 7.31 (d, J = 7.3 Hz, 2H), 
7.19 (d, J = 7.3 Hz, 1H), 5.18 (dd, J = 10.0 Hz, 8.3 Hz, 1H), 4.38 (dd, J = 10.8 Hz, 8.3 
Hz, 1H), 3.93 (t, J =  8.3 Hz, 1H), 2.11-1.70 (m, 12H), 1.59 (s, 3H), 1.54-1.31 (m, 
10H), 1.02-0.92 (m, 2H), 0.84-0.78 (m, 1H);  13C NMR (100.67 MHz, C6D6) δ 169.6 
(d, 3JCP = 2.9 Hz), 143.9, 128.6 (+, 2C), 127.44 (+), 127.40 (+), 127.3 (+), 74.6 (-), 
70.5 (+), 35.1 (d, 1JCP = 13.9 Hz, +), 34.7 (d, 1JCP = 11.7 Hz, +), 31.2 (d, JCP = 16.1 
Hz, -), 30.9 (d, JCP = 17.6 Hz, -), 29.6 (d, JCP = 8.9 Hz, -), 29.5 (d, JCP = 6.6 Hz, -), 
27.9-27.6 (m, -, 5C), 27.0 (d, JCP = 2.9 Hz, -), 23.0 (+), 22.2 (d, 1JCP = 22.0 Hz, +), 
20.0 (d, 2JCP = 7.3 Hz), 18.6 (d, 2JCP = 7.3 Hz, -), 31P NMR (161.98 MHz, C6D6) 
δ -4.02;  αD25 -116.7o (c 1.00, CH2Cl2); HRMS (TOF ES) Calculated for C25H37NOP 
(M+H) 398.2613, Found 398.2604 (2.3 ppm). 
 
L6: was prepared in a similar manner from 666 mg (2.38 
mmol) of (4S)-2-[(1S,2S)-2-bromo-1-methylcyclopropyl]-4-
phenyl-4,5-dihydro-1,3-oxazole (27).  Purification of the final 
product by preparative column chromatography was performed in a nitrogen-filled 
glove box using degassed Silica gel and CH2Cl2/EtOAc (40:1) as an eluent.  Yield 
354 mg (0.92 mmol, 39 %). 
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1H NMR (400.13 MHz, C6D6) δ 7.73-7.64 (m, 4H), 7.44-7.42 (m, 2H), 7.31-7.15 (m, 
9H), 5.07 (dd, J = 10.1 Hz, 8.3 Hz, 1H), 4.27 (dd, J = 10.1 Hz, 8.1 Hz, 1H), 3.85 
(ps.-t, J = 8.3 Hz, 8.1 Hz, 1H), 1.98 (ddd, 2JPH = 12.9 Hz, J = 6.8 Hz, 4.6 Hz, 1H), 
1.58 (d, 4JPH = 1.5 Hz, 3H), 1.46 (ddd, 3JPH = 6.1 Hz, J = 9.1 Hz, 6.8 Hz, 1H), 0.93 
(ddd, 3JPH = 7.3 Hz, J = 9.1 Hz, 4.6 Hz, 1H);  13C NMR (100.67 MHz, C6D6) δ 169.1 
(d, 3JCP = 3.7 Hz), 143.5, 141.0 (d, 1JCP = 11.7 Hz), 140.1 (d, 1JCP = 12.4 Hz), 133.6 
(d, 2JCP = 19.8 Hz, +, 2C), 132.2 (d, 2JCP = 17.6 Hz, +, 2C), 128.8 (d, 3JCP = 8.8 Hz, +, 
2C), 128.7 (d, 3JCP = 10.3 Hz, +, 2C), 128.7 (+), 128.6 (+, 2C), 128.1 (+), 127.4 (+, 
2C), 127.3 (+), 74.7 (-), 70.4 (+), 26.8 (d, 1JCP = 11.7 Hz, +), 22.9 (d, 3JCP = 1.5 Hz, 
+), 22.4 (d, 2JCP = 7.3 Hz), 18.9 (d, 2JCP = 11.0 Hz, -); 31P NMR (161.98 MHz, C6D6) 
δ -9.03; αD25 -178.7o (c 1.25, CH2Cl2); HRMS (TOF ES) Calculated for C25H25NOP 
(M+H) 386.1674, Found 386.1680 (1.6 ppm). 
 
X-Ray crystallography data from Pd(L1) and Pd (L4) complexes are detailed in the 
appendix. 
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Chapter 2.  Asymmetric Hydroformylation of Styrenes 
 
2.1.  Introduction 
 
2.1.1  Rhodium Catalyzed Hydroformylation 
 
Hydroformylation, also known as oxo synthesis, is an important industrial 
process for the direct transformation of olefins into aldehydes. This chemical reaction 
entails the transition metal-catalyzed addition of a formyl group (CHO) and a 
hydrogen atom to a carbon-carbon double bond.42,43  Many of the early examples of 
this process made use of stoichiometric amounts of metals such as cobalt and 
manganese.  Otto Roelen first described his cobalt catalyzed “oxo” reaction toward 
the end of the 1930’s.44  Since the discovery of the reaction, much has been done to 
advance the state of the art of this important process which is still being actively 
investigated by many research groups around the world.   
The first examples of rhodium catalyzed hydroformylations were published 
toward the middle of the 1960’s.45 In these studies, RhCl3 and Rh/Al2O3 showed 
significantly higher catalytic activity under milder conditions than did the analogous 
cobalt catalysts,43 which justified the transition to rhodium catalysis for this class of 
reactions in most of the further applications in spite of the higher cost for Rh-
complexes. 
Hydroformylation was significantly advanced by the discovery that the 
addition of phosphine ligands on the rhodium greatly enhanced the rate and 
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corresponding yields of the reactions.  An early example of utilizing a phosphorus 
containing ligand in rhodium catalyzed hydroformylations is documented in a patent 
issued to the Shell Oil Company in 1966.45  It was noted in this patent that RhCl3 in 
the presence of tributylphosphine gave reasonable conversions of 1-pentene to the 
corresponding aldehydes while a similar system devoid of the phosphine resulted in 
no conversion.  
 Wilkinson was instrumental in bringing rhodium catalysis to the forefront of 
hydroformylation through his discovery that arylphosphine ligands further activate 
the metal and make the process proceed under much milder conditions than were 
previously known.46  
Around the same period that Wilkinson was investigating the effects of 
arylphosphines on hydroformylation, Pruett, a chemist working at Union Carbide, 
found phosphite ligands are also capable of affecting the reaction.47  By varying the 
steric and electronic nature of the phosphites, Pruett was able to fine tune the reaction 
and successfully demonstrated higher conversions in some cases than had been 
previously reported by Wilkinson.  
Pruett’s and Wilkinson’s investigations were primarily focused on different 
classes of monodentate phosphorous-containing ligands.  However, in other metal-
catalyzed processes there was beginning to be a shift away from monodentate ligands 
toward ligands capable of binding to a metal center in multiple coordination sites.  
These new ligands began appearing in processes such as asymmetric hydrogenation, 
but it was not until later that these ligands began to be used in asymmetric 
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hydroformylation.  Many of the bidentate ligands currently used in hydroformylation 
began as hydrogenation ligands.  It was not until the 1980’s that bidentate phosphorus 
ligands became mainstream in rhodium catalyzed hydroformylation. 
2.1.2  Mechanism/Mechanistic Discussion 
 
The general mechanism of rhodium-catalyzed hydroformylation43 is depicted 
in Scheme 16.  The process begins with the coordination of the olefin as an 2η-ligand 
to the rhodium hydride species 28 (LE1), followed by a migratory insertion or 
hydrometallation of the olefin into the metal-hydrogen bond (MI1).  Regiochemistry 
of this migratory insertion determines the outcome of the reaction.  Thus, new 
carbon-metal bond can be installed either at the terminal position of the olefin (path 
A), leading to alkylmetal complex 30, and ultimately to the linear aldehyde. 
Alternatively, installation of metal-carbon bond at the internal position (path B) 
results in formation of complex 34, which provides the branched aldehyde.  
Hydrometallation (MI1) is followed by coordination of a CO-ligand onto the metal 
center (LE2) to form complexes 31 and 35, after which migratory insertion of CO into 
the C-Rh bond (MI2) provides acylrhodium species 32 and 36, respectively.  Insertion 
of the metal into a molecule of H2 (OA) followed by reductive elimination (RE) 
yields the product aldehydes and regenerates the Rh-H active catalyst. 
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Scheme 16.  Mechanism of Hydroformylation 
 
 
 
 
The rate determining step of each one of the pathways depicted in Scheme 16 
has a different rate depending upon the steric environment surrounding the metal 
center.  In the case of pathway A (the linear product), oxidative addition of the metal 
into H2 is significantly more facile than that of the metal species associated with the 
same step in pathway B.  This phenomenon can be explained by the different steric 
environments of the metal in the two key intermediate acyl complexes 33 and 37 
(Scheme 16).  In pathway A, the primary alkyl substituent in species 33 results in a 
significant decrease in the steric environment around the metal center compared to 
complex 37, which possesses a secondary alkyl group.  Accordingly, associative 
process OA, proceeds much faster, when it leads to less sterically hindered species 33 
(path A) compared to a similar process resulting in a more encumbered species 37 
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(path B).  On the other hand, a dissociative process, such as reductive elimination 
(RE), is also sensitive to sterics.  At this step, however, the steric driving force of the 
reaction producing the linear product from species 33 (path A) is lower compared to 
the analogous process, providing branched product from species 37 (path B).  
Accordingly, the kinetic rate of the latter process is higher.  
In addition to changing the steric environments around the metal, the relative 
rates of the reaction can also be controlled by changing the effective concentration of 
either CO or H2 present in the system.  According to the rate equation shown in 
Scheme 17, the rate of the reaction is directly proportional to the partial pressure of 
H2 while it is inversely proportional to the concentration of CO.  This is because 16-
electron acylrhodium complexes 32,36 in the presence of excess CO form 
catalytically inactive 18-electron species 38 (Scheme 17), inhibiting oxidative 
addition of hydrogen (OA).  When a bulky phosphine ligand is present on the metal 
center 39, the slow step of the catalytic cycle becomes the ligand exchange LE1 of a 
CO for the olefin.  This is due primarily to the increased sterics around the metal 
center that comes with the presence of the phosphine ligand.  Also, increased steric 
demand renders the formation of the branched alkylrhodium species 41 unfavorable, 
and the fast reverse β-hydride elimination process shuts down the channel for 
formation of the branched product, resulting in significantly improved regioselectivity 
favoring linear product 40.  For α-olefins possessing allylic C-H bonds, β-hydride 
elimination in an alternative direction is possible, leading to the formation of 
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isomerized internal olefin byproduct, which is inactive in catalytic hydroformylation 
under normal reaction conditions. 
 
Scheme 17.  Relative Rates of Reaction 
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The enantioselectivity of the reaction is governed primarily by steric factors in 
the asymmetric environment created by the chiral ligands bound to the metal center.  
Steric bulk on the metal restricts the orientation in which the substrate coordinates to 
the metal in such a way as to allow a minimum number of favorable diastereomeric 
complexes.  By changing the structure of the ligands on the metal, the chiral pocket 
can be finely tuned to require substrate orientation in a single fashion for each 
iteration of the catalytic cycle resulting in the formation of a single enantiomer.  An 
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example of how the asymmetric control could be realized in Rh-catalyzed 
hydroformylation of styrene in the presence of chiral phosphinoxazoline ligand is 
shown in Figure 2.  The favorable orientation of the olefin substrate in the trigonal 
bipyramidal Rh(I) complex is such that it minimizes any unfavorable steric 
interactions.  The approach of the styrene molecule to the catalytically active rhodium 
species from the North-West (Figure 2, model I), ultimately resulting in the formation 
of linear aldehydes, would be accompanied by significant steric interactions between 
the phenyl ring of the styrene and the aromatic group on the phosphine ligand.  These 
interactions are visualized on the model as a break in the mesh representing the 
solvent accessible surface of the ligand.  In a similar manner, upon North-East 
approach, which would also result in formation of linear product, (Figure 2, model 
II), the steric hindrance is experienced between the phenyl group of the styrene and 
the phenyl substituent on the oxazolidine.  As the result, the amount of linear product 
formed is diminished.  The approach from the South-West (Figure 2, model III), is 
the most favorable, as there is very little unfavorable steric interaction between the 
substrate and the bidentate ligand on the metal, accordingly the (S)-enantiomer of the 
branched product formed from this approach is the major product in the reaction.  
Finally, approach from the South-East (Figure 2, model IV) is accompanied by a 
significantly more unfavorable interaction compared to model III, resulting in 
formation of minute amounts of the branched product with opposite absolute 
configuration (R).  While the example below (Figure 2) on the origins of 
enantioselectivity in this reaction uses a specific oxazolidinone ligand, it is believed 
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the same rationale governs the enantioselectivity of rhodium species in the vast 
majority of catalytically active, bidentate rhodium species used in the 
hydroformylation of olefins. 
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Figure 2.  Enantioinduction in Rh-catalyzed asymmetric hydroformylation reaction in 
the presence of chiral ligands. 
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2.2  Ligands/Accomplishments in Asymmetric Hydroformylation 
 
2.2.1. Phosphine-Phosphites 
 
The members of this class of ligands for asymmetric hydroformylation are the 
highest performing yet discovered.  (R,S)-BINAPHOS 42 (Figure 3) is the current 
benchmark standard in this process as it exhibits not only high selectivity, but is also 
effective on a wide array of substrates making it one of the most useful chiral ligands 
to aid in this transformation.   
 
 
Figure 3.  (R,S)-BINAPHOS 
 
 
A significant advancement in the technology of asymmetric hydroformylation 
was made by Takaya in 1993.48  He synthesized a novel class of phosphine-phosphite 
ligands that revolutionized the way asymmetric hydroformylations were performed.  
Prior to the discovery of (R,S)-BINAPHOS in 1993, the best ee’s from all the known 
rhodium catalyzed asymmetric processes had been no higher than 60 %.42  The ligand 
was extraordinary not only in the ee’s it produces out of the process but also due to  
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the ease of preparation.  Starting from optically active 1,1’-binaphthalene-2-2’-diol 
BINAPHOS can be obtained on a preparative scale in three high yielding steps 
(Scheme 18).  In the seminal paper, asymmetric hydroformylation of a variety of 
substrates ranging from vinyl acetates to substituted styrenes gave ee’s ranging from 
73 – 95 %.48,49 
 
Scheme 18.  Preparation of (R,S)-BINAPHOS 
 
 
A recent trend in the hydroformylation of olefins has been the immobilization 
of the catalyst using polymer bound chiral ligands.  This keeps the catalyst bound to 
the polymer support and facilitates its easy separation and recovery while not 
necessarily adversely affecting the outcome of the reaction.  Hiyama successfully 
bound BINAPHOS to polystyrene linkers to create a polymer bound version of the 
Rh-BINAPHOS catalyst.50  He observed there was little difference when the ligand 
was linked into the polymer in a single place (46, Figure 4) between first complexing 
the metal to the ligand followed by polymerization or in first polymerizing the ligand 
and then complexing the metal to it.  
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Figure 4.  Polymer Bound Ligands 
 
 
The only marked difference came when there were three points of attachment 
between the ligand and polymer 47 (Figure 4).  In that case, where polymerization 
occurred prior to the complexation of the metal, significant loss of enantioselectivity 
was observed.  This is due to the loss of flexibility in the ligand that is tethered in 
three positions.  Since it can no longer flex to reach the optimum orientation with 
respect to the metal center, there is a corresponding decrease in the enantioinduction.  
When the metal is complexed prior to the polymerization of the ligand, there is little 
change in the ee, since the ligand is able to orient itself prior to being incorporated in 
the polymer.  These polymer bound ligands were then applied to solventless 
hydroformylation using vapor phase techniques and the results were promising.  Not 
only were the selectivities in the reaction high, the authors also demonstrated the 
reusability of the catalyst by running subsequent hydroformylation batches with the 
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same catalyst and a variety of olefins.  The drawback to this process is the percent 
conversion.  The branched-to-linear (B:L) ratio is normally high as is the ee, but the 
typical conversions are less than 50 %.51  BINAPHOS has been successfully applied 
in the asymmetric hydroformylation of a wide range of substrates including enol 
ethers.52 
Variations of BINAPHOS have been developed including a class of ligands 
containing perfluorinated alkyl pony tails for the use in supercritical CO2 (scCO2) or 
perfluorinated solvents.  Ligand 48 (Figure 5) gave 73 % conversion with a 91:0 B:L 
and > 82 % ee employing perfluorinated toluene as the solvent.53 
 
 
 
 
Figure 5. 
 
 
The binding orientation of the BINAPHOS to the metal center is one of the 
keys to its success as a chiral ligand.  In 2000, a derivative of BINAPHOS was 
reported (49) in which a remote chiral center was incorporated into an alkyl tether  
(Figure 5).  It was hypothesized that ligand 49 would operate in a fashion similar to 
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BINAPHOS and due to the increased sterics at the remote site could potentially result 
in an enhancement of enantioselectivity.  However, a decrease in the enantioinduction 
of the catalyst was observed, and upon closer inspection it was found to be due to the 
increased sterics of the remote chiral center, the new ligand coordinated to the Rh in 
reverse fashion compared to how BINAPHOS is known to bind.  In the case of the Rh 
complex 50 (Figure 5) formed from ligand 49, the phosphite moiety is bound in the 
equatorial position while the phosphine is bound apically.  The resulting catalytic 
system gave moderate conversions (~ 50 %), moderate B:L ratios (~ 10:1) and 
moderate ee’s (~ 50 %).  This is in direct contrast to BINAPHOS which typically 
gives excellent results.54 
2.2.2.  Diphosphines 
 
One of the interesting phenomena observed with the use of bidentate ligands 
is the effect the ligand bite angle has on not only the regioselectivity of the catalytic 
cycle, but on the enantioselectivity as well.  Whiteker and his colleagues discovered 
there is indeed a documentable relationship between the outcome of the reaction and 
bite angle of the ligand.  They determined ligands with a more flexible backbone, 
allowing for a smaller bite angle, yielded higher branched selectivity and a higher 
enantioselectivity as well, but they also concluded the optimum ligand for each 
process is greatly dependent upon the identity of the substrate itself.55  It has also 
been observed for diphosphine ligands that the selectivity of the reaction is related to 
both the size of the metallacycle formed from the ligand and the metal as well as the 
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concentration of the ligand present in the system.  For ligands forming five-
membered metallacycles it has been observed that a decrease in the concentration of 
the ligand favorably affects the outcome of the reaction, while for ligands forming a 
six-membered cycle the process benefits from an increase in the ligand concentration.  
This difference is believed to arise from the equilibrium established between species 
51 and 52 in Figure 6.  Species of type 51 are known to be present in Rh/P ligand 
systems and they have been characterized for the (S,S)-2,4-
bis(diphenylphosphine)pentane (bdpp) ligand.56  It is believed an excess of additional 
phosphine ligand shifts the equilibrium in favor of 52 which, in turn, makes 
coordination to the olefin significantly more difficult.  Since enantio- and 
regiodifferentiation in the reaction take place at the stage of coordination of the olefin 
substrate, any modifications to the ligand sphere on the metal during this event would 
drastically affect the selectivities of the reaction.  Since its unfavorable sterics would 
prevent coordination of the olefin to a Rh species of type 52, the active species in the 
catalytic cycle in the case of increased phosphine ligand concentration is proposed to 
be 53 where one of the arms of the bidentate ligand has been replaced with another 
phosphine (Figure 6).  Existence of this equilibrium could account for the change in 
selectivity by varying the metal to ligand ratio.57 
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Figure 6. 
 
 
 An example of using a racemic, cationic Rh(I) species in the hydroformylation 
of a variety of olefins is given by Yamamoto.58  His group synthesized racemic ligand 
54 and prepared cationic complex [Rh(nbd)(54)]+ClO4- by mixing 54 with 
Rh(nbd)(acac) in the presence of perchloric acid (Figure 7).   This species was then 
used in the hydroformylation of substituted styrenes and vinylnaphthalenes in high 
yields and high branched to linear ratios.59   
 
 
Figure 7. 
 
Bakos and his group successfully demonstrated the use of a C1-symmetric 
diphosphine ligand 55 in the hydroformylation of styrene.  This reaction afforded a 
branched to linear ratio of 92/8 although their conversions and ee’s were moderate 
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(57 % conv., 47 % ee). 60  An early example of the employment of an achiral 
diphosphine comes from a comparative study between the activity and selectivity of a 
Rh complex from bis(diphenylphosphino)ethane (dppe) to that of an active species 
formed from triphenylphosphine (tpp).  It was determined the complex with dppe 
tended to give lower branched to linear ratios than the analogous tpp complex. A 
build-up of a significant amount of internal olefin by-product in the hydroformylation 
of linear α-olefins in the presence of dppe revealed the ability of the dppe complex to 
promote the isomerization of the alkene.  This was explained by more difficult 
coordination of CO to the metal center in the presence of chelating dppe-ligand; 
moreover, the corresponding sterics-driven β-hydride elimination becomes more 
facile resulting in the formation of isomerized olefinic products.61  
2.2.3.  Phospholanes  
 
This is a class of ligands which has generated a significant amount of interest 
in the last few years.  This is largely due to one member of this class (R,R)-phenyl-
bis-phospholanoethane (Ph-BPE 56, Figure 8).  This ligand was discovered by 
Zanotti-Gerosa, from the Dow Chemical Company and was first reported as an 
asymmetric hydrogenation ligand in 2003.62  In 2005, it was reported to be active in 
the asymmetric hydroformylation of styrenes. 63 , 64   Ph-BPE is one of the few 
challengers which can compete with the numbers chemists have been generating with 
BINAPHOS over the last fifteen years.  This ligand is finding increased use not only 
in the AHF of styrenes and other vinyl arenes, but also with such functionalized 
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alkenes as allyl cyanides and vinyl acetates.  Klosin and co-workers have 
demonstrated the versatility of the ligand by conducting concurrent hydroformylation 
experiments on the mixture of three substrates; styrene, allyl cyanide, and vinyl 
acetate.  Under the conditions they describe, they were successfully able to 
demonstrate the AHF of all three substrates in excellent conversion, B:L ratio and 
ee.65  Due to its high enantioselectivity, substrate scope, and faster kinetic rate than 
BINAPHOS, this is the ligand chosen to be the benchmark for the ligand screening 
experiments described in the coming sections.   
 
 
Figure 8. (R,R,R,R)-Ph-BPE 
 
2.2.4.  Diphosphinites. 
  
This class of ligands has been used in asymmetric hydrogenation 66  and 
hydroboration,67 but only recently has their use in asymmetric hydroformylation been 
evaluated.  While a substantial amount of work has been done to determine the 
potential of this class of ligands, thus far, the demonstrated activities and selectivities 
are inferior when compared to the diphosphine class of ligands. 
Some recent work by Claver has demonstrated the usefulness of chiral 
diphosphinites in the asymmetric hydroformylation of styrenes.  His design is based 
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on using furanoses as modular scaffolds for the preparation of their sugar based 
ligands.  They successfully demonstrated the use of two of these ligands (57,58) on a 
number of different olefins giving moderate yields albeit with quite low 
enantioselectivities.   The outcome of the reaction depended heavily on the nature of 
the substrate.  Thus, with styrene and its derivatives the enantioselectivity of the 
reaction was very poor; however, for vinylnaphthalenes the enantioselectivities 
improved greatly.68  In the case of ligand 59, conversions of substituted styrenes up to 
> 80 % with excellent regioselectivity and ee’s > 78 % were achieved.69   
 
 
Figure 9. 
 
2.2.5.  Diphosphites. 
 
This class of ligand suffers from many of the same drawbacks which plague 
the diphosphinites.  Work done by Sunchi demonstrates diphosphites which are 
tethered together through a binaphthyl type moiety 60 (Figure 10) give excellent 
conversions (> 99 %) and very high branched to linear ratios (> 75 %), albeit with 
marginal enantioselectivities.70      
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Figure 10. 
 
 
Furanoside based diphosphinite ligands originally appeared to offer significant 
advantages over other diphosphinites.  While many phosphinites suffer from low ee’s, 
the furanoside based diphosphite ligand 59 (Figure 9) seems to offer excellent 
conversions, regioselectivity, and respectable ee’s > 78 %.69  Unfortunately, this 
ligand seems to be the exceptional example as a subsequent paper published by the 
same authors included the screening results of fifteen novel furanoside ligands.  All of 
the new ligands paled in comparison to 59.  The authors explained these results based 
on the coordination of the ligands to the metal.  Based on the authors’ observations, 
they determined ligands binding in a bis-equatorial fashion exhibited significantly 
higher ee’s than ligands binding in the equatorial-axial fashion.71   
2.2.6.  P,N-Type Bidentate Ligands 
 
This is a rather broad class of hydroformylation ligands that includes 
aminophosphines, aminophosphine-phosphinites, phosphine-phosphoramidites.  A 
library of nine different P-chiral ligands was synthesized and tested in the AHF of 
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styrene in order to evaluate the effect of bringing the ligand’s center of chirality as 
close to the metal as possible.  It was found that ligand 61 (Figure 11) was able to 
give a B:L of 98:2 and an ee of 75 %.  This is in direct comparison to 
(R,S)-BINAPHOS which under the same reaction conditions was found to yield an ee 
of 92 %.  Complete conversion of the olefin was achieved by allowing longer reaction 
times, and the authors did not note any appreciable deterioration in the final ee of the 
product.72   
 
 
 
Figure 11. 
 
 
An extension of the furanoside chemistry discussed previously (Figure 9) is 
the development of phosphite-phosphoramidite ligands based upon the naturally 
occurring carbohydrate D-(+)-xylose.  These ligands are easily prepared from 
naturally occurring furanosides and the desired chlorophosphines.  This type of ligand 
falls well short of the performance characteristics of the phosphine-phosphite 
furanosides.  The conversions were reasonable at ~ 70 % with excellent B:L ratio 
> 96 %, but the enantioselectivity of this type of ligands is significantly lacking.  The 
highest ee obtained with a ligand of this type was 65 % with a conversion of 12 % 
while the average ee of a reaction with a reasonable conversion was ~ 20 %.73    
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2.2.7.  Applications of asymmetric hydroformylation  
 
There are a number of reasons catalytic, asymmetric hydroformylations have 
become increasingly attractive recently.  One of the biggest drivers behind this surge 
comes from the ability to use this process as a key transformation in the synthesis of 
various non-steroidal anti-inflammatory drugs (NSAIDs).  Such common over the 
counter pain relievers as ketoprofen 62, ibuprofen 63, and naproxen 64 (Figure 12) 
can all be easily synthesized from the hydroformylation of the corresponding vinyl 
arenes followed by the subsequent oxidation of the chiral aldehydes. 
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Figure 12. 
 
AHF is also being used in industry as a method for the synthesis of a number 
of different chemicals which are important to agriculture and fragrances.  Recently, 
AHF was published as a method for obtaining Florhydral® 68.  The investigation 
began by looking at the possibility of selectively hydroformylating only one of the 
olefins in 1,3-diisopropenylbenzene 65 to obtain the aldehyde 66 or in the event of 
dihydroformylation dialdehyde 67.  A mixture of these compounds could potentially 
be reduced to yield the desired product Florhydral® 68 (Scheme 19).   
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Scheme 19. 
 
 
The major challenge associated with the synthetic route outlined in Scheme 19 
proved to be finding a set of conditions to optimize the ratio of the products formed in 
the hydroformylation step.  Due to the presence of two olefins in the substrate 65, the 
catalyst must produce only the monohydroformylated product 66 in preference to the 
dihydroformylated product 67.  This proved to be an insurmountable obstacle and 
resulted in the proposal of a different synthetic route involving the α-methylstyrene 
derivative 70 having only a single olefin. (Scheme 20.)  For the attempted AHF of 70, 
three different ligands were screened, (R)-BINAP and two representative examples of 
the JOSIPHOS class of chiral ferrocenyl diphosphine ligands.  Unfortunately, none of 
the three ligands were able to yield anything higher than a 5 % ee although the yield 
on the transformation was 94 %.74 
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Scheme 20. 
 
 
 
 
Abboud and co-workers have recently published the synthesis of optically 
active isoxazolines and imidazoles obtained from the hydroformylation of 
vinylacetates 71 (Scheme 21).  Using diazophospholane type ligand 72 they 
successfully demonstrated the AHF of vinylacetate with a 94 % conversion, 29:1 B:L 
and 96 % ee in scales up to 180 g.  These chiral aldehydes were then subjected to a 
series of synthetic steps finally yielding the chiral isoxazolines 74 and imidazoles 
75.75  
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Scheme 21.  Synthesis of isoxazoline and imidazoles 
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An example of the usefulness of AHF in the preparation of difficult to access 
biologically active materials is in the synthesis of 1-methylcarbapenem precursors.  
1-methylcarbapenem (Scheme 22) is known to have a variety of different biological 
properties, namely strong anti-bacterial attributes.  It is a member of the β-lactam 
class of antibiotics, one of the most famous of which is penicillin.  One of the first 
attempts to prepare this compound using AHF was done by Nozaki in 1996.76  In that 
paper, they described the synthesis using BINAPHOS which resulted in good 
diastereoselectivity, but the regioselectivity of the reaction (77,78 to 79) Scheme 22 
was rather poor.  Park and co-workers revisited the AHF in an attempt to further 
optimize the process for use in the preparation of 1-methyl carbapenem precursors 
(77,78 Scheme 22).  A number of different ligands were screened and it was found 
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that excellent regio- and diastereoselectivities could be obtained when the ligand was 
(S,S)-bis(diphenylphosphino)pentane ((S,S)-BDPP).  This was an important 
improvement over the results originally obtained by Nozaki as it was also discovered 
that BDPP is useful in catalyzing this transformation and the regioselectivity issues 
which were present in Nozaki’s protocol can be eliminated based upon the choosing 
of the proper chiral ligands.77 
 
Scheme 22. 
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2.2.8.  Conclusions 
 
Asymmetric hydroformylation is a powerful tool for the synthesis of chiral 
aldehydes and their derivatives.  A number of classes of chiral ligands have been 
developed which allow this process to be applicable to a wide array of substrates 
containing many different functional groups.  A lot of effort has been invested into 
the potential of this method to serve as a convenient way to make NSAIDs such as 
those shown in Figure 12.  The ability to convert various olefins into readily 
functionalizable, synthetically useful, biologically active compounds is one of the 
many attractive qualities that have drawn and will continue to draw research efforts 
into this essential process. 
Chiral ligands such as (R,S)-BINAPHOS, a member of the phosphine-
phosphite class of ligands, and (R,R)-Ph-BPE of the phospholane family have 
demonstrated exceptional B:L ratios while providing high yields and very high 
enantioselectivities across numerous different substrates under a wide variety of 
conditions. 
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2.3.  High Throughput Optimization of the Rhodium-Catalyzed Asymmetric 
Hydroformylation of Styrene 
 
2.3.1.  Introduction 
 
 
Catalytic asymmetric hydroformylation (AHF) of olefins is a powerful 
synthetic method allowing for simultaneous installation of a stereogenic center and a 
new C-C bond in a highly atom economic fashion.  Synthesis of chiral aldehydes via 
AHF is very attractive from the standpoint of cost-effectiveness, due to the ready 
availability of olefins as compared to other substrates used in production of 
aldehydes.42,43  However, a number of challenges associated with AHF, such as low 
reaction rates and problems of simultaneous control of regio- and stereoselectivity, 
which thus far have been only partially addressed, 78  significantly limit practical 
application of this method.  Accordingly, a major challenge exists in 
multidimensional optimization of chemo-, diastereo-, and enantioselectivity, as well 
as overall catalyst efficiency (or turnover frequency, TOF), which is usually tackled 
through rational ligand design.  Due to the cost-related issues associated with the 
metals and ligands used in this process, as well as technical requirements for an 
industrial reactor design, it is essential for the transition metal complex to catalyze 
this process efficiently while operating at elevated temperatures and low catalyst 
loadings.  However, in contrast to other transition metal catalyzed asymmetric 
processes, there is general lack of effective and selective chiral ligands suitable for 
AHF.  As it was demonstrated earlier, a few classes of ligands are known to catalyze 
this process and they include: phospholanes (Chapter 2.2.3.),79 phosphinites (Chapter 
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2.2.4.), 80  phosphines (Chapter 2.2.2.), 81  diazophospholine, 82  bis-
diazophospholanes,75,83 phosphine-phosphites (Chapter 2.2.1),84 and phosphite-phos-
phoramidites.73  Unfortunately, most of them are very substrate-specific, which 
necessitates empirical optimization of the catalyst and reaction conditions for every 
given olefin.  From this perspective, a high throughput screening method serves as an 
excellent tool for rapid evaluation of the most promising ligands and optimization of 
the reaction parameters. Along this line, Klosin recently reported the results of 
parallel ligand screening, which led to the discovery of a highly efficient and selective 
catalyst system for AHF of olefins, employing phospholane ligand Ph-BPE 
(83).79,85,86 To intensify the screening routine, an equimolar mixture of three different 
substrates was employed in each run.  While this approach certainly allows 
shortening of the screening time, it does not guarantee that the selectivities obtained 
using mixtures of olefins will be the same as in the reactions with individual alkenes. 
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Figure 13. Chiral Phosphine Ligands Tested in the Asymmetric Hydroformylation of 
Styrenes 
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Indeed, some olefins, especially those possessing functional groups, might act 
as co-solvents or ligands, thereby altering the polarity of the reaction media and the 
coordination sphere of a chiral catalyst.  However, the additive effect on the 
enantioselectivity of hydroformylation has never been systematically investigated.87   
   
2.3.2.  Results and Discussion 
 
 
Accordingly, the primary focus of this work was (1) to develop an express 
screening protocol for the asymmetric hydroformylation reaction that would permit 
quick and efficient assessment of chiral ligand efficacy; and (2) to evaluate the 
influence of various reaction parameters on the AHF of olefins using a single olefin 
substrate.   For our studies we selected asymmetric hydroformylation of styrene (128) 
as a model process (Table 7).  A ten parallel reactor array was used for screening and 
the obtained data were analyzed using an automated GC/MS and a chiral GC.  All 
reactions were stopped at 3 h, which significantly accelerated the screening process 
and permitted direct comparison with literature data.79,85,86  The initial screening 
involved testing 48 different commercially available ligands (Figure 13) known to 
provide high enantioselectivities in the asymmetric hydrogenation88 of olefins  (Table 
7).  The apparent difference between our results on AHF of styrene as a sole substrate 
and Klosin’s data obtained in the analogous runs carried out with a 1:1:1 mixture of 
styrene, vinyl acetate, and allylcyanide (provided in parentheses), is noteworthy.   
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Table 7. Selected Results of Ligand Screening 
 
 
 
No. Liganda ee (%)b X(B)e TOF (h-1)c A 
1 (83) 90 (94) 0.96 (0.98) 759 (740) 656 
2 (86) 61 0.94 187 109 
3 (87) 28 (-24) 0.78 (0.85) 473 (470) 106 
4 (88) 10 (-10) 0.74 (0.87) 220 (150) 17.7 
5 (92) 40 (38) 0.95 (0.95) 606 (450) 231 
6 (95) -42 0.68 251 75.7 
7 (101)d -33 (-44) 0.62 (0.94) 13 (100) 2.84 
8 (104)d -30 (-83) 0.57 (0.92) 54 (150) 10.0 
9 (114) 29 0.77 222 51.4 
10 (124) 32 (-10) 0.87 (0.95) 139 (240) 39.9 
11 (125) 16 (-29) 0.74 (0.81) 505 (190) 61.3 
12 (126) 79 0.93 378 280 
a
 Reaction conditions: Rh(acac)(CO)2 (2.9 µmol, stock solution, 0.05 M), ligand (5.8 µmol), octane 
(internal standard, 2.60 mmol), styrene (8.73 mmol), PhMe (4 mL), syn gas (1:1 CO:H2, 150 psi 
isobaric); 80 °C; 800 rpm stirring rate. b Negative ee’s represent predominant formation of the (S)-
enantiomer. c Literature values given in parentheses (refs 79,85,86). d Used the opposite enantiomer to 
that employed in the comparison literature experiments. e Mol fraction of the branched products. 
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Figure 14. A-values obtained in the ligand screening. 
 
 
Thus, while the outstanding performance of Ph-BPE (83) was essentially 
reproduced (entry 1), another ligand regarded as potent,79 iPr-DUPHOS (104), 
showed only moderate enantioselectivity in our experiments. 89   Remarkably, in 
several cases the opposite enantiomer of the branched aldehyde 129 was obtained in 
our studies (entries 3,4,10,11), compared to that reported by Klosin in his multi-
substrate screening protocol,79,85,86 while using the same enantiomers of the chiral 
ligands.  Conversely, products with the same absolute stereochemistry were obtained 
in some cases using chiral ligands of the opposite configurations to those reported in 
the literature79,85,86 (entries 7,8).  The significant discrepancy between our data and 
the previously reported results strongly suggest involvement of one of the co-
substrates, vinyl acetate or allylcyanide, in the stereodifferentiation step of AHF of 
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styrene in the latter case. This finding prompted us to investigate the solvent effect on 
the selectivity of AHF.  Since three parameters have to be taken into account 
simultaneously (enantioselectivity, mole fraction of branched product, X(B), and 
TOF, see Figure 14 for equation), a single parameter A defined as the product of 
these three values was introduced, which served as criterion for assessing the overall 
ligand efficiency (Figure 14).  Four chiral ligands have been selected for solvent 
screening as leads (86,92,95,126). 90   Three other ligands (101,104,124), which 
provided significantly different enantioselectivities in our hands (Table 7) compared 
to the data obtained in the multisubstrate AHF,79,85,86 were also included in the test.  
The selected series was screened against 14 different solvents (Figure 15).  It was 
found that the solvent nature had indeed a profound effect on the reactivity and 
selectivity of the AHF. Interestingly, several ligands demonstrated improved 
performance in hexane (104,124,126).  However, due to limited solubility of some 
rhodium diphosphine complexes, the effective concentration of catalyst in this solvent 
was affected by other factors, such as reaction temperature and conversion, which led 
to irreproducible results.   
More remarkably, EtOAc appeared to be a superior solvent for many ligands 
tested, providing comparable or higher values of A than those obtained in toluene 
(Figure 15).  Thus, significant improvement of the reaction efficiency was observed 
for Taniaphos (95), (R,R)-iPr-DUPHOS (104), and catASium® d(R) (124) upon 
switching from toluene to EtOAc (A = 139, 253, 171 vs 76, 10, 40, respectively, 
Figure 15).  Notably, the enantioselectivity and X(B) obtained for 104 in EtOAc     
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(ee = 85 %, X(B) = 0.90) were very close to the corresponding values reported by 
Klosin79,85,86 in the AHF of styrene performed in toluene with the olefin mixture (ee = 
83 %, X(B) = 0.92), which may suggest EtOAc and vinyl acetate indeed have a 
similar solvation effect on this hydroformylation catalyst.   
 
 
 
 
Figure 15.  A-values obtained in the solvent screening. 
 
 
The results of solvent screening demonstrated that a single ligand, (R,R,S,S)-
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conditions tested remained moderate.  This discovery of 126 as a good candidate for 
the AHF of styrenes is not completely surprising since it is a structural derivative of 
(R,R,S,S)-TANGPHOS (127) a ligand which has been demonstrated to be very active 
the AHF of olefins.91 The discrepancies between the numbers that were obtained in 
this study for 127 versus what has been published can be attributed to a difference in 
the ligand to Rh ratio under our screening conditions.  It has been demonstrated that 
for small, electron rich diphosphines, an increase in the ligand to Rh ratio can have a 
detrimental effect on the selectivity of the catalytically active species.86 
With the best ligand-solvent combinations in hand, we investigated whether 
the efficiency of the AHF catalyzed by Rh-126 complex could be further improved by 
adjusting the reaction temperature (Table 8).92  Screening of this catalyst system in 
toluene and EtOAc93 in the range from 50 to 110 °C revealed a similar temperature 
profile for both solvents (Table 8).  Thus, a significant improvement in branched-to-
linear ratios, but dramatically decreased reaction rates were observed in AHF in these 
solvents at low temperatures. In contrast, the enantioselectivities remained essentially 
unchanged within a wide temperature range and deteriorated only slightly above 
95 °C (Table 8). At the same time, the reaction rates reached practical values at 
temperatures above 80 °C,94 and nearly complete conversions were observed after 3 h 
at 110 °C in both solvents (entries 5,10).  Although the reactions in EtOAc were 
somewhat more sluggish than in toluene, the corresponding ee’s and branched-to-
linear ratios were higher in the former solvent (Table 8). 
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 Table 8. Results of Temperature Screening 
 
 
 
 
 
(R,R,S,S)-Duanphos (126) in EtOAc 
No. T,°Ca 
%ee x(B) Conv., % TOF, h-1 A, h-1 
1 50 87 0.954 1.3 13 10.8 
2 65 86 0.943 7.2 72 58.4 
3 80 82 0.930 26.3 263 201 
4 95 82 0.904 58.3 583 432 
5 110 68 0.818 96.8 968 538 
(R,R,S,S)-Duanphos (126) in toluene 
6 50 78 0.935 2.0 20 14.6 
7 65 80 0.940 8.9 89 66.9 
8 80 79 0.930 37.8 378 278 
9 95 71 0.888 78.7 787 496 
10 110 62 0.815 99.2 992 501 
a
 Reaction conditions: Rh(acac)(CO)2 (2.9 µmol, stock solution, 0.05 M), ligand (5.8 µmol), octane 
(internal standard, 2.60 mmol), styrene (8.73 mmol), solvent (4 M), syn gas (1:1 CO:H2, 150 psi, 
constant supply), 800 rpm stirring rate, 3 hrs.  
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Once the high-throughput screening routine described above was developed, we 
decided to investigate the effects of substituents in the aromatic ring system on the 
reaction performance and selectivity.  A unique feature of our high throughput 
screening method is the ability to screen multiple ligands side by side in the same 
process and obtain all the results simultaneously.  This cuts down on any 
inconsistencies which can potentially arise from running ligands in different batches 
at different points in time.  It also allows for much faster generation and comparison 
of data as all of the reactions are completed at the same time and are quickly ready for 
analysis.  For the investigation of substrate scope, we screened a variety of substituted 
styrenes.  We were looking to directly compare the activity of two ligands: Ph-BPE 
(83), the benchmark ligand for this study, and DUANPHOS (126), the closest 
competitor as determined from earlier optimization studies.  The optimized conditions 
for (83), reported by Klosin, and the conditions found within this study for (126) were 
used.  The results are summarized in Table 9.  It was determined in reactions 
catalyzed by BPE-complexes, substituents in the ortho-position of the ring yield 
higher ee’s than the same substituents placed at other locations on the ring.  This 
could possibly arise from an increase in steric interactions between the aryl rings of 
the ligand and the substituent, thereby increasing the enantioselectivity of the reaction 
(Table 9 entries 2,4,7,12).  Strongly electron withdrawing groups such as NO2 
(entry 11) drastically decrease the yield of the reaction while still maintaining a 
reasonably high ee’s.  This most likely results from the inability of the metal to 
efficiently insert into the electron deficient olefin at the beginning of the catalytic 
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cycle, dramatically decreasing the rate and subsequent conversion of the reaction.  It 
was also found that (126) gave very similar yields regardless of the substituent on the 
aryl ring, but in all cases the B:L of the product was not as high as that obtained for 
Ph-BPE.  The ee’s of the reactions were also very similar with some notable 
exceptions.  When the substituent was 4-Cl or 4-OMe, (126) gave slightly higher ee’s 
than Ph-BPE (Table 9 entries 5,8) and when the substituent was 4-F, (126) gave a 
racemic mixture.  When substituents on the aryl ring were methyl or tert-butyl 
(entries 9,12), there was very little difference in either the activity or 
enantioselectivity of the catalysts.  However, placing fluorine in either the ortho- or 
para- position resulted in higher yields and significantly higher ee’s from (83) 
(entries 2,3).  That was reversed when the substituents were either a chlorine or 
methoxy group in the para position (entries 5,8).  The reason for this phenomenon is 
not clearly understood, and further investigations are ongoing in our laboratories.  It 
was generally determined that (83) is the ligand of choice for a wide variety of 
substrates, but it was discovered that through careful optimization of the reaction 
conditions, it is possible to further enhance the selectivity of ligands that may have 
been previously overlooked in the AHF of olefins. 
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Table 9.  (R,R)-Ph-BPE vs. (R,R,S,S)-DUANPhos Substituted Styrenes Results 
 
 
No. R NMR Yield (%) B:L %ee Yield (%)c,d 
1 H >99 (28) 22:1 (12:1) 90 (79) 64a (N/D) 
2 2-F 99 (46) 15:1 (1:1) >99 (N/D) 84 (N/D) 
3 4-F 93 (>99) 16:1 (4:1) 74 (0) 85 (87) 
4 2-Cl >99 156:1 89 96 
5 4-Cl 99 (99) 6:1 (5:1) 38 (81) 99 (99) 
6 3-OMe >99 20:1 N/Db 99 
7 2-OMe >99 (>99) 8:1 (0.66:1) 80 (N/D) 96 (N/D) 
8 4-OMe >99 (>99) 10:1 (3:1) 68 (88) 96 (94) 
9 4-tBu >99 (99) 4:1 (2:1) >99 (94) >99 (91) 
10 4-CF3 >99 8:1 20 90 
11 4-NO2 28 7:1 97 <12 
12 2-CH3 >99 (99) 17:1 (1:1) 81 (83) 93 (92) 
13 3-CH3 >99 44:1 N/Db 90 
14 4-CH3 >99 (99) 36:1 (1:1) 81 (N/D) 95 (N/D) 
15 4-iBu >99 7:1 60 97 
16 
6-MeO-2-
Naph 
>99 8:1 N/Db 99 
a
 This isolation has not been optimized.  b Unable to separate enantiomers via chiral GC. c Isolated 
Yield. d Data shown in parenthesis represent DUANPHOS catalyzed reactions. 
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2.3.2. Conclusions 
 
In conclusion, application of the high throughput technique to ligand 
screening and optimization of the reaction conditions of the Rh-catalyzed asymmetric 
hydroformylation of styrene was demonstrated.  Direct comparison of the obtained 
data with the previously reported results of multi-substrate AHF screening reveals a 
number of discrepancies putatively arising from interference of functionalized co-
substrates with some of the chiral catalyst systems. Although not comprehensive by 
any means, the described screening protocol allowed express analysis of a large series 
of chiral ligands, which led to the discovery of a novel efficient catalyst system, 
[Rh(CO)2acac]-Duanphos, for the asymmetric hydroformylation of styrene, and 
highlighted the dramatic effect of reaction conditions on the efficiency of the AHF.  
 
2.4.  Experimental 
 
High Throughput Optimization of the Rhodium-Catalyzed Asymmetric 
Hydroformylation of Styrenes 
 
2.4.1.  General Information 
 
 
See Chapter 1.4.1. for instrumentation details. 
 
 Anhydrous hexane, dichloromethane, toluene, diethyl ether, tetrahydrofuran, 
and acetonitrile were obtained by passing degassed HPLC-grade commercially 
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available solvents consecutively through two columns with activated alumina 
(Innovative Technology).  Anhydrous benzene, chlorobenzene, and carbon 
tetrachloride were obtained by distillation of ACS-grade commercially available 
materials over calcium hydride in a nitrogen atmosphere.  Anhydrous chloroform and 
EtOAc were obtained by drying ACS-grade commercially available solvents over 
activated 4Å molecular sieves. All manually dried solvents were degassed using a N2 
spurge. Anhydrous dimethylformamide, dimethylacetamide, 1,2-dichloroethane, and 
dimethylsulfoxide were purchased form Sigma-Aldrich or Acros Organics and used 
as received.  The Rh(CO)2(acac) complex and chiral ligands were obtained from 
Strem Chemicals and Solvias.  Styrene was purchased from Sigma-Aldrich. 
 All materials were handled in nitrogen-filled glovebox (< 8 ppm residual 
oxygen and moisture). 
 
2.4.2.  Special Equipment 
 
 
Ten reactions were run concurrently in a BarnStead RS10 ten cell control unit.  
This unit allows for individual programming and control of heating and stirring 
regimens in all reaction vessels.  The pressure vessels used were custom-made by 
Parr Instrument and were obtained from BarnStead.  Each pressure vessel is made 
from stainless steel, has a total reactor volume of 10 mL (8mL if using the optional 
glass liners), and is rated to a maximum pressure of 2000 psi at 150 °C.  The pressure 
in the vessel can be monitored by an analog pressure gauge which is mounted to the 
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top of each pressure vessel.  The ten vessels were attached to a high-pressure 
manifold which facilitates the delivery of the syn gas into the system by means of a 
quick disconnect valve stem.  The construction of this manifold including technical 
drawings is detailed in the following section. 
 
 
Figure 16. Barnstead RS10 Reactor 
 
2.4.3.  Synthesis Gas Manifold Construction 
 
 
All of the parts used in the construction of this manifold are made from 
stainless steel and are obtainable from Swagelok.  (The following CAD drawing 
shows the various pieces needed for construction Figure 17): 
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Figure 17.  Synthesis Gas Delivery Manifold 
 
 
Part numbers for the labeled pieces are provided in bold and the numbers of pieces 
needed for construction have been place in parenthesis. 
 
(A)  SS-QC4-B-4PM; Quick connect body 0.2 CV, 1/4" male NPT (10); 
(B)  SS-TH4PF4PF4; PTFE-Lined stainless braided hose 1/4" female NPT fittings 
3/16" hose, 24" long (10); 
(C)  SS-4-mt; Male tee, 1/4" NPT (5); 
(D)  SS-400-7-4; 1/4" female NPT, 1/4" tube OD Swagelok tube fitting adapter (1); 
(E)  SS-4-st; tee 1/4" female NPT, 1/4" male NPT, 1/4" female NPT (4). 
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This manifold is designed to attach to a standard ¼” OD soft copper tubing.  It 
should be noted that using this manifold does not allow for individual control of the 
syn gas pressure in each pressure vessel since the overall pressure of the system is set 
using a pressure regulator attached to the syn gas tank. 
 
2.4.4.  General Procedure for Ligand Screening 
 
 
For the ligand screening procedure all of the reactor vessels were loaded in a 
glovebox under a N2 atmosphere.  The optional glass liners were used in each of the 
pressure vessels and were found to double nicely as weighing vials.  To each of the 
glass liners was added 5.82 µmol of ligand and 2.91 µmol of the Rh source (58 µL of 
a 0.05 molar Rh(acac)(CO)2 stock solution in toluene)95 followed by 3.5 mL of dry 
toluene and 423 µL (2.60 mmol) of octane as an internal standard. Styrene (1 mL, 
8.73 mmol) was then added to give a total vessel volume of ~ 4.5 mL and a substrate 
to catalyst ratio of 3000:1.  The vessels were removed from the glove box and placed 
in the RS10 unit.  The reactions were stirred at 800 rpm and heated to 80 °C for three 
hours.  A constant supply of syn gas (1:1 H2:CO) was provided through the manifold 
at a pressure of 150 psi.  After three hours the temperature was crashed to 15 oC and 
the vessels were vented and opened (after this point all the operations were performed 
in air).  Aliquots (5 µL) were taken from the crude reaction mixtures and dissolved in 
dichloromethane (1 mL) for GC/MS and chiral GC analysis. 
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2.4.5.  Analytical Procedure 
 
 
Yields of hydroformylation and branched-to-linear ratios were determined by 
quantitative high throughput GC/MS analysis.  The temperature of the oven was 
started at 50 °C held for two minutes then ramped to 200 °C at a rate of 20 °C/min.  
The flow rate through the column was 0.68 mL/min with a constant linear velocity of 
29.9 cm/sec.  Total flow rate for the system was 15.3 ml/min with a 20:1 split ratio.  
The following parameters were set: injector temperature 275 oC, MS interface 
temperature 275 oC, and ion source temperature 225 oC.  To accelerate the analytical 
sequence, the length of each run was limited to 9.5 minutes.  To remove heavy 
materials from the analytical column, after every 10 runs a conditioning program was 
performed (20 minutes heating to 320 oC, MS acquisition turned off).  Quantitative 
measurements were performed based on 7-point TIC calibration curve vs n-octane as 
internal standard (Figure 18).  TIC integration was performed in automatic mode 
(max number of peaks: 12; peak width: 2 sec; max height: 0) using the batch 
processing option, integrated in Shimadzu’s GCMS Solution suite.96  Components 
were identified using NIST05 Mass-Spec Library,97 and independently by comparison 
with GC/MS data of authentic samples, purchased from Sigma-Aldrich.  A typical 
chromatogram shows the retention times, integration parameters and NIST library 
search results for the major components in crude reaction mixture. 
Enantioselectivities were assessed by quantitative GC on a J&W CyclosilB chiral 
column.  Baseline separation was achieved using a 75 oC isothermic program.  The 
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flow rate through the column was 1.19 ml/min with a constant linear velocity of 30.0 
cm/sec.  Total flow rate for the system was 27.9 mL/min with a 20:1 split ratio.  To 
save time, the method of overlapping GC runs was employed.  The interval between 
automatic injections was set for 40 min, i.e. each new analysis was beginning shortly 
after both enantiomers of the branched products were coming out of the column.  
Under these conditions, the elution of linear isomer was observed at the beginning of 
the next run.  A typical chromatogram is depicted in Figure 20.   
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Figure 18.  GC/MS calibration data for Styrene (starting material), Ethylbenzene 
(reduction product), Phenylpropanal (linear product), and 
α-Methylphenylacetaldehyde (branched product) vs n-Octane. 
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Peak 
# 
R. 
Time 
I. 
Time 
F. 
Time 
Area %Area Compound 
1 4.081 4.048 4.12 270172 15.31 Octane 
2 4.957 4.94 4.978 2238 0.13 Ethylbenzene 
3 5.368 5.33 5.413 1103733 62.53 Styrene 
4 7.577 7.547 7.613 285488 16.18 
Benzeneacetaldehyde, 
α-methyl- 
5 8.135 8.107 8.168 103286 5.85 Benzenepropanal 
 
Figure 19. Typical TIC trace, integration and NIST library search report obtained in 
high throughput GC/MS analysis of crude reaction mixtures in the asymmetric 
hydroformylation reaction. 
 
  
91 
2.5 5.0 7.5 10.0 12.5 15.0 17.5 20.0 22.5 25.0 27.5 30.0 32.5 35.0 37.5 min-0.50
-0.25
0.00
0.25
0.50
0.75
1.00
1.25
1.50
1.75
2.00
2.25
2.50
2.75
3.00
3.25
3.50
3.75
4.00
4.25
4.50
4.75
5.00 uV (x10,000)
 
 
Figure 20. A typical chiral chromatogram with integration showing the % ee of the 
branched aldehydes and the linear aldehyde from the previous run. 
35.25 35.50 35.75 36.00 36.25 36.50 36.75 37.00 37.25 37.50 37.75 38.00 38.25 38.50 38.75 39.00 min
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
1.1
1.2
1.3
1.4
1.5
uV(x10,000)
 Chromatogram
67
90
9
34
50
16
Linear aldehyde from 
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Table 10. Results for General Ligand Screening 
 
Ligand ee,c,d % x(B) TOF, h-1 A, h-1 
(R)-BINAP (80)86 -3(28) 0.444(0.911) 66(80) 0.88(20.4) 
(R)-Tol-BINAP (81) 1 0.444 89 0.40 
(R)-Xylyl-BINAP (82) 3 0.583 389 6.80 
(R,R)-Ph-BPE (83)86 90(94) 0.959(0.978) 761(740) 657(680) 
(R,R)-Me-BPE (84)63 2(-43) 0.524(0.933) 66(80) 0.69(32.1) 
(R,R)-Et-BPE (85)63 14(52) 0.756(0.919) 290(100) 30.7(50.5) 
catASium m(R) (86) 61 0.939 190 109 
SL-M001-1 (87)86 20(-24) 0.778(0.848) 486(470) 106(95.7) 
SL-M004-1 (88)86 10(-10) 0.737(0.868) 240(150) 17.7(13.0) 
SL-J001-1 (89)86 -2(39) 0.583(0.922) 157(140) 1.83(50.3) 
SL-J002-1 (90)86 -4(43) 0.474(0.844) 23(50) 0.44(18.1) 
SL-J003-1 (91)86 0(-47) 0.000(0.844) 1(30) 0(11.9) 
SL-J005-1 (92)86 40(38) 0.949(0.952) 609(450) 231(162) 
SL-W001-1 (93)86 27(44) 0.565(0.706) 743(980) 113(304) 
SL-W002-1 (94) -3 0.677 550 11.2 
SL-T001-1 (95) -42 0.677 266 75.7 
SL-T002-1 (96) 3 0.762 294 6.72 
(S)-Phanephos (97) -14 0.744 325 33.8 
CTH-(S)-Xylylphanephos (98) -8 0.600 116 5.57 
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Table 10. Continued 
CTH-(R)-P-Phos (99) 7 0.500 51 1.79 
CTH-(R)-Xylyl-P-Phos (100)86 17(-8) 0.600(0.898) 81(270) 8.26(19.4) 
(S,S)-Me-DUPHOS 
(101)63,(R,R)a 
-33(-44) 0.615(0.940) 14(100) 2.84(41.4) 
(S,S)-Et-DUPHOS (102)63,(R,R),a -5(-52) 0.615(0.932) 126(140) 3.88(67.8) 
Rhophos SL-P001-2 (103) 0 0 15 0 
(R,R)-(iPr)-
DUPHOS (104)63,(S,S),a 
-30(-83) 0.565(0.919) 59(150) 10.0(114) 
(R,R)-NORPHOS (105)86 6(-17) 0.750(0.940) 179(230) 8.06(36.8) 
(R)- catASium T2 (106)86 18(-26) 0.875(0.897) 309(120) 48.7(28.0) 
(S,S)-CHIRAPHOS (107)57,86 -12(2) 0.722(0.941) 352(50) 30.5(0.94) 
CARBOPHOS (108)86 2(-6) 0.629(0.859) 583(610) 7.34(31.4) 
(R)-(iPr)-PHOX (109) 1 0.920 153 1.41 
CTH-(R)-BINAM (110)86 -5(2) 0.667(0.677) 171(120) 5.70(1.62) 
(R)-SYNPHOS (111) 20 0.919 86 15.8 
(R)-SOLPHOS (112) 4 0.807 120 3.88 
(R)-Xylyl-SOLPHOS (113) 18 0.892 48 7.71 
(R)-DIFLUOROPHOS (114) 29 0.767 231 51.4 
SL-A101-1 (115) 21 0.882 68 12.6 
SL-A109-1 (116) 0 0.697 527 0 
(R)-Cl-MeO-BIPHEP (117) 14 0.923 242 31.3 
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Table 10.  Continued     
(R)-C3-TUNEPHOS (118)86 2(-19) 0.444(0.917) 70(80) 0.622(13.9) 
CTH-(R)-SPIRO-P (119)86 7(-14) 0.583(0.667) 261(400) 10.7(37.6) 
(R)-SDP (120) -2 0.545 123 1.34 
(S)-BINAPINE (121)86 21(-94) 0.697(0.905) 363(120) 53.1(102) 
(S)-BINAPHANE (122) -16 0.600 31 2.98 
(R,R)-DIOP (123)86 ,(S,S),a -8(13) 0.565(0.600) 150(480) 6.78(37.4) 
catASium D(R) (124)86 32(-10) 0.872(0.949) 143(240) 39.9(22.8) 
catASium I(R) (125)86 16(-29) 0.737(0.808) 520(190) 61.3(44.5) 
(S,S,R,R)-DUANPHOS (126) 79 0.956 383 280 
(S,S,R,R)-TANGPHOS 
(127)86,b 
21(65) 0.600(0.937) 42(100) 5.29(60.9) 
 
a
 Absolute configuration of the corresponding ligand employed in the multi-substrate screening.  b The 
ratio of ligand to Rh described in this reference is 1.2:1 which differs from the 2:1 loading that was 
used in this study as dictated by the optimum conditions for the benchmark ligand 4.  This could 
account for the significant difference in efficacy as compared to the literature data.  c Negative ee’s 
represent predominant formation of the (S)-enantiomer. d Data shown in parenthesis represent 
DUANPHOS catalyzed reactions. 
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2.4.6.  General Procedure for Solvent Screening 
 
 
All reactor vessels were loaded in the glove box under an inert atmosphere.  
The stock solution of Rh(acac)(CO)2 (0.05 M) was prepared in the solvent to be used 
in the screening run. The remaining parameters were the same as previously 
described in the general reaction conditions outlined above with the exception of 
substituting the solvent to be screened in the place of PhMe used in the general 
procedure. 
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2.4.7.  Results of the Solvent Screening Procedure 
 
 
 
Table 11.  Results of Solvent Screening 
 
SL-T001-1 (95) SL-J005-1 (92) 
No. Solvent 
%ee X(B) TOF, h-1 
A, h-
1
 
%ee X(B) TOF, h-1 A, h-1 
1 THF -53 0.833 22 9.71 -2 0.947 12 0.227 
2 DCM -77 0.949 43 31.4 32 0.972 205 63.8 
3 Et2O 0 0.565 21 0 0 0.792 8 0 
4 Hex -57 0.961 28 15.3 44 0.982 154 66.5 
5 DMA -21 0.836 31 5.44 5 0.969 139 6.73 
6 DMF -65 0.875 57 32.4 21 0.954 159 31.9 
7 MeCN 0 0.500 56 0 5 0.971 35 1.70 
8 DMSO -63 0.767 37 17.9 22 0.973 194 41.5 
9 PhCl -68 0.767 30 15.7 2 0.444 37 0.33 
10 CCl4 0 0 0 0 0 0 0 0 
11 PhH -73 0.808 139 82.0 -3 0.655 442 8.69 
12 DCE -70 0.821 18 10.4 0 0 0 0 
13 EtOAc -76 0.815 225 139 38 0.912 437 151 
14 CHCl3 -78 0.756 83 48.9 0 0 0 0 
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Table 11. Continued 
 
catASium m(R) (86) catASium d(R) (124) 
No. Solvent 
%ee X(B) TOF, h-1 A, h-1 %ee X(B) TOF, h-1 A, h-1 
15 THF 3 0.500 22 0.33 20 0.744 76 11.3 
16 DCM 0 0.474 102 0 35 0.946 114 37.8 
17 Et2O 0 0.474 10 0 36 0.714 22 5.66 
18 Hex 0 0.500 68 0 44 0.944 431 179 
19 DMA -2 0.706 16 0.23 1 0.954 151 1.44 
20 DMF 6 0.821 67 3.30 1 0.957 205 1.96 
21 MeCN 19 0.697 15 1.99 4 0.976 80 3.12 
22 DMSO 62 0.950 102 60.1 1 0.968 84 0.81 
23 PhCl 3 0.474 23 0.33 17 0.565 43 4.13 
24 CCl4 0 0 0 0 0 0 0 0 
25 PhH 4 0.474 31 0.59 29 0.744 147 31.7 
26 DCE -3 0.444 22 0.29 36 0 9 0 
27 EtOAc 1 0.583 166 0.97 42 0.938 435 171 
28 CHCl3 0 0.583 7 0 49 0.951 14 6.52 
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Table 11. Continued 
 
(R)-Difluorophos  (114) (S,S,R,R)-DUANPHOS (126) 
No. Solvent %e
e 
X(B) TOF, h-1 A, h-1 %ee X(B) TOF, h-1 A, h-1 
29 THF 3 0.474 54 0.77 7 0.583 86 3.51 
30 DCM 34 0.895 205 62.4 79 0.926 208 152 
31 Et2O 0 0.444 7 0 0 0.500 13 0 
32 Hex 18 0.744 299 40.0 80 0.917 392 287 
33 DMA 7 0.643 26 1.17 7 0.930 123 8.00 
34 DMF 16 0.851 82 11.2 2 0.944 83 1.57 
35 MeCN 24 0.878 46 9.69 34 0.818 109 30.3 
36 DMSO 29 0.926 164 44.0 0 0.969 31 0 
37 PhCl 6 0.444 79 2.11 28 0.524 60 8.80 
38 CCl4 0 0 0 0 0 0 0 0 
39 PhH 35 0.877 183 56.1 38 0.600 127 29.0 
40 DCE 18 0.545 69 6.77 83 0.929 30 23.1 
41 EtOAc 4 0.677 404 11.0 82 0.925 256 194 
42 CHCl3 39 0.907 10.4 36.8 0 0 1 0 
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Table 11. Continued 
 
 
(R,R)-iPr-DUPHOS (104) (S,S)-Me-DUPHOS (101) 
No. Solvent 
%ee X(B) TOF, h-1 A, h-1 %ee X(B) TOF, h-1 A, h-1 
43 THF -33 0.545 38 6.84 -40 0.706 86 16.1 
44 DCM -67 0.921 144 88.8 0 0 208 0 
45 Et2O 0 0.583 9 0 -40 0.583 13 5.37 
46 Hex -81 0.915 273 202 -9 0.941 392 13.0 
47 DMA -24 0.859 34 7.01 9 0 123 0 
48 DMF -13 0.933 76 9.22 1 0 83 0 
49 MeCN -52 0.970 18 9.08 0 0 109 0 
50 DMSO -25 0.991 222 55.0 0 0 31 0 
51 PhCl -29 0.565 43 7.05 0 0 60 0 
52 CCl4 0 0 0 0.00 0 0 0 0 
53 PhH -67 0.825 66 36.5 -70 0.961 127 31.6 
54 DCE -82 0 6 0 0 0 30 0 
55 EtOAc -85 0.901 331 253 -13 0.939 256 24.3 
56 CHCl3 0 0 0 0 0 0 1 0 
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2.4.8.  Typical Procedure for Temperature Screening 
 
 
All reactor vessels were loaded in a glove box under an inert atmosphere.  The 
stock solution of Rh(acac)(CO)2 (0.05 M) was prepared in EtOAc.  Five reactor 
vessels were loaded with the same amount of material as described in the general 
procedure section, employing (R,R,S,S)-Duanphos (126) as a ligand.  They were then 
run at 15 °C increments in a range from 50 °C to 110 °C for 3 hours at a stirring 
speed of 800 rpm.  After 3 hours the reactions were worked up and analyzed 
according to the general procedure method. 
 
 
2.4.9.  Typical Preparative Procedure  
 
 
 
13498: In a glove box under an atmosphere of N2 a stock solution of 
0.05 M Rh(acac)CO2 was prepared (12.9 mg of Rh(acac)CO2 in 1 
mL of dry PhMe) and was allowed to stir at room temperature overnight.  In a glove 
box under N2 to one of the 8 mL glass inserts for the Parr stainless steel reactors was 
added 5.67 mg (11.0 µmol) of (R,R)Ph-BPE followed by 58 µL of the 0.05M Rh 
stock solution (5.59 µmol).  Upon mixing the evolution of CO gas was observed.  
This was diluted with 3.5 mL of dry PhMe, and 1 mL (1.025 g, 8.39 mmol) of o-
fluorostyrene was added and the vessel was placed into the reactor and sealed.  The 
reactor was placed into the Barnstead RS10 stirring unit and hooked to the gas 
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manifold. It was charged with 150 psi of syn gas (H2/CO 1:1) and stirred at 800 rpm 
at 80 °C for 18 hrs.  Then, the reactor was cooled down to room temperature, vented 
under a fumehood, and the reaction mixture was condensed under vacuum.  The 
compound was purified by vacuum distillation in a Kugelröhr apparatus at an oven 
temperature of 80 °C and 0.6 torr.  Obtained as a colorless oil 1.07 g (7.00 mmol, 84 
%, 15:1 B:L). 
 
 
13598: This compound was obtained according to the typical 
procedure. It was purified by vacuum distillation in a Kugelröhr 
apparatus at 83 °C and 0.6 torr.  It was obtained as a clear oil. 1.08 g (7.12 mmol, 85 
%, 20:1 B:L) 
 
 
 
136: The product was obtained according to the typical procedure.  It 
was purified by vacuum distillation in a Kugelröhr apparatus with an 
oven temp of 100 °C and pressure of 0.6 torr.  It was obtained as a clear oil.  1.17 g 
(7.13 mmol, 96 %, 8:1 B:L). 
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137 99 : The product was obtained according to the typical 
procedure.  It was purified by vacuum distillation in a 
Kugelröhr apparatus with an oven temp of 110 °C and pressure of 0.6 torr.  It was 
obtained as a clear oil.  1.17 g (7.12 mmol, 99 %, 20:1 B:L). 
 
  
 
138 100 : The product was obtained according to the typical 
procedure.  It was purified by vacuum distillation in a 
Kugelröhr apparatus with an oven temp of 115 °C and pressure of 0.6 torr.  It was 
obtained as a clear oil.  1.17 g (7.12 mmol, 96 %, 10:1 B:L). 
 
 
139 101 : The product was obtained according to the typical 
procedure.  It was purified by vacuum distillation in a 
Kugelröhr apparatus with an oven temp of 130 °C and pressure of 0.6 torr.  It was 
obtained as a clear oil.  1.11 g (5.83 mmol, > 99 %, 4:1 B:L). 
 
 
140101: The product was obtained according to the typical 
procedure.  It was purified by vacuum distillation in a Kugelröhr 
apparatus with an oven temp of 142 °C and pressure of 0.6 torr.  It was obtained as a 
clear oil.  1.24 g (7.36 mmol, 99 %, 14:1 B:L) 
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14199: The product was obtained according to the typical 
procedure.  It was purified by vacuum distillation in a 
Kugelröhr apparatus with an oven temp of 132 °C and pressure of 0.6 torr.  It was 
obtained as a clear oil.  1.23 g (6.07 mmol, 90 %, 8:1 B:L) 
 
 
142102: The product was obtained according to the typical procedure.  
It was purified by vacuum distillation in a Kugelröhr apparatus with 
an oven temp of 138 °C and pressure of 0.6 torr.  It was obtained as a clear oil.  1.27 g 
(7.51 mmol, 96 %, single) 
 
 
143 103 : The product was obtained according to the typical 
procedure.  It was purified by vacuum distillation in a 
Kugelröhr apparatus with an oven temp of 163 °C and pressure of 0.2 torr.  It was 
obtained as a yellow oil.  0.16 g (0.893 mmol, < 12 %, 7:1 B:L) 
 
 
144104: The product was obtained according to the typical procedure.  
It was purified by vacuum distillation in a Kugelröhr apparatus with 
an oven temp of 124 °C and pressure of 0.6 torr.  It was obtained as a clear oil.  1.07 g 
(7.23 mmol, 93 %, 8:1 B:L) 
 
 
 
CHO
O2N
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145 105 : The product was obtained according to the typical 
procedure.  It was purified by vacuum distillation in a Kugelröhr 
apparatus with an oven temp of 126 °C and pressure of 0.6 torr.  It was obtained as a 
clear oil.  1.00 g (6.78 mmol, 90 %, 44:1 B:L) 
   
 
146101: The product was obtained according to the typical 
procedure.  It was purified by vacuum distillation in a kugelrohr 
apparatus with an oven temp of 128 °C and pressure of 0.6 torr.  It was obtained as a 
clear oil.  1.07 g (7.19 mmol, 95 %, 36:1 B:L) 
 
 
147106: The product was obtained according to the typical 
procedure.  In order to push the reaction of completion it was 
necessary to allow the reaction to run for 48 hrs at 800 rpm of stirring, 80 °C, and 150 
psi of 1:1 H2\CO.  It was purified by vacuum distillation in a Kugelröhr apparatus 
with an oven temp of 158 °C and pressure of 0.6 torr.  It was obtained as a clear oil.  
1.01 g (5.31 mmol, 97 %, 7:1 B:L) 
 
  
148106: The product was obtained according to the typical 
procedure.  It was purified by vacuum distillation in a 
Kugelröhr apparatus with an oven temp of 168 °C and 
pressure of 0.2 torr.  It was obtained as an off white solid.  1.15 g (5.37 mmol, 99 %, 
8:1 B:L)  
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149 107 : The product was obtained according to the typical 
procedure.  It was purified by vacuum distillation in a 
Kugelröhr apparatus with an oven temp of 162 °C and pressure of 0.2 torr.  It was 
obtained as an off white solid.  1.20 g (6.42 mmol, 99%, 8:1 B:L) 
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Chapter 3.  Hydroformylation of Cyclopropenes 
 
 
3.1.  Synthesis of Cyclopropenes 
 
 
Cyclopropenes are known to be useful in a variety of processes and are found 
in different compounds and precursors used in the pharmaceutical and agriculture 
industries. They are finding increased utility owing to a number of unique properties 
which they posses.  Cyclopropenes are highly strained small cycles which possess ~ 
60 kcal/mol of energy in the C=C pi-bond.108  This strain energy makes the olefin 
much more reactive than analogous non-strained alkenes.  It also makes potentially 
reversible reactions unfavorable in the reverse direction since the energy of activation 
needed for the reaction to proceed in reverse is high.  The nature of the three 
membered cycle makes the species completely rigid allowing it to maintain a high 
degree of stereochemical information, yet due to its small size, it does not drastically 
add to the molecular weight or complexity of the molecule.  
A number of methods exist for the synthesis of cyclopropenes.109  One of the 
more useful of these approaches is the rhodium catalyzed [2+1] cycloaddition 
(Chapter 3.1.1.) of a diazo compound to an alkyne110 (A, Scheme 23).  Other methods 
which have been used include: cycloisomerizations of vinyl carbenes B (Chapter 
3.1.2.) 111 , 1,2-elmination from dihalocyclopropanes C (Chapter 3.1.4.), silicon 
migrations D (Chapter 3.1.5.)112, and derivatization of pre-formed cyclopropenes E 
(Chapter 3.1.7.). 
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Scheme 23. 
 
 
 
3.1.1.  [2+1] Cycloadditions 
 
One of the more common methods for the formation of cyclopropenes is the 
[2+1] cycloaddition of carbene equivalents to olefins.110a,c  Most of the carbenoids 
used in this reaction are metal carbene complexes formed primarily using either 
rhodium or copper catalysts with an empty coordination site and diazocompounds.  
Coordination of the diazocompound with the empty site of the metal and extrusion of 
N2 results in the formation of the metal carbene used in the transformations. For 
cyclopropenation, Rh is the first metal of choice and the best catalysts found to affect 
this transformation are those which are Rh dimers bearing multiple identical ligands.  
Doyle reported one of the first highly enantioselective dirhodium catalysts for the 
asymmetric cyclopropenation using diazoacetates and alkynes dirhodium(II) tetrakis 
[methyl 2-oxopyrrolidine-5(S)-carboxylate], Rh2(5S-MEPY)4 150 (Figure 21).  This 
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catalyst was found to promote the cyclopropenation of terminal alkynes in moderate 
yields with the ee’s ranging from ~ 40 % to as high as 98 %.113  
Davies also has demonstrated a rhodium catalyst that is highly effective at the 
asymmetric cyclopropenation of alkynes with diazoesters.114  His catalyst, dirhodium 
tetrakis ((S)-N-(dodecylbenzenesulfonyl)prolinate) Rh2(DOSP)4 151 (Figure 21), 
enables the transformation in yields as high as 74 % and ee’s up to 92 %.  This 
catalyst has been utilized with a number of different aryl-diazoesters and terminal 
alkynes with great success. 
Corey has shown the catalyst he developed, Rh2(OAc)(DPTI)3 
(diphenyltriflylimidazolindinone, DPTI) 152, catalyzes the asymmetric 
cyclopropenation of a number of terminal acetylenes in reasonable yield (> 60 %) and 
high ee (> 92 %).115   
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Figure 21. 
 
Until recently, one of the major drawbacks associated with the use of diazo-
compounds in cyclopropenations stemmed from their intolerance to β-hydrogens  
(155, Scheme 24).  It has been known for a while there is a significant amount of 
elimination to yield α,β-unsaturated esters that takes place with these substrates 
resulting in a significantly decreased yield of cyclopropene compared to substrates 
without β-hydrogens.  Research from Fox and coworkers116 has recently addressed 
this problem and found a workable solution.  They found the rate of elimination 
depends significantly on the steric environment created around the metal center by the 
ligands.  The bulkier the ligands on the metal are, the less favorable the β-elimination 
is.  They screened a number of structurally diverse ligands on Rh and found two 
ligands which gave them modest yield in the cyclopropenation of 
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α-ethyldiazobutanoate with phenylacetylene.  Through their studies, Rh2(Piv)4 and 
Rh2(CO2Me2Ph)4 were found to give the best ratio of cyclopropenation to elimination, 
with the pivalate structure giving a slightly improved yield of the cyclopropene.  It is 
also noteworthy that catalysts which are known to give a high yield of cyclopropenes 
and high enantioselectivity using diazoacetates without β-hydrogens such as Rh2(S-
DOSP)4 151, Rh2(S-PTPA)4 154, Rh2(4S-MEOX)4 153, and Rh2(5S-MEPY)4 150 
(Figure 21) gave absolutely no formation of the cyclopropene product using 155.  The 
pivalate catalyst was tested on a variety of diazoesters and acetylenes 156 and was 
able to produce cyclopropenes 157 in moderate to good yields (43 – 75  %) while 
limiting the amount of acrylate product 158 formed.116 
 
Scheme 24. 
 
 
 
Gevorgyan has recently reported the use of the Davies’ Rh2(S-DOSP) catalyst 
to promote the insertion of triazoles 159 (Scheme 25) into alkynes resulting in the 
formation of cyclopropenes 160.117  This method is extremely efficient in producing 
pryidyl containing cyclopropenes which are difficult to obtain by more conventional 
methods.118  This method for their production is very general and is tolerant of both 
electron rich and poor triazoles and provides alkynes in yields often exceeding 80 %. 
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Scheme 25. 
 
 
3.1.2.  Cycloisomerizations. 
 
One of the key intermediates in the cyclization to form cyclopropenes is vinyl 
carbenes (Path B, Scheme 23). 119  The latter are readily generated through Graham’s 
procedure for the halogenation of alkyl- or arylamidines and isoureas (Scheme 26).120 
The resulting diazirines then give the vinyl carbene and release N2 upon thermal 
treatment. A limited number of these carbenes have been characterized in their singlet 
state via spectroscopic methods including IR, NMR, and UV/VIS.  
 
Scheme 26. 
 
 
 
Vinylcarbenes in the singlet state are primarily responsible for the 
isomerization into cyclopropenes, and halogens have been demonstrated to exhibit a 
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stabilizing effect on the singlet state of the carbene. 121   As a result of this, the 
carbenes that have been examined are primarily halovinylcarbenes.122   
Vinylcarbenes have also been observed resulting from the flash vacuum 
pyrolysis of anhydride 165 (Scheme 27) in argon producing the vinylcarbene 166, 
which quickly isomerized into difluorocyclopropenone 167, CO2, and a negligible 
amount of difluoroacetylene 168.123 
 
Scheme 27. 
 
 
 
Cycloisomerizations resulting in the formation of cyclopropenes are also 
known to occur from allenyl structures (Scheme 28). 124  Allenes upon exposure to 
light can rearrange into vinyl carbenes which potentially undergo cycloisomerizations 
to produce cyclopropenes.  Homolytic cleavage of the allenyl pi-bond 169 results in 
the formation of a diradical intermediate 170,171 which can then form the carbene in 
two possible conformations 172,173.  The more thermodynamically favored form 172 
resulted in the formation of the desired cyclopropene, while the disfavored carbene 
173 resulted in the formation of the substituted acetylene (Scheme 28).  The 
reasoning for the observed ratio of product formation is the steric repulsion exhibited 
between the tBu group and the phenyl rings.  When the tBu group is farthest away 
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from the phenyl substituents  (anti-) 172, these steric factors are markedly decreased 
compared to when the tBu group is close to the phenyl rings (syn-) 173 (Scheme 28).  
The difference in the energy associated with these conformations as determined by 
DFT calculations was found to be ~18 kcal/mol making the syn- conformation 
significantly less stable.124   
 
Scheme 28. 
 
 
 
 
Vinylcarbenes can be stabilized in a singlet form via formation of 
organometallic vinylidene complexes.  These complexes, usually formed with Ru or 
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Mo metals, undergo rearrangements into cyclopropenes mediated by a number of 
different bases including tetrabutylammonium fluoride, tetrabutylammonium 
hydroxide, DBU, and potassium hydroxide.  The plausible mechanism of this 
transformation (Scheme 29) begins with deprotonation at the β-position to the 
vinylidene 177 the resulting anion 178 then can attack the electrophilic carbenoid 
moiety to afford cyclopropenyl metal species 179.125 
 
Scheme 29. 
 
 
 
An example of isomerizations of methylenecyclopropanes to cyclopropenes 
was reported by Bubnov.126  He demonstrated the rearrangement of a methylene-
cyclopropylborane 180 into a cyclopropene 182 under solvolytic conditions in 
methanol (Scheme 30).  When the reaction was carried out in the presence of 
deuterated methanol, incorporation of a deuterium label in the methyl group of the 
cyclopropene was observed.126 
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Scheme 30. 
 
 
 
Examples of cycloisomerization to produce cyclopropenes under photolytic 
conditions are also known.  By irradiating methano-epoxydienes 183 (Scheme 31) it 
is possible to induce the formation of vinyl carbenes which can then isomerize into 
cyclopropenes.  The first step is the photoinduced heterolytic cleavage of the epoxide 
resulting in ring expansion and the formation of the zwitterionic species 184.  
Cleavage of the seven-membered ring affords the more stable vinylcarbene 185 
which then undergoes the cycloisomerization to form the cyclopropene 186 in a 44 % 
yield.127  
 
Scheme 31. 
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3.1.3.  Elimination from dihalopropanes  
 
Another method for the preparation of cyclopropenes is from the elimination 
of dihalopropanes.  By treating the dihalopropanes with a base under the right 
conditions, these substrates can be made to undergo first a cyclization to form the 
halocyclopropane, followed by a subsequent dehydrohalogenation to generate the 
cyclopropene.   
 An example of this process has been discussed by Breslow where he describes 
the synthesis of the dihalopropane 188 starting from alkene 186 (Scheme 32).  By 
treating 188 with KNH2 in liquid NH3 he succeeded in isolating 3,3-
dimethoxypropene 189 in 40 – 65 % yield which upon further treatment with acid 
could yield cyclopropanone 190.128 
 
Scheme 32. 
 
 
 
 
3.1.4.  1,2-Elimination from halocyclopropanes 
 
This is a well established method for the formation of cyclopropenes.  One of 
the more common ways of forming cyclopropenes, via a dehydrohalogenation, was 
developed using primarily bases, such as tBuOK and KOH in DMSO, although other 
leaving groups such as sulphones have also been employed.129  Dehydrohalogenation 
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works well for the synthesis of non-polar substrates containing alkyl or aryl 
substituents.  Cyclopropenes with polar groups, such as esters, amides, or groups not 
stable in the presence of strong bases suffer from diminished yields in this process.136  
When the cyclopropyl precursor contains such polar groups as amide, it becomes 
difficult to separate the resulting cyclopropenes from the solvent which results in 
significantly lower yields of the product than what could be obtained from other 
methods. 
 1,2-elimination of dihalocyclopropanes 191 (Scheme 33) to yield 
halocyclopropenes upon treatment with a potassium alkoxide base using either 
alcohols or DMSO as a solvent afforded essentially no cyclopropenyl product due to 
the propensity of halocyclopropenes 192, under the reaction conditions, to undergo a 
proton shift forcing the opening of the ring and resulting in the formation of β-halo-
alkynes which can then undergo a second dehydrohalogenation to give enynes 193.130   
 
Scheme 33. 
 
 
 
While this process was widely believed to proceed via a halocyclopropenyl 
intermediate 192, there was little success at hindering the subsequent rearrangements 
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and eliminations.  Baird found that by treating 191 with MeLi the reaction was able to 
be stopped at 192 with a 52 % yield. 130   He later adapted his method for  
1,2-elimination to tri-halocyclopropenes 194 (Scheme 34) and found this method was 
able to generate cyclopropenes 196 from many different substrates.  It is believed the 
first step of the reaction is the lithium-halogen exchange forming the 
metallocyclopropane 195 which can then eliminate X- from the β-position and yield 
the cyclopropene.  
 
Scheme 34. 
 
 
3.1.5.  Silicon Shifts  
 
Silicon shifts involve the migration of a silyl group usually, in either a 1,2- or 
1,3-fashion, and result in the formation of a cyclopropene.  An example of a 1,2-silyl 
migration starts with a dibromocyclopropane 197 (Scheme 35).  When this species is 
treated with methyl lithium, it undergoes a lithium-bromine exchange followed by 
α-elimination to form a cyclopropylidene 198.  This carbene then undergoes a 1,2-
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silyl shift moving the silyl group to the carbon which previously held the geminal 
bromines to give silylcyclopropene 199.  This type of shift has been demonstrated on 
variously substituted cyclopropanes with reasonable yields (48 – 94 %).112 
 
Scheme 35. 
 
 
 
3.1.6.  Extrusion of N2  
 
Lai and coworkers demonstrated the photoinduced electron transfer and 
extrusion of N2 from 3H-pyrazoles resulting in the formation of cyclopropenes.131    
The mechanism of this transformation is thought to begin with light and an electron 
deficient Ph3P+ abstracting an electron from the C-N σ-bond of pyrazole 200 to give 
radical cation 201.  This undergoes the loss of nitrogen to form the resonance 
stabilized radical cation 202 which, through a single electron transfer process, can 
gain an electron to form the carbene 203.  By closely monitoring the exposure of the 
system to light, they were successfully able to produce predominantly the 
photoextrusion product 204.  When the reaction was allowed to remain exposed to 
light for longer periods of time they observed the formation of dimer 205, but they 
observed very little formation of the solvent adduct 206.  The amount of 206 formed 
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in the reaction can also be controlled by the electronic nature of the substituents on 
the C4 and C5 positions of pyrazole 200 (Scheme 36).  By placing withdrawing 
substituents on both the C4 and C5 positions or by replacing an electron withdrawing 
group at the C4 position with a phenyl ring, the amount of 206 formed was minimal.  
 
Scheme 36. 
 
 
 
3.1.7.  Derivatization of Pre-formed Cyclopropenes 
 
Another method for the preparation of cyclopropenes stems from the 
derivatization of cyclopropenes which have already been formed.  This includes such 
reactions as functional group transformations, deprotonation of the cyclopropene and 
subsequent trapping with electrophiles, and ene-type oligomerization reactions 
(Scheme 37).   
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Scheme 37.  Functionalization of Pre-formed Cyclopropenes 
 
 
 
 
A paper describing an example of oligomerization reactions of cyclopropenes 
while still maintaining the integrity of the C=C double bond in the cyclopropene 
appeared in 2008 by Plemenkov. 132   In it he describes the oligomerization of 
3,3-disubstituted cyclopropenes bearing a CN group as one of the substituents 207 
(Scheme 38).  This tetramerization is the first example of Alder-ene chemistry to ever 
be demonstrated on a 3,3-disubtituted cyclopropene.  Another key feature of this 
reaction is migration of the CN group from one cyclopropenyl moiety to the other.   
This reaction is believed to proceed via the diradical intermediate 209.  The upper 
radical can abstract the CN group generating a radical on the carbon bearing the 
methyl group.  This radical can then combine with the one on the β carbon and 
regenerate the cyclopropene.132   
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Scheme 38. 
 
  
 
There has been a renewed interest recently in the ability to functionalize 
cyclopropenes through deprotonation of one or both of the acidic sp2-H bonds and 
then trap the resulting cyclopropenyl anion with various electrophiles.  This chemistry 
has been around since the 1960’s when alkyl- and aryl-Li species were being used to 
deprotonate cyclopropenes and the resulting cyclopropenyl lithium species were 
subsequently trapped with electrophiles. 133 , 134   However, there are significant 
challenges associated with using this process on substituted cyclopropenes, especially 
those containing carbonyl functionalities.  These substrates, upon deprotonation, 
readily ring open and give isomerized products rather than the desired cyclopropenes.  
Much of the knowledge of this process has come through the contributions of Fox and 
his group from the University of Delaware. 135  He has described the formation of a 
dianion 216 (Scheme 39) resulting from the double deprotonation of the 
cyclopropenyl carboxylic acid both on the carbons of the olefin and to form the 
carboxylate.  One of the problems inherent with this process is the ability of a 
cyclopropenyl anion 212 to rearrange into an alkyne 214 much faster than it 
undergoes electrophilic trapping 213.  This appears to be the case when at least one of 
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the substituents at the position 3 of the cyclopropene is an ester 211.  When the ester 
is hydrolyzed to form the acid, the Columbic repulsion between the carboxylate and 
the cyclopropenyl anion is sufficient to keep the ring intact allowing electrophilic 
trapping to occur resulting in very little isomerization to 215 and shifting the major 
product of the reaction to be the electrophilically trapped species 217.  The yields in 
this process are reasonably high (> 65 %) and in the case of a chiral starting material, 
the reaction proceeds with retention of configuration of the substrate.135 
 
Scheme 39. 
 
  
 
 
It has also been recently discovered that cyclopropenyl carboxamide can 
undergo the same kind of deprotenation/electrophilic trapping process as the 
carboxylic acids with a negligible amount of ring opening (Scheme 40). 136 This is 
believed to be due to reduced electron withdrawing capability of the amides, which 
destabilizes the buildup of negative charge β to the amide making the isomerization 
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to 218 more energetically disfavored allowing for the electrophilic trapping to occur 
(220). 
 
Scheme 40. 
 
 
 
Gevorgyan showed in 2005 (Scheme 41) that by taking trisubstituted 
cyclopropenes, with at least one of the substituents in the 3 position being an ester 
221, in the presence of a palladium catalyst and an aryl halide; a coupling process 
analogous to Heck coupling occurs between the CH of the olefin in the cyclopropene 
and the aryl halide in reasonable yields 222.  Starting with a chiral cyclopropene, it 
was demonstrated the coupling proceeded uneventfully and with full retention of the 
stereochemistry.  This reaction proceeds under mild conditions and gives moderate to 
high yields.137 
 
Scheme 41. 
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3.1.8.  Conclusions 
 
 
Functionalized cyclopropenes are increasingly becoming available from a 
variety of different processes.  These important substrates possess unique 
characteristics due to the rigidity of the small cycle and the amount of ring strain 
inherent in the system.  By harnessing their reactivity and unique properties, it is 
possible to use cyclopropenes in processes which normal olefins will not undergo.  
Many of these processes proceed irreversibly due to the amount of energy required to 
form the C=C pi-bond in the cycle.  This makes cyclopropenes interesting and useful 
candidates for metal catalyzed, asymmetric processes in which β-hydride elimination 
can cause racemization of the stereocenter set during the reaction.  As more people 
realize the ease of preparing them, and their synthetic utility, new processes involving 
cyclopropenes will continue to arise. 
 
3.2.  Improved preparative route toward 3-arylcyclopropenes 
 
3.2.1.  Introduction 
 
The chemistry of cyclopropenes has increasingly become a focus of research 
in the past decade, as these unique synthons often provide an inimitable opportunity 
for preparation of stereodefined cyclopropyl scaffolds with otherwise inaccessible 
substitution patterns. 138   Development of powerful methods for catalytic 
enantioselective cyclopropenation of alkynes,113,114,115,139,140 as well as novel efficient 
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protocols for chiral separation 141  and chiral kinetic resolution 142  of racemic 
cyclopropenes opened new opportunities for the use of optically active cyclopropenes 
in asymmetric synthesis.137,138a,143  On the other hand, several efficient diastereo- and 
enantioselective transformations involving prochiral CS-symmetric 3,3-disubsituted 
cyclopropenes have been recently reported, which highlight the remarkable versatility 
of these compounds (Scheme 42).  They include: the Alder-ene reaction with 
homochiral alkenes (a);144 asymmetric carbomagnesation in the presence of chiral 
amino alcohols (b);145 iron-catalyzed asymmetric alkylzincation (c)146  and ROM-CM 
reaction (d).147 Furthermore, this type of substrate was also used in preparation of 
optically active cyclopropyltins and cyclopropylboronates via the Rh(I)-catalyzed 
asymmetric hydrometallations (e,f),148  as well as in catalytic hydroformylation of 
cyclopropenes (g).149   
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Scheme 42.  
 
 
 
With the growing number of impressive novel methodologies utilizing 3,3-
disubstituted cyclopropenes, the question is repeatedly raised as to whether these 
strained and very reactive synthons can be efficiently prepared in a multigram scale.  
Herein we disclose a detailed improved synthetic procedure applicable for medium 
and large scale preparation of a series of 3-arylcyclopropenes.  We also comment on 
the stability and reactivity of 3-arylcyclopropenes, as well as the corresponding 
precursors, possessing various substituents in the aryl group at C3.  
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Scheme 43. 
 
 
 
3.2.2.  Results and Discussion 
 
 
Two general approaches to cyclopropenes unsubstituted at the double bond 
are depicted in Scheme 43.  The first approach involves the Rh-catalyzed [2 + 1] 
cycloaddition of carbenoid species to acetylene gas. This method provides rapid 
access to monosubstituted cyclopropenes possessing an ester function at C3. 150 
Alternatively, 3,3-disubstituted ester-containing cyclopropenes can be prepared via 
the Cu- or Rh-catalyzed reaction between a diazocarbonyl compound and bis-
trimethylsilylacetylene or trimethylsilylacetylene, followed by in situ protio-
desilylation of the resulting trisubstituted cyclopropene 224 (Scheme 43, Method 
A).151  The latter route provides high yields with phenyl diazoacetate and electron 
poor aryl diazoacetates; however, our experience suggests that it is poorly applicable 
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to the synthesis of analogs possessing electron-donating substituents in the aryl ring. 
The main problem lies in the poor chemoselectivity of the reaction, which produces 
significant amounts of fumarates 226 or diazines via the concurrent Rh-catalyzed 
dimerization of diazoacetate 223. 152   Furthermore, cyclopropenes 224 possessing 
electron-rich aryl groups are more prone to partial decomposition in the presence of 
Rh(II) via the ring expansion into furans 225.153   
An alternative synthetic approach toward 3,3-disubstituted cyclopropenes 
involves a three-step sequence, including initial [2 + 1] cycloaddition of a 
dihalocarbene to 1,1-disubstituted olefin 228,154 followed by partial reduction of the 
resulting dibromocyclopropane 229 to afford bromocyclopropane 230, and 1,2-
elimination of HBr with an appropriate base (Scheme 43, Method B).  Method B was 
successfully utilized to assemble cyclopropenes possessing aryl, 155  alkenyl, 156 
alkynyl, 157  and ferrocenyl 158  substituents at C3.  Furthermore, this protocol was 
demonstrated to be compatible with several functional groups, such as ethers,159 silyl 
ethers,147 acetals,148a, 160  carboxylates,148b, 161  and nitriles. 162   A few rather exotic 
compounds containing a spiro-bicyclic scaffold,36a, 163  and tethered bis-
cyclopropenes40c, 164  were also obtained via this method.  Until recently, one 
substantial limitation of the described approach was the lack of highly selective and 
general methods for preparative partial reduction of dibromocyclopropanes 229 into 
monobromides 230.  Although a plethora of various reduction protocols has been 
developed, most of them provide an insufficient degree of chemoselectivity, as 
judged by our own experience and the data in the literature.165  Thus, to avoid product 
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loss associated with purification, the chemoselectivity of the reduction method should 
exceed 98 %. Specifically, the method should allow for complete control over 
eventual overreduction, which results in inevitable contamination of the target 
cyclopropene with a cyclopropane side product. A few known, highly chemoselective 
reducing agents, such as (EtO)2POH166 and Bu3SnH,167 are extremely toxic, which 
becomes a major liability for synthesis scale-up.  A viable, more environmentally 
benign alternative to the latter methods was suggested by Baird and Bolesov who 
demonstrated the possibility of selective partial reduction of geminal 
dihalocyclopropanes 229 into monohalocyclopropanes 230 by use of ethylmagnesium 
bromide in the presence of catalytic amounts of titanium(IV).37  This reduction 
protocol was successfully incorporated into Method B and used in the synthesis of a 
few 3,3-disubstituted cyclopropenes.147,148,151   
Our studies of novel synthetic transformations involving 
cyclopropenes143g,149,168 stimulated us to develop a general and practical approach to a 
series of 3-arylcyclopropenes possessing differently substituted aromatic ring.  It 
should be mentioned that, although the parent 3-methyl-3-phenylcyclopropene was 
previously synthesized from the commercially available α-methylstyrene on a 
multigram scale,151 no preparative syntheses of analogs functionalized at the aryl 
group have been reported to date.169  
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3.2.3.  Synthesis of α-methyl styrenes  
 
Multigram scale preparation of diverse 3,3-disubstituted cyclopropenes via the 
1,2-elimination protocol (Scheme 43, Method B) greatly relies on the availability of 
the corresponding 1,1-disubstituted olefins.  While α-methylstyrene (225a) is a 
monomer industrially produced in a multi-ton scale, the corresponding substituted 
analogs are not available from commercial sources.  Most of styrenes 228 described 
in this report were prepared from the readily available alkyl benzoates (233) or 
acetophenones (234) via a two-step sequence including addition of Grignard reagent 
followed by the acid-catalyzed dehydration of the resulting tertiary alcohols (235) 
(Scheme 44).  Maintaining the temperature around 80 °C during the dehydration step 
allowed for minimizing the concurrent acid-catalyzed cationic polymerization. The 
reaction times varied significantly depending on the electronic properties of the 
substituents at the aromatic ring of styrenes 228.  Thus, substrates possessing 
electron-rich groups (235b-e,i) reacted within 1 hr, the chlorosubstituted analogs 
235f,g required 2-3 hrs for complete conversion, while dehydration of the electron 
poor alcohol 235h took almost 9 days (Scheme 44). Preparation of olefins highly 
susceptible to acid-catalyzed cationic polymerization (228k,l) was carried out via the 
Wittig olefination (Scheme 45).  Although this route is somewhat more expensive, it 
avoids exposing olefins 228 to strong acid. We found it convenient to carry out steps 
233→ 228 without purification, which dramatically expedited the synthesis, and 
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helped to significantly improve the overall yields, mainly by avoiding partial 
polymerization of olefin 228 upon purification.   
 
Scheme 44. 
 
 
 
Scheme 45. 
 
 
 
 
3.2.4.  Synthesis of dibromocyclopropanes  
 
Dibromocyclopropanes 229 were prepared by cyclopropanation of crude 
olefins 228 with dibromocarbene generated under modified Makosza’s PTC 
conditions 170  (Table 12).   It was found that employment of the addition mode 
opposite to that originally described by Makosza (i.e., the dropwise addition of 
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concentrated aqueous base solution to a vigorously stirred mixture of the organic 
components) was also beneficial for the reaction yields.  This modification allowed 
for significantly suppressing the formation of resins and, accordingly, for more 
efficient isolation of the product.  To control the intensive heat released at the initial 
stages of the reaction, it was found convenient to carry out the reaction in a 1:1 (v/v) 
mixture of bromoform and dichloromethane, refluxing of which prevented 
overheating of the reaction mixtures above 40 - 45 °C.  At the later stages of the 
process, after the intense exothermic effects have ceased, the remaining 
dichloromethane was boiled off by heating the reaction mixture at 50 °C. 
It is well documented that kinetic rates of cyclopropanation under the phase 
transfer conditions greatly depend on the structure of the phase transfer catalyst.  
Thus, the highest rates and best conversions are normally obtained with benzyl-
triethylammonium (TEBA) salts.170  We found, however, that employment of 
tetrabutylammonium (TBA) and TEBA salts brings about additional problems with 
excessive foaming and formation of steady emulsions during aqueous workup, when 
the reaction is performed in a large scale.  In contrast, much better separation of the 
biphasic solutions was observed when hexadecyl- or tetradecyltrimethylammonium 
salts were employed as catalysts.  As a result, extraction could be done faster and 
more efficiently, which ultimately provided better overall yields.  Isolation of the 
final product in a large scale was done using short-path vacuum distillation at 
temperatures below 100 °C.  In smaller scale (up to 10 g) a simple filtration through a 
short pad of silica gel was used instead.  Albeit this isolation method does not allow 
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for removal of all the residual bromoform, it was found that small amounts of this 
impurity do not compromise the next step. 171   Therefore, simple removal of 
bromoform in vacuum followed by filtration afforded material sufficiently pure to use 
in the following transformations.   
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Table 12.  Dibromocyclopropanes 229 via [2 + 1] cycloaddition to styrenes. 
 
 
 
Isolated yield 
of 229, % # R time, h 
scale, 
mmol 
based on 228 overalla 
1 Ph 228a, 229a 30 700 92 N/A 
2 p-MeC6H4 228b, 229b 120 55.8 66 56 
3 m-MeC6H4 228c, 229c 36 66.5 73 65 
4 o-MeC6H4 228d, 229d 48 42.7 93 53 
5 p-(tBu)C6H4 228e, 229e 24 45.0 ND 72 
6 p-ClC6H4 228f, 229f 24 19.0 ND 91 
7 o-ClC6H4 228g, 229g 48 20.0 ND 74 
8 p-CF3C6H4 228h, 229h 216 29.2 75 58 
9 1-Naphthyl 228i, 229i 72 28.4 66 61 
10 p-FC6H4 228j, 229j 48 56.4 86 71 
11 p-MeOC6H4 228k, 229k 48 61.3 86 79 
12 o-MeOC6H4 228l, 229l 48 49.3 70 55 
a
 Yield over 2 steps starting from acetophenones 234 
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3.2.5.  Partial reduction of dibromocyclopropanes.  
 
 
Reduction of dibromocyclopropanes (Table 13) was performed according to 
the previously reported protocol,37b with a few practical modifications that became 
essential during scale up.  First, since the reaction is accompanied by evolution of 
gaseous flammable byproducts, including ethylene and ethane, it should be set up in a 
well ventilated fumehood.  The reaction flask should not be more than one third full 
and must be equipped with an efficient reflux condenser.  This extra space is used as 
a damper against uneven boiling and sudden splashes, and also proves indispensable 
during the quench, when a lot of heat and a large volume of gases are evolved. 
Second, the reaction has a certain initiation period, during which the first 20 mol % of 
the Grignard reagent, added dropwise, is being used to reduce the Ti(IV) complex 
into the Ti(II) species. Complete formation of the catalytically active complex can be 
judged by the color change from pale-yellow to very dark-brown.  This, however, 
does not always indicate the completion of the activation period, which may take 
longer, in case the initial addition of the Grignard reagent was carried out too quickly 
(i.e., much faster than the rate of the Ti(IV)→Ti(II) reduction).  In the latter case the 
risk of violent boiling off and splashing of the reaction mixture dramatically 
increases. Accordingly, at the initial stages of the reaction it is crucial to maintain a 
reasonably slow dropwise addition of the Grignard reagent, such as to allow relatively 
slow boiling of the solvent and evolution of the gaseous byproducts.   
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Table 13. Ti-catalyzed partial reduction of dibromocyclopropanes 229 en route to 
bromocyclopropanes 230. 
 
 
 
# R 
scale, 
mmol 
trans/cis 
ratioa 
Yield 230, %b 
1 Ph 229a, 230a 644 1.2:1 85 
2 p-MeC6H4 229b, 230b 30.8 2.0:1 68 
3 m-MeC6H4 229c, 230c 28.9 2.4:1 64 
4 o-MeC6H4 229d, 230d 39.5 trans only 71 
5 p-(tBu)C6H4 229e, 230e 34.3 2.6:1 82 
6 p-ClC6H4 229f,  230f 17.4 1.8:1 72 
7 o-ClC6H4 229g, 230g 14.7 5.9:1 84 
8 p-CF3C6H4 229h, 230h 21.5 1.7:1 76 
9 1-Naphthyl 229i, 230i 17.3 trans only 80 
10 p-FC6H4 229j, 230j 47.8 1.9:1 75 
11 p-MeOC6H4 229k, 230k 52.8 2.3:1 60 
12 o-MeOC6H4 229l, 230l 34.3 2.5:1 84 
a
 Determined by 1H NMR.  b Isolated yields of mixtures of trans-230 and cis-230. 
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Finally, the reaction should be carefully monitored by GC analysis to avoid 
overreduction of the target monobromide 230 into cyclopropane 232 (Scheme 43,  
Method B). The possibility of this side process occurring increases when the exact 
concentration of the employed Grignard reagent batch is unknown (i.e., it was not 
titrated prior to use, or moisture was present in the reaction mixture). We found it 
convenient to add ca. 1.1 equiv of EtMgBr using a graduated addition funnel, then 
allow the reaction mixture to stir for 15 minutes, and analyze it by GC.  An additional 
amount of Grignard reagent, if needed, could be accurately estimated based on GC 
conversion.  In a typical reaction run, the crude reaction mixture would consist of 98-
99 % of bromocyclopropane 230, and no more than 1 % of the starting material 229 
and cyclopropane 232 (Scheme 43, Method B).  In the perspective of the next step, it 
is better to leave behind some dibromide 229 rather than allow overreduction into 
232, since 229 will eventually be destroyed upon treatment with tBuOK during the 
1,2-elimination step, while separation of cyclopropene 231 and cyclopropane 232 is 
essentially impossible.  Therefore, if notable amounts of the overreduced product 232 
were obtained, monobromide 230 must be purified by vacuum distillation, which also 
allows for removal of the by-product 236, resulting from radical dimerization of 
diethyl ether (Table 13).  Purification by column chromatography can be an option, if 
the reaction is performed in a relatively small scale and side product 232 is present in 
insignificant amounts.  In the latter case it is essential to completely remove any 
remaining ethereal solvent from the crude product by evaporation in vacuum, as even 
a small amount of diethyl ether in the mixture affects the polarity of the system and 
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complicates separation.  The yields of monobromides 230 were generally high, while 
the diastereoselectivity depended on the nature of aromatic substituent at C3.  
Generally, substrates possessing bulky aryl groups, such as ortho-substituted phenyls 
(Table 13, entries 4,7), or 1-naphthyl (entry 9) provided higher diastereoselectivities, 
than those bearing less bulky  para- or meta-substituted arenes.  In contrast, both 
para- (230k) and ortho-(230l) anisyl cyclopropanes were obtained as mixtures of 
trans- and cis-isomers with almost the same ratios (entries 11,12).  In the context of 
cyclopropene synthesis, however, the diastereoselectivity is not an issue since both 
diastereomers of 230 are reactive toward dehydrohalogenation. 
 
3.2.6.  Dehydrohalogenation of monobromocyclopropanes. 
 
 
Synthesis of cyclopropenes 231 from monobromocyclopropanes 230 was 
carried out in anhydrous DMSO in the presence of slight excess of tBuOK (Table 
14).155  It should be mentioned that the reaction is very sensitive to both traces of 
moisture and oxygen, and must be set up with appropriate precautions.  In all our 
experiments potassium tert-butoxide was stored and handled in the nitrogen-filled 
glovebox, while Schlenk techniques were used for operations with all other reagents 
and solvents.  The level of oxygen and moisture in the system could be visually 
monitored by the color of the reaction mixture which, depending on the substitution 
pattern, ranged from a baltic blue to dark spruce.  The correctly set up reaction 
develops color very quickly and retains it until completion; however, in the presence 
of even small amounts of moisture and oxygen the mixture rapidly turns dark brown. 
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The product should be extracted and purified as quickly as possible after completion 
of the reaction to avoid decomposition.  We found that extraction can be carried out 
under ambient atmosphere, as the product is reasonably stable in solution towards 
aqueous work up. Removal of solvents after extraction can be carried out using a 
rotovap; however, upon completion, the rotovap should be filled with inert gas in 
order to avoid exposure of the concentrated crude product to air. Final purification by 
distillation should be carried out in vacuum at the highest possible rate, at 
temperatures below 65 °C.  The purified product should be stored in a freezer and 
handled under inert atmosphere, if prolonged storage is planned.  We noticed that 
accidental brief exposure of arylcyclopropenes to air causes their slow 
decomposition, potentially, via a free radical-catalyzed polymerization.  Thus, when a 
sample of cyclopropene 231a was exposed to air for one hour at room temperature, 
and then was sealed under nitrogen, it completely decomposed within two weeks.  
Generally, cyclopropenes possessing electron-donating groups (231b-d,k,l) were 
more susceptible to decomposition, while more electron-deficient compounds 
231f-h,j were significantly more stable.  However, with all the above-mentioned 
precautions the shelf life of arylcyclopropenes can be extended to more than a year.  
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Table 14. Synthesis of cyclopropenes 231 
  
R Me
Br
230
R Me
231
t-BuOK
DMSO
RT, 18 hrs
 
 
# R scale, 
mmol bp, 
oC(torr) Yield 231, %a 
1 Ph151 230a, 231a 540 61-62(10) 79 
2 p-MeC6H4 230b, 231b 17.8 30-35 (0.4) 77 
3 m-MeC6H4 230c, 231c 18.4 60-61(5) 76 
4 o-MeC6H4 230d, 231d 27.9 25-29 (0.4) 68 
5 p-(tBu)C6H4 230e, 231e 34.3 NDb 86 
6 p-ClC6H4 230f, 231f 12.5 NDb 79 
7 o-ClC6H4 230g, 231g 12.3 NDb 86 
8 p-CF3C6H4 230h, 231h 16.3 49-52 (5) 69 
9 1-Naphthyl 230i, 231i 17.3 NDb 66 
10 p-FC6H4 230j, 231j 47.8 58-61(10) 76 
11 p-MeOC6H4 230k, 231k 25.2 64-65(5) 82 
12 o-MeOC6H4 230l, 231l 28.9 64-65(5) 92 
a
 Isolated yields.  b Boiling points were not determined; compounds were isolated by flash column 
chromatography. 
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3.2.7.  Synthetic Studies toward 3-Methyl-3-(4-nitrophenyl)cyclopropene  
 
 
In order to investigate the scope and limitations of the developed method, we 
also attempted synthesis of cyclopropene 231m possessing a strongly electron-
withdrawing para-nitro substituent.  Our initial approach involved the Wittig 
olefination of acetophenone 234m, followed by cyclopropanation of the resulting 
olefin 228m with a dibromocarbene generated under the optimized PTC conditions 
(Scheme 46).  These two transformations proceeded uneventfully, efficiently 
providing dibromocyclopropane 229m.  However, all our attempts to perform partial 
reduction of 229m into bromocyclopropane 230m were unproductive.  The most 
efficient reduction protocols, such as Ti(IV)-catalyzed reduction with EtMgBr,28 Mg- 
or Zn-assisted reductions,172 and radical reduction with tributyltin hydride27 produced 
no reaction, while an attempt to carry out the reduction in the presence of 
methyllithium173 lead to complete decomposition of the starting material. 
 
Scheme 46.  
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Accordingly, alternative approaches to monobromide 230m were explored (Scheme 
47).   First, we attempted cyclopropanation of 228m with a monohalocarbene 
generated from dibromomethane and MeLi;174 however, this reaction did not provide 
the desired product.  In contrast, the electrophilic nitration175 of bromocyclopropane 
230a provided para-nitro-derivative 230m along with small amounts of an ortho-
isomer (Scheme 47).  However, all our attempts to carry out 1,2-dehydrobromination 
of 230m in the presence of tBuOK in DMSO at various temperatures failed, leading 
to complete decomposition of the starting material (Scheme 47).   
 
Scheme 47.  
 
 
 
3.2.8.  Conclusions 
 
In conclusion, an efficient preparative protocol for synthesis of various 
3-arylcyclopropenes in a multigram-scale was designed. Optimization of the reaction 
conditions and isolation procedures allowed for significant improvement of the 
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chemical yields of these strained products.  The described protocol was used for 
efficient preparation of a series of 3-methyl-3-arylcyclopropenes possessing different 
substituents in the aromatic ring. Further work to expand the scope of this method to 
3-alkyl-3-aryl- and 3-alkyl-3-hetarylcyclopropenes is currently underway in our 
laboratories.  
 
3.3.  Synthesis of Cyclopropenes via 1,2-Elimination of Bromocyclopropanes 
Catalyzed by Crown Ether 
 
3.3.1.  Introduction 
 
As it was described in section 3.1 of this chapter, two general methods have 
largely been used for the synthesis of cyclopropenes 237.  These include the transition 
metal-catalyzed addition of carbenoids 238 to alkynes 239 (Scheme 48, 
Path A)113,114,140a,141, 176  and a protocol involving 1,2-elimination of H-
Hal36a,39b,156,163d,174b or Hal-Hal130,142c,143, 177  entities from cyclopropyl halide 
precursors 240 (Scheme 48, Path B). The former method has been receiving much 
attention from the synthetic community, resulting in substantial expansion of its 
scope, thereby making available a range of cyclopropenes,116,117a including optically 
active compounds.113,114,115,140a In contrast, the second approach has not undergone 
any significant development in decades178 since the first report on the synthesis of 
3,3-disubstituted cyclopropenes via the 1,2-elimination of a hydrogen halide in the 
presence of tBuONa and DMSO.179 At the same time, the requisite use of DMSO as a 
reaction medium significantly limits the potential of the method for scale up and its 
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appeal for process development. Furthermore, it becomes a major liability when the 
target cyclopropene is relatively hydrophilic. In this case, repetitive washing of the 
organic phase with water, necessary for complete removal of DMSO (Chapter 
3.5.6),178 leads to substantial loss of the product.  Alternative approaches involving 
removal of DMSO by distillation or column chromatography usually do not provide 
satisfactory results, particularly in multigram scale syntheses.  In an attempt to 
overcome this issue, we considered the possibility of replacing DMSO with 
alternative, more practical solvents. We rationalized that employment of chelating 
agents, such as crown ethers,180 could potentially help enhance the basicity of tBuOK 
and enable an efficient elimination reaction in less polar media.  It should be 
mentioned that preparative methods for 1,2-dehydrohalogenation in non-polar media 
employing 18-crown-6 ether as phase-transfer catalyst have been previously 
reported;180 however, they have never been used for the preparation of strained 
olefins.  Herein we wish to report a new protocol for the synthesis of cyclopropenes 
via a base-assisted 1,2-elimination in ethereal solvents in the presence of catalytic 
amounts of 18-crown-6 ether.  We also demonstrate the application of the new 
method for the efficient synthesis of cyclopropenyl-3-carboxamides, an important 
class of functionalized cyclopropenes.142b,150b.181 
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Scheme 48.  Two most important retro-synthetic approaches to cyclopropene core 
 
 
 
3.3.2.  Results and Discussion 
 
First, we tested dehydrobromination of 2-bromo-1-methyl-1-
phenylcyclopropane (230a) with potassium tert-butoxide in THF in the presence of 
various amounts of 18-crown-6 ether (Table 15, entries 1-3). It was found that 
addition of stoichiometric amounts of crown ether facilitated a rapid 
dehydrohalogenation; however, notable decomposition of product 231a was observed 
leading to moderate overall yields. Decreasing the amount of crown ether was 
beneficial for the reaction yield (Table 15, entries 2,3), and with additional 
optimization we discovered yields can be further improved by lowering the reaction 
temperature to 30 oC (Table 15, entry 4). Screening of various ethereal solvents 
demonstrated that THF and diethyl ether appear to be the most suitable media for this 
transformation. In contrast, reactions in dibutyl ether and diglyme did not produce 
any product at all (Table 15, entries 6,9), while employing other ethers resulted in a 
much slower and less efficient reaction.  Although both THF and diethyl ether 
provided essentially the same results, we chose THF as a more practical solvent. 
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Table 15. Optimization of 1,2-Elimination Reaction 
 
 
 
entry 18-crown-6 
(equiv) 
Solvent Time (h) T (oC) GC yield (%) 
1 1.2 THF 1 50 40 
2 0.3 THF 3 50 65 
3 0.1 THF 3 50 70 
4 0.1 THF 14 30 93 
5 0.1 1,4-
dioxane 
48 30 86 
6 0.1 Bu2O 48 30 0 
7 0.1 TBDME 48 30 76 
8 0.1 DME 48 30 21 
9 0.1 Diglyme 48 30 0 
10 0.1 Et2O 14 30 84 
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Table 16. Preparative Syntheses of Cyclopropenes 
 
 
 
entry R Time 
(h) 
T (oC) Yield (%)a 
1 Ph (230a, 231a) 18 30 85b (79) 
2 2-Naphthyl (230n, 231n) 18 30 84 
3 2-FC6H4 (230o, 231o) 18 40 75 
4 C(O)NEt2 (230p, 231p) 3 30 90c (60) 
5 C(O)N(i-Pr)2 (230q, 231q) 2 30 85 (69) 
6 C(O)N(CH2CH2)2O (230r, 231r) 1 30 81 (30) 
7 C(O)N(CH2CH2)2CH2 (230s, 231s) 1 30 85 (61) 
8 C(O)N(CH2CH2)2NMe (230t, 231t) 1 30 75 (50) 
9 C(O)N(n-Hex)Me (230u, 231u) 2 30 95 
10 C(O)NPh2 (230v, 231v) 2 30 0 
11 C(O)N(C6H4NO2-4)Et (230w, 231w) 18 40 0 
12 C(O)NPhEt (230x, 231x) 2 30 30 
13 C(O)N(C6H4OMe-4)Et (230y, 231y) 24 30 53 
a
 Isolated yields (250 mg scale); isolated yields obtained in DMSO are provided in parentheses. b The 
reaction was performed on a 10.0 g scale. c The reaction performed on a 15.0 g scale afforded 230o in 
89 % yield. 
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Preparative scale synthesis under the optimized conditions provided 3-methyl-
3-phenylcyclopropene (231a) in high yield, which slightly exceeded that obtained in 
DMSO (Table 16, entry 1).178  Similarly, other 3-methyl-3-arylcyclopropenes 
(231n,o) were efficiently synthesized using the THF protocol (Table 16, entries 2,3).  
The major advantage of the new method was revealed in the synthesis of significantly 
more polar cyclopropenylcarboxamides 231p-u,x,y (Table 16, entries 4-9, 12, 13).  
Thus, in contrast to the reactions performed in DMSO, which suffered from 
substantial product loss due to high hydrophilicity of the compounds, the new 
conditions allowed for high isolated yields for all alkyl-substituted amides tested.   
 
Scheme 49.  Decomposition of cyclopropene-3-carboxamides upon nucleophilic 
attack by tert-butoxide species 
 
 
 
 
On the other hand, an attempted reaction employing N,N-diphenyl-
carboxamide 230v did not lead to the formation of a cyclopropene (Table 16, entry 
10).  The only product detected by GC/MS analysis of the crude reaction mixture was 
diphenylamine, suggesting this type of substrate has increased carbonyl activity.182   
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Apparently, the less electron rich nitrogen in diphenylamide 230v as compared to 
dialkylamide analogs (Scheme 49), results in a greater positive charge on the carbon 
atom of carbonyl group.  Furthermore, diphenylamide species 241 (R = Ph) makes a 
much better nucleofuge then dialkylamide equivalents, altogether making arylamides 
much more sensitive towards nucleophilic substitution by an alkoxide.  To prove this 
rationale, we tested the dehydrobromination reaction on a series of N-ethyl-N-
arylamides 230w-y.  Expectedly, the reaction of monobromide 230w possessing the 
electron-poor p-NO2C6H4 group resulted in rapid alcoholysis, affording N-ethyl-p-
nitroaniline as the sole reaction product.  It should be mentioned that formation of 
tert-butyl ester 243 was observed in this case at early stages of the reaction183 (Table 
16, entry 11).  Similar results were obtained with phenyl-substituted amide 230x; 
however, product decomposition proceeded much slower, permitting isolation of the 
corresponding cyclopropene 231x in poor yield (Table 16, entry 12).  Finally, more 
electron-rich anisidine-derived amide 230y afforded cyclopropene 231y in moderate 
yield (Table 16, entry 13).  Overall, these results demonstrated a clear-cut trend 
between the electronic nature of the carboxamide and the stability of the 
corresponding product towards nucleophilic attack under the described reaction 
conditions. 
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3.3.3.  Conclusions 
 
In conclusion, a convenient, general protocol for the synthesis of 
cyclopropenes via dehydrobromination of bromocyclopropanes has been developed. 
The new optimized conditions significantly improved the scale-up compatibility of 
the method and allowed for expanding the scope of available cyclopropenes, 
particularly those possessing polar functionalities. Application of the new protocol for 
the efficient preparation of cyclopropene-3-carboxamides has been demonstrated. 
While all the cyclopropenes used in this work have a methyl group at C3, there is no 
indication that the presented synthetic method is limited to this particular type of 
substrates. The latter were chosen for this studies as the most readily available model 
compounds.  
 
3.4.  Rhodium-Catalyzed Hydroformylation of Cyclopropenes 
 
3.4.1.  Introduction 
 
Cyclopropylcarboxaldehydes are arguably some of the most sought after 
compounds in the chemistry of small cycles.  Not only are they themselves important 
biologically active targets, 184  but also are extremely versatile synthons as the 
aldehyde moiety can be readily transformed into a number of useful functionalities.185  
Established synthetic approaches towards these important targets include various 
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modes of [2 + 1] cycloadditions (Scheme 50, path a), such as Michael-initiated ring-
closure reaction (MIRC)186 the cyclization of conjugated aldehydes with carbenoid 
equivalents derived from dihalomethanes, 187 , 188  diazocompounds, 189  nitrogen 
ylides,190 sulphur ylides,191 or arsonium ylides;192 as well as functional group trans-
formations in pre-existing cyclopropyl rings, such as oxidation of 
cyclopropylmethanols (Scheme 50, path b), 193  reduction of cyclopropylcarboxylic 
acid derivatives (Scheme 50, path c),194 and oxidative cleavage of the double bond in 
vinylcyclopropanes (Scheme 50, path d). 195   In light of the recent advances in 
chemistry of cyclopropenes,138,143e-g, 196  we envisioned an alternative approach to 
cyclopropylcarboxaldehydes via catalytic hydroformylation 197  of the cyclopropene 
double bond (Scheme 50, path e).  We hoped to develop a practical, atom economic, 
and mild protocol for the stereoselective installation of a new carbon-carbon bond in 
the three-membered cycle, while avoiding the use of reactive organometallic reagents 
invoked in most C-C bond forming reactions involving cyclopropenes. 138,142c,146, 
198,199
   
 
Scheme 50.  Synthetic Approaches toward Formylcyclopropanes 
 
CHO
OH
CO2R
CHO
a
b
c d
e
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To date, hydroformylation of cyclopropenes is represented by a few stoichio-
metric reactions mediated by HMn(CO)5 or HCo(CO)4, reported by Orchin and 
Noyori.200,201  Orchin first demonstrated that 1,2-substituted cyclopropenes undergo 
hydroformylation in the presence of Mn- and Co-complexes to afford low yields of 
aldehyde 246, accompanied by large amounts of the reduction product 245 (Scheme 
51).  Application of micellar catalysis allowed for improved yields of aldehydes (up 
to 93%); however, this reaction produced mixtures of syn- and anti-addition 
products.200c Later, Noyori investigated the hydroformylation reaction using a 
stoichiometric HMn(CO)5 complex in various solvents, including scCO2, yet was 
unsuccessful in obtaining an aldehyde yield above 40%.201   
 
Scheme 51. 
 
 
 
Herein we report the first examples of catalytic diastereo- and enantioselective 
hydroformylation of prochiral cyclopropenes to produce tri- and tetrasubstituted 
cyclopropylcarboxaldehydes, proceeding under mild conditions and very low catalyst 
loading (Scheme 52). 
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3.4.2.  Results and Discussion 
 
Scheme 52. 
 
 
 
The long-standing challenge associated with the use of coordinatively 
unsaturated electron-deficient transition metal catalysts derived from metal carbonyl 
complexes in cyclopropene chemistry lies in the significantly more facile migratory 
insertion of cyclopropene into a metal-carbon bond (Scheme 53, Path II) as compared 
to the CO insertion step (Path I). Another commonly encountered problem is a very 
fast formal [2 + 2] dimerization of cyclopropenes occurring in the presence of 
electron-poor transition metal reagents (Scheme 53, Path III). 202 , 203   These two 
dominating side processes do not allow efficient incorporation of the carbonyl 
functionality into the final product, leading instead to the formation of polymers and 
mixtures of oligocarbocyclic hydrocarbons and ketones.204  To date, only one highly 
selective carbonylative transformation involving cyclopropenes, the Pauson-Khand 
reaction, has been reported; however, this process requires use of at least 
stoichiometric amounts of metal carbonyl complexes.143d,205   
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Scheme 53.  Mechanistic Pathways for Different Processes Occurring in the Rh(I)-
Catalyzed Hydroformylation of Cyclopropenes 
 
 
In line with the reasoning mentioned above, our initial experiments 
demonstrated that treatment of 3-methyl-3-phenylcyclopropene (231a) with syngas in 
the presence of standard hydroformylation catalyst, Rh(acac)(CO)2, afforded 
quantitatively dimeric product 249 (Scheme 54).  Attempts to suppress the unwanted 
cyclization by saturating the coordination sphere of the transition metal with 
monodentate phosphine ligands206a,b were unsuccessful (Scheme 54).  Next, we tested 
several bidentate diphosphine ligands,206c,d anticipating their chelating effect would 
help stabilize the catalytically active Rh(I) species in a more saturated form.  It was 
found that employment of dppm, dppp, and dppb in combination with Rh(acac)(CO)2 
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allowed for suppressing of the redundant cyclization, however, it did not promote the 
hydroformylation reaction, leading instead to complete recovery of cyclopropene 
231a (Scheme 54).  In contrast, the Rh(acac)(CO)2/dppe combination produced 
desired product 247a in low yield, whereas the analogous complex with a more rigid 
ferrocenyl backbone (dppf) provided complete conversion of 231a into formylcyclo-
propanes 247a and 248a (Scheme 54).  The hydroformylation reaction proceeded 
very diastereoselectively affording less sterically hindered aldehyde 247a as a major 
product.  Remarkably, no products of ring-opening were detected in this reaction. 
Based on the ligand effect observed, it would be reasonable to propose the reaction is 
very sensitive to the ligand bite angle; however, the enhanced catalytic activity of the 
dppf complex might also be explained by the increased electronic density provided by 
the ferrocenyl backbone.  
 
Scheme 54. 
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Preparative scale hydroformylation of 231a also proceeded smoothly under 
these conditions providing aldehyde 247a in high isolated yield.  It was found that as 
little as 0.067 mol % of Rh(I) was enough to drive this reaction to completion under 
very mild conditions (Table 17, entry 1).  Efficient isolation of products could be 
achieved either by column chromatography or by direct vacuum distillation of the 
reaction mixtures.  The scope of this novel transformation was examined on a series 
of 3,3-disubstituted cyclopropenes (Table 17). Cyclopropenes 231f,j bearing 
substituted aryl groups at C3 reacted uneventfully to provide the corresponding 
aldehydes 247f,j (entries 1-3). Both acetal (entry 4) and ester (entry 5) protecting 
groups for a primary alcohol function were perfectly compatible with the reaction 
conditions: the corresponding aldehydes 247z and 247aa were obtained in high yield 
and good selectivity.  The diastereoselectivity of this transformation is largely 
controlled by steric factors. Thus, the reaction of electron-deficient cyclopropene 
231ab provided a nearly equimolar mixture of two diastereomeric cyclopropyl-
carboxaldehydes 247ab and 248ab due to the similar effective size of the substituents 
at C3 (entry 6).  At the same time, the analogous ester derivative bearing a small Me-
group at C3 (231ac) reacted very selectively (entry 7).  Finally, the substrate 
possessing a very bulky Bn-protected tertiary alcohol function (231ad) provided a 
single diastereomer of formylcyclopropane 247ad (entry 8).   We also tested 
hydroformylation reaction of 1,3,3-trisubstituted cyclopropene 231ae, which 
represents a more challenging model, as it can potentially produce four different 
products in the syn-specific addition and, therefore, requires simultaneous control of 
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facial and regioselectivity. It was found that standard reaction conditions using 
0.067 mol % of Rh-catalyst did not produce any reaction with 231ae, presumably, 
due to the increased steric demand in the substrate. However, increasing catalyst 
loading to 1 mol % provided tetrasubstituted cyclopropane 247ae in good yield and 
high regio- and diastereoselectivity (entry 9).   
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Table 17. Rh(I)-Catalyzed Hydroformylation of 3,3-Disubstituted Cyclopropenes 
 
 
Entry R1 R2 R3 
 
Rxn time, hrs 
(246:Rh ratio)a 
Yield of 
247, %c 
dr (247:248)b 
1 Ph Me H 231a 18 (1500:1) 247a 87 11:1 
2 p-Cl-C6H4 Me H 231f 18 (1500:1) 247f 71d 8:1 
3 p-F-C6H4 Me H 231j 18 (100:1) 247j 91d 12:1 
4 Ph CH2OMOM H 231z 36 (1500:1) 247z 72 10:1 
5 Ph CH2OAc H 231aa 36 (1500:1) 247aa 75 7:1 
6 Ph CO2Me H 231ab 18 (1500:1) 247ab 90d 1:1 
7 CO2Me Me H 231ac 36 (1500:1) 247ac 64 24:1 
8 CMe2OBn Me H 231ad 72 (1500:1) 247ad 91 -e 
9 Ph Me Me 231ae 18 (100:1) 247ae 80d 7:1f 
a dppf:Rh molar ratio of 2:1 was employed.  b Determined by 1H NMR analysis of crude reaction 
mixtures. c Isolated yields of a major diastereomer. d Combined isolated yields of two diastereomers. e 
A single diastereomer 247ad was obtained. f Regioselectivity of >10:1 was observed. 
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Naturally, having in hand efficient conditions for the diastereoselective 
hydroformylation, we were very intrigued by the possibility of performing an 
asymmetric hydroformylation of prochiral cyclopropenes (Table 18).  We began our 
optimization207 by testing several commercially available ligands, which were shown 
to produce high enantioselectivities in the asymmetric hydroformylation (AHF) of 
styrene.42,80,81,82,84,85,208 However, all of these ligands provided unsatisfactory results 
in the hydroformylation of cyclopropene 231a.  Thus, Ph-BPE (83),86 reported by 
Klosin as one of the best-performing ligands for the AHF of terminal olefins, 
provided 247a with 42% ee only (Table 18, entry 1). Another highly reputed AHF 
ligand BINAPINE (121) afforded 18% ee in the reaction with 231a (entry 2).  Further 
optimization demonstrated that, generally, all C2-symmetric phospholane ligands 
provided significantly lower enantioselectivities than those observed in the AHF of 
styrenes (entries 3-7).  Next, we screened a series of C1-symmetric ligands with 
planarly chiral ferrocene backbone (entries 8 - 19).  This family of ligands 209 
possesses great structural diversity and a wide spectrum of electronic properties.  
Here again, it was found that several ligands showing respectable selectivities in 
hydroformylation of styrenes, demonstrated less than satisfying results in the reaction 
with 231a (entries 10,11).  And vice versa, the “obvious outsiders” unexpectedly 
produced promising enantioselectivities (entry 19).  While not comprehensive, this 
screening clearly demonstrated that the existing immense experience in ligand 
optimization acquired  
  
161 
Table 18. Ligand Screening in the Asymmetric Hydroformylation of 
3-Methyl-3-phenylcyclopropene (231a). 
 
 
# Ligand 
conv, %             
(NMR) 
drc 
247a:248a 
eed % 
247a  
ee % 
248a  
1 (R,R,R,R)-Ph-BPE (83) 100 12:1 -42 -3 
2 (R)-BINAPINE (121) 49 13:1 +18 +1 
3 (R,R,S,S)-Tangphos (127) 100 2.9:1 +31 -24 
4 (R,R,S,S)-DUANPHOS (126) 100 14:1 +8 -3 
5 (S,S,S,S)-Me-DUPHOS (101) 6 4:1 -10 N/D 
6 (R,R,R,R)-iPr-DUPHOS (104) 100 13:1 -18 +43 
7 CatASium m(R) (86) 0 - - - 
8 Josiphos J001-1 (89) 82 14:1 +14 -6 
9 Josiphos J002-1 (90) 80 10.6:1 +56 -41 
10 Josiphos J003-1 (91) 95 18.5:1 +24 -7 
11 Josiphos- J008-1 (249) 100 14:1 +16 -20 
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 Table 18. Continued     
12 Josiphos- J010-1 (250) 23 27:1 -19 -4 
13 Walphos W001-1 (93) 100 5.4:1 +50 +33 
14 Walphos W002-1 (94) 100 10.3:1 +42 +28 
15 Taniaphos T001-1 (95) 96 7:1 -43 -34 
16 Taniaphos T003-1 (251) 100 12:1 -47 -36 
17 Taniaphos T021-1 (252) <1 - N/D N/D 
18 Mandyphos M001-1 (87) <1 - N/D N/D 
19 Mandyphos M004-1 (88) 100 27:1 -73 +23 
20 (R)-BINAP (80) 84 12:1 -13 +28 
21 (R)-Tol-BINAP (81) 72 13:1 -1 +19 
22 (R)-Xyl-BINAP (82) 52 20:1 +14 -10 
23 CTH-(R)-BINAM (110) 0 - - - 
24 (R)-SYNPHOS (111) 86 15:1 -64 +77 
25 (R)-SOLPHOS (112) 70 22:1 -68 +78 
26 (R)-Xyl-SOLPHOS (113) 50 31:1 -53 N/D 
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 Table 18. Continued     
27 (R)-C3-TUNEPHOS (118) 100 25:1 -74 +78 
28 (R)-DIFLUOROPHOS (114) 86 12:1 -36 +64 
29 BIPHEP SL-A101 (115) 4 13:1 -8 -3 
30 BIPHEP SL-A109 (116) 36 34:1 -45 +10 
31 (R)-Cl-MeO-BIPHEP (117) 64 13:1 -41 +47 
32 CTH-R-P-PHOS (99) 100 15:1 -27 +55 
33 CTH-R-Xyl-P-PHOS (100) 100 36:1 -13 +22 
34 (R,R)-NORPHOS (105) 2 9:1 N/D N/D 
35 (R,R)-DIOP (123) 100 10:1 -16 +27 
36 (S,S)-CHIRAPHOS (107) 91 16:1 -5 +10 
37 (S)-PHANEPHOS (97) 0 - - - 
38 (S)-Xyl-PHANEPHOS (98) 0 - - - 
39 CARBOPHOS (108) 30 11:1 +13 0 
40 (R,R)-BINAPHANE (122) 8 6:1 +2 +20 
41 (R)-SDP (120) 0 - - - 
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 Table 18. Continued     
42 CTH-R-SpiroP (119) 90 5:1 +36 -50 
43 CatASium I (125) <1  N/D N/D 
44 CatASium T2 (106) 7 4.4:1 +2 0 
45 CatASium DR (124) 50 13:1 +12 -6 
46 Rhophos P001-2 (253) 0 - - - 
a
 A Rh:L ratio of 1:1.2 was employed.86 b In the cited literature the opposite enantiomers of these 
ligands were employed; accordingly, the opposite enantiomers of the products were obtained. 
c Determined by 1H NMR analysis of crude reaction mixtures. d Negative values of ee are provided 
when the levorotatory (R,R)-enantiomer was obtained as major product.  Positive values of ee indicate 
the predominant formation of the dextrorotatory (S,S)-product.  
 
 
through the AHF of terminal olefins cannot be directly applied to the 
hydroformylation of small cycles.  Such a discrepancy is not surprising, considering 
the significant difference in geometry, electronic properties, and reactivity of the two 
types of substrates.   
 Accordingly, we performed an independent search for the best catalytic 
system.  To this end, we performed screening of a few more sets of commercially 
available chiral diphosphine ligands, which included a group of C2-symmetric ligands 
with a flexible axially chiral backbone (entries 20-33), and several other types of 
chiral ligands featuring both flexible and rigid scaffolds (entries 34-46).  Although no 
promising results were obtained in the latter case, the screening of the former group 
appeared to be more rewarding.  Thus, promising results were obtained for 
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SYNPHOS (111, entry 24), SOLPHOS (112, entry 25), and DIFLUOROPHOS (114, 
entry 28), while the best conversion and enantioselectivity were attained in the 
presence of C3-TUNEPHOS (118, entry 27). Notably, C3-TUNEPHOS was 
previously reported to be a marginal ligand for the AHF of styrene.86  
3.4.3.  Stereochemical Rational 
 
The following rationale, based on molecular mechanics modeling (UUF), was 
used to account for the origins of diastereo- and enantioselectivity in the asymmetric 
hydroformylation reaction (stereomodels A1 and A2, Figure 22).210   As mentioned 
above, the facial selectivity of the reaction is controlled by sterics, as the approach of 
the rhodium hydride species predominantly occurs from the less hindered face of the 
cyclopropene (i.e., syn- to a smaller substituent, Figure 22).  The absolute 
stereochemistry of the process is determined by the relative orientation of the 
cyclopropene in the resulting rhodium complex (A1 vs A2).  Molecular modeling 
suggests the two pseudo-equatorial phenyl rings at the phosphorus atoms of (R)-C3-
TUNEPHOS obstruct quadrants II and IV (shaded in gray in Figure 22), while 
quadrants I and III, with the pseudo-axial phenyl groups slightly tilted back, remain 
relatively unhindered.211   Accordingly, the orientation of the cyclopropene in the 
trigonal bipyramidal rhodium complex A1 is such that it minimizes the unfavorable 
interaction of the small substituent “S” with the phenyl groups of the ligand, favoring 
complex A1 vs A2, which explains the absolute stereochemistry of the obtained 
products 247a (Figure 22).212 
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Figure 22. Proposed stereomodels for the Rh/(R)-C3-TUNEPHOS-catalyzed 
hydroformylation. 
 
3.4.4.  Scope and Limitation Studies 
 
To investigate the scope of the asymmetric hydroformylation reaction, we 
tested a series of cyclopropenes possessing different substituents at C3 in the presence 
of Rh/C3-TUNEPHOS catalyst (Table 19).  It was found that the enantioselectivity of 
this reaction depended significantly on the substrate nature. Thus, phenyl- and ester-
substituted cyclopropenes 231ac and 231a provided the corresponding 
formylcyclopropanes with 74 % ee (entries 1,3), while hydroformylation of 
cyclopropene 231ad possessing a benzyl-protected tertiary alcohol function afforded 
aldehyde 247ad with only moderate ee of 57 % (entry 2).    Remarkably, in the 
hydroformylation of the 3-arylcyclopropene series (Table 19, entries 3-5), 
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introduction of an electron-withdrawing substituent in the para-position of the aryl 
ring led to a notable improvement of enantioselectivity (entry 4), whereas installation 
of an electron-donating group resulted in deterioration of ee (entry 5).  The reasons 
for this unusual electronic effect are not yet completely understood. Further work to 
improve the enantioselectivity of this asymmetric transformation, and to understand 
the origins of the observed significant electronic effect on the enantioinduction of 
hydroformylation, is currently underway in our laboratories. 
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Table 19. Rh-Catalyzed Asymmetric Hydroformylation of 3,3-Disubstituted 
Cyclopropenes 
 
# R1  
246: 
[Rh] ratio 
dr 
(247:248) 
ee % 
247 
Yield, 
% 
[α]D 
(conc., CH2Cl2) 
1 CO2Me 231ac 750:1 22:1 74 63 -109.8 (c 1.17) 
2 CMe2OBn 231ad 375:1 247 only 57 82 -24.6 (c 1.25) 
3 Ph 231a 750:1 25:1 74 86 -114.3 (c 1.42) 
4 p-Cl-C6H4 231f 375:1 17:1 83 54 -137.8 (c 0.64) 
5 p-Me-C6H4 231b 750:1 17:1 68 78 -128.1 (c 1.56) 
 
3.4.5.  Conclusions 
 
In conclusion, we demonstrated the first catalytic diastereo- and 
enantioselective hydroformylation of prochiral cyclopropenes proceeding under very 
mild conditions and low loadings of the Rh(I)-catalyst.  Optimization of the reaction 
protocol allowed for complete suppression of the dominating side processes, and 
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permitted design of a novel, efficient catalytic carbonylative transformation amenable 
for scale-up production. This methodology opens new avenues toward efficient 
preparation of optically active cyclopropylcarboxaldehydes, valuable building blocks 
for synthetic chemistry.   
 
3.5.  Experimental Section 
 
3.5.1  Improved Preparative Route toward 3-Arylcyclopropenes (DMSO 
Method) 
 
3.5.2.  General Information 
 
See Chapter 1.4.1. for instrumentation details.   
Anhydrous dimethylsulfoxide was purchased form Acros Organics and used 
as received.  Anhydrous diethyl ether and tetrahydrofuran were obtained by passing 
degassed HPLC-grade commercially available solvents consecutively through two 
columns with activated alumina (Innovative Technology).    All other chemicals were 
purchased from Sigma-Aldrich or Acros Organics, and used as received. 
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3.5.3.  Preparation of dibromocyclopropanes  
 
Typical procedure:  
229f: Magnesium turnings (1.44 g, 60 mmol) were stirred in 
anhydrous ether (60 mL) and methyl iodide (3.7 mL) was added 
dropwise maintaining moderate reflux of the reaction mixture.  Then 
the mixture was stirred for 30 min and ethyl p-chlorobenzoate (3.50 
g, 19 mmol) in ether (10 mL) was added dropwise.  The resulting mixture was stirred 
for 2 hrs, then quenched with saturated aqueous NH4Cl and extracted with ether.  
Combined ethereal layers were washed consecutively with 5% aqueous HCl, 10% 
NaHCO3, and brine, dried with MgSO4, filtered and concentrated.   The residue was 
dissolved in toluene (50 mL), p-toluenesulfonic acid (100 mg) was added, and the 
mixture was stirred at reflux for 2 hrs.  When GC analysis showed the reaction 
complete, the mixture was cooled to room temperature, and quenched with aqueous 
NaHCO3.  The organic phase was separated, aqueous layer was extracted with EtOAc 
(2 x 30 mL).  The combined organic phases were washed with brine, dried with 
MgSO4, filtered and concentrated.  To the vigorously stirred solution of the resulting 
residue, bromoform (61 mmol, 4.9 mL) and cetrimide (100 mg) in dichloromethane 
(20 mL), 50 % aqueous solution of NaOH (5 mL) was added dropwise.  The stirring 
at room temperature was continued for 24 hrs, when GC analysis showed the reaction 
complete.  Then the mixture was quenched with water (100 mL) and extracted with 
dichloromethane (3 x 50 mL).  Combined organic phases were washed consecutively 
with dilute aqueous HCl, water, and brine, then dried with MgSO4, filtered and 
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concentrated in vacuum.  Flash column chromatography of the residual oil on Silica 
gel (eluent - hexane) gave dibromocyclopropane 229f as colorless oil.  Overall yield 
5.63 g (17.4 mmol, 91 %).  
 
1H NMR (CDCl3, 400.13 MHz) δ 7.36 (d, J = 8.0 Hz, 2H), 7.26 (d, J = 8.0 Hz, 2H), 
2.15 (d, J = 7.6 Hz, 1H), 1.81 (d, J = 7.6 Hz, 1H), 1.72 (s, 3H); 13C NMR (CDCl3, 
100.61 MHz) δ 140.8, 133.0, 129.9 (+, 2C), 128.6 (+, 2C), 36.0, 35.2, 33.8 (-), 27.5 
(+). GC/MS (EI 70 eV) 12.01 min, m/z 324 (M+, <1%), 309 (M-Me, 1%)+, 245 
(34%), 163 (55%), 129 (100%);  HRMS (TOF ES) Found 242.9578, Calculated for 
C10H9BrCl (M-Br) 242.9576 (0.1 ppm). 
 
229b:213  1H NMR (400.13 MHz, CDCl3) δ 7.25 (d, J = 8.3 Hz, 2H), 
7.22 (d, J = 8.3 Hz, 2H), 2.40 (s, 3H), 2.19 (d, J = 7.6 Hz, 1H), 1.81 (d, 
J = 7.6 Hz, 1H), 1.75 (s, 3H); 13C NMR (100.67 MHz, CDCl3) δ 139.3, 
136.9, 129.1 (+, 2C), 128.3 (+, 2C), 37.1, 35.4, 33.7 (+), 27.7 (-), 21.2 (+);  HRMS 
(TOF ES) Found 223.0122, Calculated for C11H12Br (M-Br) 223.0122 (0.0 ppm). 
 
229c:  1H NMR (400.13 MHz, CDCl3) δ 7.28 (t, J = 7.8 Hz, 1H), 
7.15 (s, 1H), 7.14 (d, J = 7.8 Hz, 2H), 2.41 (s, 3H), 2.19 (d, J = 7.6 
Hz, 1H), 1.80 (d, J = 7.6 Hz, 1H), 1.74 (s, 3H);  13C NMR (100.67 
MHz, CDCl3) δ 142.2, 138.0, 129.2 (+), 128.2 (+), 128.0 (+), 125.5 (+), 36.9, 35.7, 
33.7 (-), 27.8 (+), 21.5 (+);  HRMS (TOF ES) Found 223.0114, Calculated for 
C11H12Br (M-Br) 223.0122 (3.6 ppm). 
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229d:214  1H NMR (400.13 MHz, CDCl3) δ 7.29 (d, J = 7.6 Hz, 1H), 
7.25 (ps.-t, J = 7.6 Hz, 7.1 Hz, 1H), 7.19 (ps.-t, J = 7.3 Hz, 7.1 Hz, 
1H), 7.13 (d, J = 7.3 Hz, 1H), 2.58 (s, 3H), 2.14 (d, J = 7.3 Hz, 1H), 
1.84 (d, J = 7.3 Hz, 1H), 1.69 (s, 3H);  13C NMR (100.67 MHz, CDCl3) δ 140.9, 
137.6, 130.8 (+), 128.4 (+), 127.3 (+), 126.0 (+), 37.7, 35.8, 34.4 (-), 25.7 (+), 20.0 
(+); 
   
229e:  1H NMR (400.13 MHz, CDCl3) δ 7.40 (d, J = 8.3 Hz, 2H), 
7.26 (d, J = 8.3 Hz, 2H), 2.19 (d, J = 7.6 Hz, 1H), 1.80 (d, J = 7.6 
Hz, 1H), 1.74 (s, 3H), 1.36 (s, 9H);  13C NMR (100.67 MHz, 
CDCl3) δ 150.0, 139.2, 128.0 (+, 2C), 125.2 (+, 2C), 37.1, 35.3, 
34.5, 33.7 (+), 31.4 (+, 3C), 27.7 (-); HRMS (TOF ES) Found 265.0588, Calculated 
for C14H18Br (M-Br) 265.0592 (1.5 ppm). 
 
229g:  1H NMR (CDCl3, 400.13 MHz) δ major atropomer: 7.47 (m, 
1H), 7.28-7.24 (m, 2H), 7.20 (m, 1H), 2.11 (d, J = 7.6 Hz, 1H), 1.84 
(d, J = 7.6 Hz, 1H), 1.75 (s, 3H); minor atropomer: 7.59 (dd, J = 7.6 
Hz, 1.8 Hz, 1H), 7.38 (dd, J = 7.7 Hz, 1.3 Hz, 1H), 7.33 (td, J = 7.6 Hz, 1.3 Hz, 1H), 
7.28 (m, 1H), 2.21 (d, J = 8.1 Hz, 1H), 2.05 (d, J = 8.1 Hz, 1H), 1.69 (s, 3H); 13C 
NMR (CDCl3, 100.61 MHz) δ major atropomer: 140.4, 135.2, 130.2 (+), 130.0 (+), 
128.7 (+), 127.0 (+), 36.2, 35.6, 34.3 (-), 24.5 (+); minor atropomer: 138.8, 134.1, 
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132.7 (+), 130.1 (+), 128.5 (+), 126.4 (+), 37.5 (-), 36.2, 34.1, 27.1 (+); GC/MS (EI 
70 eV) 11.75 min, m/z 324 (M+, <1%), 309 (M-Me, 3%)+, 245 (35%), 163 (58%), 
129 (100%);  HRMS (TOF ES) Found 242.9576, Calculated for C10H9BrCl (M-Br) 
242.9576 (0.0 ppm). 
 
229h:  1H NMR (400.13 MHz, CDCl3) δ 7.65 (d, J = 8.3 Hz, 2H), 
7.46 (d, J = 8.3 Hz, 2H), 2.21 (d, J = 7.6 Hz, 1H), 1.87 (d, J = 7.6 
Hz, 1H), 1.75 (s, 3H); 13C NMR (100.67 MHz, CDCl3) δ 146.2, 
129.5 (q, 2JCF = 32.9 Hz), 129.0 (+, 2C), 125.4 (q, 3JCF = 3.7 Hz, +, 2C), 124.1 (q, 
1JCF = 272.3 Hz), 35.5, 35.2, 33.8 (-), 27.5 (+); 19F NMR (376.50 MHz, CDCl3) δ -
62.4; HRMS (TOF ES) Found 276.9843, Calculated for C11H9BrF3 (M-Br) 276.9840 
(1.1 ppm). 
 
229i:  1H NMR (400.13 MHz, CDCl3) δ 8.23 (d, J = 8.6 Hz, 1H), 
7.96 (d, J = 8.1 Hz, 1H), 7.85 (d, J = 8.1 Hz, 1H), 7.71 (ps.t, J = 
7.3 Hz, 7.1 Hz, 1H), 7.59 (t, J = 7.3 Hz, 1H), 7.46 (ps.t, J = 7.8 
Hz, 7.3 Hz, 1H), 7.36 (d, J = 7.1 Hz, 1H), 2.31 (d, J = 7.6 Hz, 1H), 2.01 (d, J = 7.6 
Hz, 1H), 1.88 (s, 3H); 13C NMR (100.67 MHz, CDCl3) δ 139.7, 134.0, 131.4, 128.6 
(+), 128.0 (+), 126.2 (+), 126.0 (+), 125.9 (+, 2C), 125.4 (+), 37.3, 35.4, 34.4 (-), 27.0 
(+); HRMS (TOF ES) Found 259.0130, Calculated for C14H12Br (M-Br) 259.0122 
(3.1 ppm). 
 
Br
Br
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3.5.4.  Preparation of dibromocyclopropanes from acid-sensitive styrenes  
 
Alternative procedure: 
Scheme 55. 
 
 
 
229j:  To a stirred at 0 °C suspension of methyltriphenylphosphonium 
bromide (41.37 g, 115.8 mmol, 1.6 equiv.) in anhydrous THF (175 
mL) was added dropwise solution of potassium tert-butoxide (7.76 g, 
69.13 mmol, 0.955 equiv.)  The resulting yellow suspension was 
stirred for 1 hr at 0 °C, then p-fluoroacetophenone (10.0 g, 8.7 mL, 72.39 mmol) was 
added dropwise.  The mixture was stirred overnight, then quenched with aqueous 
NH4Cl, and partitioned between water and diethyl ether.  The ethereal extract was 
dried with Na2SO4, filtered, and concentrated.  The residue was purified by short 
column chromatography (eluent - hexane) to afford p-fluoro-α-methylstyrene (10e) as 
a colorless oil.  Yield 7.68 g (56.4 mmol, 82%).  This material without further 
purification was mixed with bromoform (25.22 g, 8.7 mL, 99.8 mmol, 1.66 equiv.), 
benzyltriethylammonium chloride (TEBAC) (117 mg, 0.51 mmol, 0.85 mol%), and 
dichloromethane (20 mL).  The mixture was vigorously stirred, and 50% aqueous 
solution of sodium hydroxide was added dropwise.  The mixture was stirred (900-
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1100 rpm) overnight at 30-35 °C, when GC/MS analysis indicated full conversion of 
the olefin.  Then, the mixture was quenched with water (100 mL) and extracted with 
dichloromethane (3 x 50 mL).  Combined organic phases were washed with brine, 
dried with MgSO4, filtered and concentrated.  The residue was purified by flash 
column chromatography on silica gel, eluting with hexane.  Yield 14.63 g (50.97 
mmol, 86%).   
 
1H NMR (CDCl3, 400.13 MHz) δ 7.31 (dd, J = 8.3 Hz, 4JHF = 5.3 Hz, 2H), 7.07 (ps.-t, 
J = 3JHF = 8.3 Hz, 2H), 2.16 (d, J = 7.6 Hz, 1H), 1.82 (d, J = 7.6 Hz, 1H), 1.73 (s, 
3H); 13C NMR (CDCl3, 100.61 MHz) δ 161.8 (d, 1JCF = 245.9 Hz), 138.1 (d, 4JCF = 
3.7 Hz), 130.1 (d, 3JCF = 8.1 Hz, +, 2C), 115.3 (d, 2JCF = 21.2 Hz, +, 2C), 36.4, 35.1, 
33.8 (-), 27.7 (+);  HRMS (TOF ES) Found 226.9872, Calculated for C10H9BrF (M-
Br) 226.9872 (1.3 ppm). 
 
229k:155  1H NMR (400.13 MHz, CDCl3) δ 7.25 (d, J = 8.6 Hz, 
2H), 6.92 (d, J = 8.6 Hz, 2H), 3.84 (s, 3H), 2.15 (d, J = 7.6 Hz, 
1H), 1.78 (d, J = 7.6 Hz, 1H), 1.73 (s, 3H);  13C NMR (CDCl3, 
100.61 MHz) δ 158.6, 134.5, 129.5 (+, 2C), 113.7 (+, 2C), 55.2 
(+), 37.4, 35.1, 33.7 (-), 27.7 (+);  
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229l: 1H NMR (CDCl3, 400.13 MHz)  7.32 (td, J = 7.8 Hz, 1.8 
Hz, 1H), 7.09 (dd, J = 7.6 Hz, 1.8 Hz, 1H), 6.97 (d, J = 8.3 Hz, 
1H), 6.95 (ps.-t, J = 8.3 Hz, 7.6 Hz, 1H), 3.99 (s, 3H), 2.05 (d, J = 
7.6 Hz, 1H), 1.77 (d, J = 7.6 Hz, 1H), 1.69 (s, 3H);  13C NMR (CDCl3, 100.61 MHz) 
δ 158.1, 131.2, 128.9 (+), 128.6 (+), 120.4 (+), 110.8 (+), 55.6 (+), 37.5, 34.1 (-), 
34.0, 24.6 (+);  HRMS (TOF ES) Found 239.0072, Calculated for C11H12BrO (M-Br) 
239.0072 (0.0 ppm). 
 
229n: Flash column chromatography on silica gel (eluent - 
hexane) gave clear oil, yield 10.31 g (30.3 mmol, 66%).   
 
1H NMR (400.13 MHz, CDCl3) δ 7.90 (m, 4H), 7.76 (s, 1H), 7.56 (m, 2H), 2.36 (d, J 
= 7.6 Hz, 1H), 1.91 (d, J = 7.6 Hz, 1H), 1.85 (s, 3H); 13C NMR (100.61 MHz, CDCl3) 
δ 140.0, 133.3, 132.6, 128.2 (+), 127.9 (+), 127.8 (+), 127.0 (+), 126.9 (+), 126.3 (+), 
126.1 (+), 36.7, 36.0, 33.9 (-), 27.7 (+).  
 
229o: Quick filtration through a short plug of silica gel (eluent: 
hexane) afforded clear oil, yield 10.14 g (32.9 mmol, 88%).   
 
1H NMR (400.13 MHz, CDCl3) δ 7.31 (m, 2H), 7.15 (m, 2H), 2.14 (br. d, J = 7.6 Hz, 
1H), 1.84 (br. s, 1H), 1.72 (s, 3H); 13C NMR (100.61 MHz, CDCl3) δ 160.2 (d, 1JCF = 
250.3 Hz), 130.0 (br.), 129.7 (+, br.), 129.2 (+, d, J = 8.0 Hz), 124.2 (+), 115.8 (+, d, 
Br
Br
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2JCF = 21.2 Hz), 35.5 (br.), 33.8 (-, br.), 25.1 (br.), 14.1 (+, br.); 19F NMR (376.50 
MHz, CDCl3) δ -113.6.  
 
229m: [2 + 1] cycloaddition of dibromocarbene to olefin 228m was 
carried out according to the typical procedure described above.  The 
reaction was performed in 2.37 mmol scale, and afforded 674.8 mg 
(2.01 mmol, 85%) of dibromocyclopropane 229m.   
 
1H NMR (400.13 MHz, CDCl3) δ 8.24 (d, J = 8.8 Hz, 2H), 7.50 (d, J = 8.8 Hz, 2H), 
2.23 (d, J = 7.8 Hz, 2H), 1.92 (d, J = 7.8 Hz, 2H), 1.75 (s, 3H);  13C NMR (100.67 
MHz, CDCl3) δ 149.5, 145.0, 129.6 (+, 2C), 123.7 (+, 2C), 35.5, 34.5, 33.9 (-), 27.3 
(+). 
 
3.5.5.  Partial reduction of dibromocyclopropanes: 
 
Typical procedure: 
230f:  To a stirred solution of dibromocyclopropane 229f (5.63 g, 
17.4 mmol) and titanium (IV) isopropoxide (10 mol%, 1.7 mmol, 490 
µL) in anhydrous diethyl ether (50 mL) was added dropwise 3M 
solution of ethylmagnesium bromide (21 mmol, 7.0 mL).  When 
intensive gas evolution had ceased, the mixture was stirred at room temperature for 2 
hrs, then cooled in an ice bath and quenched by consecutive addition of water (10 
Br
Br
NO2
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mL) and 10 % aqueous sulfuric acid (20 mL).   Organic phase was separated; aqueous 
layer was extracted with ether (3 x 25 mL).  Combined ethereal phases were washed 
consecutively with 10% aqueous NaHCO3 and brine, dried with MgSO4, filtered, and 
concentrated in vacuum.   The residue was purified by flash column chromatography 
on Silica gel (eluent – hexane) to afford bromocyclopropane 230f as colorless oil 
(mixture of two diastereomers 1.8:1).215  Yield 3.08 g (12.5 mmol, 72%).  1H NMR 
(CDCl3, 400.13 MHz) δ major: 7.29 (d, J = 8.3 Hz, 2H), 7.21 (d, J = 8.3 Hz, 2H), 
3.20 (dd, J = 8.0 Hz, 4.8 Hz, 1H), 1.64 (ps.t, J = 8.0 Hz, 7.2 Hz, 1H), 1.62 (s, 3H), 
3.20 (dd, J = 7.2 Hz, 4.8 Hz, 1H); minor: 7.35 (d, J = 8.3 Hz, 2H), 7.28 (d, J = 8.3 Hz, 
2H), 3.11 (dd, J = 7.4 Hz, 4.5 Hz, 1H), 1.46 (s, 3H), 1.41 (ps.t, J = 7.4 Hz, 6.8 Hz, 
1H), 1.37 (dd, J = 6.8 Hz, 4.5 Hz, 1H);  13C NMR (CDCl3, 100.61 MHz) δ major: 
142.9, 132.2, 128.6 (+, 2C), 128.4 (+, 2C), 30.1 (+), 25.3, 23.8 (+), 23.3 (-); minor: 
140.7, 132.5, 130.7 (+, 2C), 128.3 (+, 2C), 27.9 (+), 27.0, 26.8 (+), 22.2;  GC/MS (EI 
70 eV) major: 10.80 min, m/z 246 (M+,
 
<1%), 165 (M-Br, 100%); minor: 10.65 min, 
m/z 246 (M+,
 
<1%), 165 (M-Br, 100%),  HRMS (TOF ES) Found 165.0047, 
Calculated for C10H10Cl (M-Br) 165.0470 (0.6 ppm). 
 
230b:  1H NMR (CDCl3, 400.13 MHz) δ major: 7.17 (d, J = 8.3 Hz, 
2H), 7.14 (d, J = 8.3 Hz, 2H), 3.23 (dd, J = 7.8 hz, 4.3 Hz, 1H), 2.35 (s, 
3H), 1.65 (ps.-t, J = 7.8 Hz, 6.5 Hz, 1H), 1.62 (s, 3H), 1.07 (dd, J = 6.5 
Hz, 4.6 Hz, 1H); minor: 7.25 (d, J = 8.1 Hz, 2H), 7.20 (d, J = 8.1 Hz, 2H), 3.11 (dd, J 
= 7.2 Hz, 4.6 Hz, 1H), 2.38 (s, 3H), 1.47 (s, 3H), 1.40-1.37 (m, 2H);  13C NMR 
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(CDCl3, 100.61 MHz) δ major 141.5, 136.1, 129.2 (+, 2C), 126.9 (+, 2C), 30.6 (+), 
25.4, 24.0 (+), 23.2 (-), 21.0 (+); minor 139.2, 136.3, 129.2 (+, 2C), 128.9 (+, 2C), 
28.4 (+), 27.2, 27.0 (+), 22.1 (-), 21.1 (+); HRMS (TOF ES) Found 223.0121, 
Calculated for C11H12Br (M-H) 223.0122 (0.4 ppm). 
 
230c:  1H NMR (CDCl3, 400.13 MHz) δ major: 7.36-7.11 (m, 4H), 
3.31 (dd, J = 8.1 Hz, 4.8 Hz, 1H), 2.43 (s, 3H), 1.72 (ps.-t, J = 8.1 
Hz, 6.3 Hz, 1H), 1.70 (s, 3H), 1.14 (dd, J = 6.3 Hz, 4.8 Hz, 1H); 
minor: 7.36-7.11 (m, 4H), 3.15 (dd, J = 7.6 Hz, 4.3 Hz, 1H), 2.47 (s, 3H), 1.53 (s, 
3H), 1.48-1.41 (m, 2H); 13C NMR (CDCl3, 100.61 MHz) δ major: 144.4, 138.1, 128.4 
(+), 127.8 (+), 127.2 (+), 124.0 (+), 30.6 (+), 27.0 (+), 25.7, 24.0 (+), 23.2 (-); minor: 
142.0, 137.6, 130.1 (+), 128.0 (+), 127.6 (+), 126.4 (+), 28.3 (+), 27.5 (+), 22.0 (-), 
21.5, 21.4 (+); HRMS (TOF ES) Found 223.0123, Calculated for C11H12Br (M-H) 
223.0122 (0.4 ppm). 
 
230d:  1H NMR (CDCl3, 400.13 MHz) δ 7.24-7.21 (m, 1H), 7.18-7.14 
(m, 3H), 3.22 (dd, J = 8.1 Hz, 4.6 Hz, 1H), 2.43 (s, 3H), 1.57 (ps.-t, J = 
8.1 Hz, 6.3 Hz, 1H), 1.52 (s, 3H), 1.09 (dd, J = 6.3 Hz, 4.6 Hz, 1H);  
13C NMR (CDCl3, 100.61 MHz) δ 142.7, 137.2, 130.6 (+), 128.9 (+), 126.9 (+), 126.0 
(+), 30.8 (+), 26.1, 23.3 (+), 23.2 (-), 19.3 (+);  HRMS (TOF ES) Found 208.9958, 
Calculated for C10H10Br (M-Me) 208.9966 (3.8 ppm). 
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230e:  1H NMR (CDCl3, 400.13 MHz) δ major: 7.41 (d, J = 8.3 Hz, 
2H), 7.26 (d, J = 8.3 Hz, 2H), 3.30 (dd, J = 7.8 Hz, 4.8 Hz, 1H), 
1.73 (dd, J = 7.8 Hz, 6.3 Hz, 1H), 1.42 (s, 3H), 1.40 (s, 9H), 1.14 
(dd, J = 6.3 Hz, 4.8 Hz, 1H); minor 7.45 (d, J = 8.3 Hz, 2H), 7.34 
(d, J = 8.3 Hz, 2H), 3.16 (dd, J = 7.3 Hz, 4.3 Hz, 1H), 1.70 (s, 3H), 1.47-1.43 (m, 
2H), 1.42 (s, 9H);  13C NMR (CDCl3, 100.61 MHz) δ major: 149.3, 141.3, 126.5 (+, 
2C), 125.4 (+, 2C), 34.4, 31.3 (+, 3C), 30.7 (+), 25.1, 23.8 (+), 23.4 (-);  minor: 149.4, 
139.0, 128.9 (+. 2C), 125.0 (+, 2C), 34.4, 31.4 (+, 3C), 28.5 (+), 27.1, 27.0 (+), 22.1 
(-);  HRMS (TOF ES) Found 187.1491, Calculated for C14H19 (M-Br) 187.1487 (2.1 
ppm). 
 
230g:  1H NMR (CDCl3, 400.13 MHz) δ major: 7.40-7.37 (m, 1H), 
7.34-7.31 (m, 1H), 7.26-7.18 (m, 2H), 3.28 (dd, J = 8.3 Hz, 4.9 Hz, 
1H), 1.61 (dd, J = 8.3 Hz, 6.2 Hz, 1H), 1.59 (s, 3H), 1.16 (dd, J = 6.2 
Hz, 4.9 Hz, 1H);  13C NMR (CDCl3, 100.61 MHz) δ major: 141.9, 135.0, 130.5 (+), 
129.9 (+), 128.2 (+), 126.9 (+), 30.3 (+), 26.1, 23.4 (-), 22.6 (+);  HRMS (TOF ES) 
Found 165.0478, Calculated for C10H10Cl (M-Br) 165.0471 (4.2 ppm). 
 
230h:  1H NMR (400.13 MHz, CDCl3) δ major: 7.59 (d, J = 8.2 Hz, 
2H), 7.39 (d, J = 8.2 Hz, 2H), 3.24 (dd, J = 8.1 Hz, 4.8 Hz, 1H), 
1.71 (dd, J = 8.1 Hz, 6.6 Hz, 1H), 1.66 (s, 3H), 1.17 (dd, J = 6.6 Hz, 
4.8 Hz, 1H); minor: 7.64 (d, J = 8.0 Hz, 2H), 7.47 (d, J = 8.0 Hz, 2H), 3.14 (dd, J = 
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7.5 Hz, 4.4 Hz, 1H), 1.50 (s, 3H), 1.47 (dd, J = 7.5 Hz, 6.6 Hz, 1H), 1.43 (dd, J = 6.6 
Hz, 4.4 Hz, 1H); 13C NMR (100.67 MHz, CDCl3) δ major: 148.4, 128.8 (q, 2JCF = 
32.9 Hz), 127.4 (+, 2C), 125.5 (q, 3JCF = 3.7 Hz, +, 2C), 124.1 (q, 1JCF = 272.3 Hz), 
30.0 (+), 25.6, 23.54 (+), 23.49 (-); minor: 146.2, 129.8 (+, 2C), 129.0 (q, 2JCF = 32.9 
Hz), 125.2 (q, 3JCF = 3.7 Hz, +, 2C), 124.1 (q, 1JCF = 271.5 Hz), 27.5 (+), 26.6 (+), 
25.6, 22.3 (-);  19F NMR (376.50 MHz, CDCl3) δ major: -62.44; minor: -62.37;  
GC/MS: major (Rt = 9.40 min) 278 (M+, <1%), 259 (M+ – F, 1%) , 209 (M+ – CF3, 
1%), 199 (M+ – Br, 100%); minor (Rt = 9.22 min) 278 (M+, <1%), 259 (M+ – F, 1%) , 
209 (M+ – CF3, 1%), 199 (M+ – Br, 100%).  HRMS (TOF ES) Found 199.0734, 
Calculated for C11H10F3 (M-Br) 199.0735 (0.5 ppm). 
 
 230i:  1H NMR (CDCl3, 400.13 MHz) δ 8.24 (d, J = 8.3 Hz, 1H), 
7.91 (d, J = 8.1 Hz, 1H), 7.79 (dd, J = 6.3 Hz, 3.3 Hz, 1H), 7.63 
(td, J = 8.3 Hz, 1.7 Hz, 1H), 7.55 (td, J = 8.1 Hz, 1.0 Hz, 1H), 
7.46-7.43 (m, 2H), 3.39 (d, J = 8.1 Hz, 4.5 Hz, 1H), 1.75 (s, 3H), 1.76 (m, 1H), 1.28 
(dd, J = 6.3 Hz, 4.5 Hz, 1H);  13C NMR (CDCl3, 100.61 MHz) δ 141.1, 134.0, 131.6, 
128.8 (+), 127.6 (+), 126.3 (+), 126.0 (+), 125.7 (+), 125.5 (+), 124.8 (+), 30.8 (+), 
25.6, 24.2 (+), 23.1 (-); HRMS (TOF ES) Found 181.1014, Calculated for C14H13 (M-
Br) 181.1017 (1.7 ppm). 
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230j:  1H NMR (CDCl3, 400.13 MHz) δ major: 7.25 (dd, J = 8.6 Hz, 
4JHF = 5.3 Hz, 2H), 7.02 (ps.-t, J = 3JHF = 8.6 Hz, 2H), 3.22 (dd, J = 
7.8 Hz, 4.8 Hz, 1H), 1.64 (dd, J = 7.8 Hz, 6.3 Hz, 1H), 1.62 (s, 3H), 
1.10 (dd, J = 6.3 Hz, 4.8 Hz, 1H);  minor: 7.31 (dd, J = 8.8 Hz, 4JHF = 5.6 Hz, 2H); 
7.07 (ps.-t, J = 3JHF = 8.8 Hz, 2H), 3.11 (dd, J = 7.3 Hz, 4.3 Hz, 1H), 1.47 (s, 3H), 
1.41 (dd, J = 7.3 Hz, 6.8 Hz, 1H), 1.37 (dd, J = 6.8 Hz, 4.3 Hz, 1H); 13C NMR 
(CDCl3, 100.61 MHz) δ major: 161.4 (d, 1JCF = 245.2 Hz), 140.2 (d, 4JCF = 2.9 Hz), 
128.7 (d, 3JCF = 8.1 Hz, +, 2C), 115.3 (d, 2JCF = 21.2 Hz, +, 2C), 30.1 (+), 25.3, 24.1 
(+), 23.2 (-); minor: 161.6 (d, 1JCF = 245.2 Hz), 138.0 (d, 4JCF = 3.7 Hz), 130.9 (d, 
3JCF = 8.1 Hz, +, 2C), 115.0 (d, 2JCF = 21.2 Hz, +, 2C), 28.1 (+), 26.97 (+), 26.94, 
22.3 (-);  HRMS (TOF ES) Found 149.0767, Calculated for C10H10F (M-Br) 149.0767 
(0.7 ppm). 
 
230k:155  1H NMR (CDCl3, 400.13 MHz) δ major: 7.20 (d, J = 8.7 
Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 3.82 (s, 3H), 3.22 (dd, J = 8.3 
Hz, 4.8 Hz, 1H), 1.63 (dd, J = 8.7 Hz, 4.1 Hz, 1H), 1.62 (s, 3H), 
1.07 (dd, J = 6.1 Hz, 4.8 Hz, 1H); minor: 7.28 (d, J = 8.7 Hz, 2H), 6.93 (d, J = 8.7 Hz, 
2H), 3.84 (s, 3H), 3.11 (ps.-t), 1.46 (s, 3H), 1.37 (d, J = 5.8 Hz, 2H);  13C NMR 
(CDCl3, 100.61 MHz) δ major: 158.2, 136.6, 128.1 (+, 2C), 113.9 (+, 2C), 55.3 (+), 
30.5 (+), 25.2, 24.2 (+), 23.2 (-);  minor: 158.3, 134.4, 130.4 (+, 2C), 113.5 (+, 2C), 
55.1 (+), 28.7 (+), 27.1 (+), 26.9, 22.2 (-); 
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230l:  1H NMR (CDCl3, 400.13 MHz) δ major: 7.29-7.23 (m, 2H), 
6.96 (t, J = 7.5 Hz, 1H), 6.91 (d, J = 8.1 Hz, 1H), 3.92 (s, 3H), 3.25 
(dd, J = 7.8 Hz, 4.8 Hz, 1H), 1.57 (s, 3H), 1.54 (ps.-t, J = 7.8 Hz, 
6.1 Hz, 1H), 1.07 (dd, J = 6.1 Hz, 4.8 Hz, 1H); minor: 7.35-7.26 (m, 2H), 7.01-6.96, 
m, 2H), 3.93 (s, 3H), 3.17 (dd, J = 7.6 Hz, 4.3 Hz, 1H), 1.46 (s, 3H), 1.39 (dd, J = 7.6 
Hz, 6.3 Hz, 1H), 1.31 (dd, J = 6.3 Hz, 4.3 Hz, 1H);  13C NMR (CDCl3, 100.61 MHz) 
δ major: 158.3, 132.6, 129.4 (+), 128.0 (+), 120.3 (+), 110.6 (+), 55.29 (+), 30.6 (+), 
23.6, 22.84 (+), 22.78 (-); minor: 158.6, 130.7 (+), 130.5, 128.2 (+), 120.2 (+), 110.7 
(+), 55.32 (+), 28.4 (+), 25.4, 24.3 (+), 22.6 (-);  HRMS (TOF ES) Found 161.0968, 
Calculated for C11H13O (M-Br) 161.0966 (1.2 ppm). 
 
230n: was obtained as a mixture of diastereomers in a ratio of 
~2:1 as determined by 1H NMR. Isolated and purified via short 
column chromatography on silica gel (eluent - hexane) to afford 
an opaque, slowly crystallizing oil.  Yield 5.185 g (30.3 mmol, 73%).  
 
1H NMR (400.13 MHz, CDCl3) δ [7.84 (m), Σ4H], [7.72 (s), Σ1H], [7.50 – 7.42 (m), 
Σ2H], [3.35 (dd, J = 8.1 Hz, 4.5 Hz) & 3.19 (dd, J = 7.3 Hz, 4.3 Hz), Σ1H], [1.81 
(ps.t, J = 6.6 Hz) & 1.57 (m), Σ1H], [1.74 (s) & 1.57 (s), Σ3H], [1.49 (ps.t, J = 7.3 
Hz) & 1.02 (ps.t, J = 6.1 Hz), Σ1H], [1.19 (dd, J = 6.3 Hz, 4.6 Hz) & 0.85 (dd, J = 5.8 
Hz, 4.0 Hz), Σ1H]; 13C NMR (100.61 MHz, CDCl3) δ 141.9, 140.0, 139.9, 133.4, 
132.5, 132.2, 128.4 (+), 128.0 (+), 127.9 (+), 127.8 (2C, +), 127.7 (2C, +), 127.6 (2C, 
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+), 126.3 (+), 125.9 (+), 125.7 (+), 125.6 (+), 125.5 (+), 30.4 (+), 28.3 (+), 27.9, 26.9 
(+), 26.3, 24.1 (+), 23.3 (-), 22.3 (-); HRMS (TOF ES) Found 181.1022, Calculated 
for C14H13 (M-Br) 181.1017 (2.8 ppm). 
 
230o: was purified through flash chromatography on silica gel (eluent 
- hexane) to afford a mixture of diastereomers in a ratio of ~ 2:1 as a 
colorless oil.  Yield 6.89 g (30.1 mmol, 91%).   
 
1H NMR (400.13 MHz, CDCl3) δ [7.27 (m), & 7.09 (m) Σ 4H], [3.27 (dd, J = 8.3, 4.8 
Hz) & 3.15 (dd, J = 7.6, 4.6 Hz), Σ1H], [1.58 (s) & 1.43 (s), Σ3H], [1.58 (m) & 1.43 
(ps.t, J = 6.6 Hz), Σ1H], [1.35 (m) & 1.10 (dd, J = 6.3, 4.8 Hz), Σ1H]; 13C NMR 
(100.61 MHz, CDCl3) δ 163.4 (d, 1JCF = 248.1 Hz), 163.0 (d, 1JCF = 248.8 Hz), 131.6, 
131.4 (+, d, J = 4.3 Hz), 130.0 (+, d, J = 4.0 Hz), 129.6, 128.8 (+, d, J = 8.3 Hz), 
128.6 (+, d, J = 7.9 Hz), 124.1 (+, d, J = 3.7 Hz), 123.9 (+, d, J = 3.7 Hz), 115.7 (+, d, 
J = 21.2 Hz), 115.6 (+, d, J = 22.0 Hz), 29.2 (+), 27.3 (+), 24.9 (+), 24.4, 23.4 (+), 
22.5, 22.4 (-), 22.3 (-); 19F NMR (376.50 MHz, CDCl3) δ -114.9, -115.8;  HRMS 
(TOF ES) Found 149.0767, Calculated for C10H10F (M-Br) 149.0767 (0.7 ppm). 
 
230m: Bromocyclopropane 230a (5.00 g, 23.7 mmol) was stirred at 
0 oC in acetic anhydride (22 mL), and nitric acid (9.9 mL) was 
added dropwise.  The mixture was stirred at 0 oC for 10 min, then 
warmed up to RT and stirred overnight, then quenched with brine (20 mL), 
Br
NO2
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neutralized with aqueous NaHCO3 (50 mL), and extracted with EtOAc (3 x 100 mL).  
Combined organic phases were dried with MgSO4, filtered, and concentrated.  The 
residue was purified by vacuum distillation on Kugelröhr (ot 110-112 oC at 0.4 torr).  
 
1H NMR (400.13 MHz, CDCl3) δ [8.24 (d, J = 8.5 Hz) & 7.82 (d, J = 8.5 Hz) & 8.18 
(d, J = 7.8 Hz), & 7.41 (d, J = 7.8 Hz) Σ 2H], 7.53 (m, 2H), [3.23 (m) & 3.16 (dd, J = 
7.6 Hz, 4.6 Hz), Σ 1H], [1.76 (ps. t, J = 7.3 Hz), & 1.45 (ps.t, 6.8 Hz), & 1.23 (dd, J =  
6.7 Hz, 4.8 Hz), & 1.15 (dd, J = 11.6 Hz, 6.8 Hz, 4.8 Hz) Σ 1H], [1.71 (s), & 1.67 
(s), & 1.62 (s), & 1.51 (s) Σ 3H], 1.53-1.43 (m, 4H); 13C NMR (100.67 MHz, CDCl3) 
δ 152.0, 149.7, 139.1, 133.0 (+), 132.2 (+), 130.4 (+), 128.1 (+), 127.7 (+), 124.4 (+), 
123.9 (+), 123.6 (+), 31.9 (+), 30.0 (+), 29.7 (+), 27.6, 27.3 (+), 26.4 (+), 25.7, 25.4, 
24.4, 24.2 (-), 23.3 (+), 23.1 (-), 22.6 (-).   
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3.5.6.  Synthesis of Amido-monobromocyclopropanes  
 
Scheme 56. 
 
 
 
251: 2-Bromo-1-methylcyclopropanecarboxylic acid (250)37b (25.9 g, 
200 mmol, mixture of diastereomers, 1:1) and freshly distilled thionyl 
chloride (50 mL) were stirred at room temperature overnight. Excess of 
thionyl chloride was distilled off at ambient pressure.  The residue was distilled in 
vacuum, b.p. 50-53 °C (10 mm Hg) to obtain a mixture of diastereomeric 
acylchlorides 1:1 as a colorless oil.  Yield 37.9 g (192 mmol, 96%).  This material 
was used as is in further acylations of primary and secondary amines as described 
below. 
230p: (Typical Procedure) To a stirred solution of freshly distilled 
diethyl amine (5.56 g, 7.94 mL, 76 mmol) under an atmosphere of N2 
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in anhydrous THF (20 mL) was added the acid chloride 251 (5 g, 25.3 mmol) in dry 
THF (35 mL) dropwise.  After ~ 1 hr of stirring at room temperature the starting 
materials was consumed as judged by GCMS analysis; then the precipitate formed in 
the reaction mixture was removed by suction filtration and the filter cake was rinsed 
with THF (2 x 20 mL).  Then, the precipitate was dissolved in water (20 mL) and 
extracted with EtOAc (2 x 20 mL).  The combined organic phases were washed with 
brine (20 mL), dried with Mg2SO4, combined with the THF filtrate and condensed in 
vacuum.  Vacuum distillation in a Kugelröhr at 90 °C at 0.6 mm Hg gave the product 
as a pale-yellow oil. Overall yield 5.64 g (24.1 mmol, 95 %).   
 
1H NMR (400.13 MHz, CDCl3) δ [3.71 (m) & 3.57 (m), & 3.32 (m), & 3.19 (m), 
Σ4H], [3.13 (dd, J = 7.3 Hz, 4.6 Hz) &  2.96 (dd, J = 7.3 Hz, 4.6 Hz), Σ1H], [1.67 
(dd, J = 6.7 Hz, 4.8 Hz) &  1.59 (dd, J = 6.7 Hz, 4.8 Hz), Σ1H], [1.25 (t, J = 14.3 Hz, 
7.1 Hz) & 1.10 (t, J = 14.0 Hz, 7.0 Hz), Σ3H], [1.43 (s) & 1.35 (s), Σ3H], [1.11-1.06 
(m) & 0.86 (dd, J = 6.7 Hz, 5.0 Hz), Σ4H]; 13C NMR (125.76 MHz, CDCl3) δ 171.1, 
169.6, 41.2 (-), 41.1(-), 39.0 (-), 38.9 (-), 27.9, 27.4 (+), 25.9 (+), 22.2 (-), 22.0, 21.6 
(+), 21.4 (-), 20.6, 13.9 (+), 13.7 (+), 12.4 (+), 12.2 (+); HRMS (TOF ES): found 
234.0490, calculated for C9H17BrNO (M+H) 234.0493 (1.3 ppm).  
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230q: This material was prepared according to the typical procedure 
starting from 2.00 g (10.1 mmol) of acyl chloride 251 and freshly 
distilled diisopropylamine (4.50 mL, 3.13 g, 30.3 mmol).  Yield 
2.31 g (8.79 mmol, 87 %).  The physical and spectral properties of this substance 
were identical to those reported in literature.216  
 
230r: This compound was obtained starting from 5.00 g (25.3 
mmol) of acyl chloride 251, and freshly distilled morpholine (6.6 
mL, 6.62 g, 76 mmol) according to a typical procedure.  Vacuum distillation in a 
Kugelröhr (oven temperature 133 °C at 0.6 torr) of the resulting residue afforded 5.52 
g ( 22.3 mmol  88 % yield) of the title compound (mixture of trans- and cis-isomers 
1:1) as a colorless oil.   
 
1H NMR (400.13 MHz, CDCl3) δ 3.68 (m, 8H), [3.15 (dd, J = 8.3 Hz, 5.1 Hz) & 2.98 
(dd, J = 7.6 Hz, 4.8 Hz), Σ1H], [1.70 (ps.t, J = 8.1) & 1.58 (dd, J = 6.8 Hz, 4.8 Hz), 
Σ1H], [1.45 (s) & 1.37 (s), Σ3H], [1.20 (ps.t, J = 7.3 Hz) & 0.91 (dd, J = 6.6 Hz, 4.8 
Hz), Σ1H]; 13C NMR (100.61 MHz, CDCl3) δ 170.6, 168.9, 67.1 (-), 66.9 (-), 66 .7 (-, 
2C), 46.4 (-), 42.6 (-), 27.5 (+), 27.1, 25.6, 25.4 (+), 21.6 (-), 21.4 (+), 21.2 (-), 19.4 
(+); HRMS (TOF ES): found 168.1026, calculated for C9H14NO2 (M-Br) 168.1025 
(0.6 ppm). 
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230s: This compound was obtained starting from 5.10 g (25.8 
mmol) of acyl chloride 251, and freshly distilled piperidine (7.7 
mL, 6.60 g, 85 mmol).  Vacuum distillation in a Kugelröhr (oven 
temperature 150 °C at 0.4 torr) of the resulting residue afforded 6.26 g (25.4 mmol, 
98 % yield) of the compound (mixture of trans- and cis-isomers 1:1) as a colorless 
oil.   
 
1H NMR (400.13 MHz, CDCl3) δ [3.70-3.57 (m) & 3.49-3.35 (m), Σ4H], [3.11 (dd, J 
= 8.1 Hz, 4.8 Hz) & 2.94 (dd, J = 8.1 Hz, 4.8 Hz), Σ1H], 1.65-1.45 (m, 7H), [1.38 (s) 
& 1.30 (s), Σ3H], [1.10 (ps. t, J = 8.6 Hz, 5.3 Hz) & 0.82 (ps.t, J = 6.8 Hz, 4.8 Hz), 
Σ1H]; 13C NMR (100.61 MHz, CDCl3) δ 170.1, 168.8, 46.9 (-), 43.2 (-), 27.9, 27.5 
(+), 26.5 (-), 26.1 (-), 26.0 (+), 25.7, 25.6 (-), 24.6 (-), 24.5 (-), 21.9 (-), 21.7 (+), 21.3 
(-), 19.5 (+); HRMS (TOF ES): found 166.1233, calculated for C10H16NO (M-Br) 
166.1232 (1.0 ppm). 
230t: This compound was obtained starting from 5.00 g (25.3 
mmol) of acyl chloride 251, and freshly distilled 1-methyl-
piperazine (8.5 mL, 7.61 g, 76 mmol).  Purification was performed by vacuum 
distillation in a Kugelröhr (oven temperature 150 °C at 0.6 torr), and afforded 5.72 g 
(21.9 mmol  87 % yield) of the compound (mixture of trans- and cis-isomers 1:1) as a 
colorless oil.   
 
  
190 
1H NMR (400.13 MHz, CDCl3) δ 3.75-3.45 (m, 4H), [3.09 (dd, J = 4.89 Hz, 4.12 Hz) 
& 2.92 (dd, J = 4.89 Hz, 4.12 Hz), Σ1H], 2.55-2.27 (m, 4H), [2.25 (s) & 2.24 (s), 
Σ3H], [1.60 (ps.t, J = 8.1 Hz, 7.1 Hz) & 1.48 (ps.t, J = 8.1 Hz, 7.1 Hz), Σ1H], [1.38 
(s) & 1.30 (s), Σ3H], [1.11 (ps.t, J = 7.7 Hz, 6.8 Hz) & 0.82 (ps.t, J = 7.7 Hz, 6.8 Hz), 
Σ1H]; 13C NMR (100.61 MHz, CDCl3) δ 170.2, 168.8, 55.4 (-), 54.6 (-), 46.1 (+), 
46.0 (+), 45.8 (-), 42.1 (-), 28.3 (-), 27.7 (+), 27.3 (+), 25.6, 25.5, 21.7 (-), 21.6 (-), 
19.5 (+); HRMS (TOF ES): found 261.0603, calculated for C10H18BrN2O (M+H) 
261.0603 (0.0 ppm) 
 
230u: To a stirred solution of diphenylamine (4.23 g, 25 mmol, 1eq.), 
DMAP (100 mg), and triethylamine (5 mL) in THF (30 mL) was 
added acid chloride 251 (4.94 g, 25 mmol, 1eq.) and the mixture was allowed to 
reflux overnight.  It was worked up according to the above procedure and isolated via 
column chromatography on silica gel (eluent – 5:1 Hexane:EtOAc, Rf = 0.4 and 0.23).  
The product was obtained as an off-white solid, yield 6.76 g (20.47 mmol, 82%).   
 
1H NMR (400.13 MHz, CDCl3); [7.38 – 7.24 (m), Σ10H], [3.42 (dd, J = 8.5 Hz, 5.3 
Hz) & 2.90 (dd, J = 7.6 Hz, 5.0 Hz), Σ1H], [2.07 (dd, J = 8.5 Hz, 6.4 Hz) & 1.53 (dd, 
J = 7.0 Hz, 5.0Hz), Σ1H], [1.17 (s) & 1.09 (s), Σ3H], [1.26 (ps.t, J = 7.0 Hz) & 0.86 
(dd, J = 6.4 Hz, 5.3 Hz), Σ1H];  13C NMR (100.61 MHz, CDCl3) δ 173.0, 171.2, 
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144.0 (2C, +) 143.5 (2C,+), 129.8 (4C, +), 129.7 (4C,+), 128.0 (4C, +), 127.8 (4C, +), 
127.4 (2C,+), 127.3 (2C, +), 30.9 (+), 29.0 (+), 28.4, 26.8, 25.2 (-), 24.5 (-), 22.8 (+), 
19.8 (+);  HRMS (TOF ES): Found 330.0485, Calculated for C17H17BrNO (M+H) 
330.0493 (2.4 ppm). 
 
 230t: was prepared according to the typical procedure starting from 
2.0 g (10.1 mmol) of acyl chloride 251 and N-ethylaniline (3.81 mL, 
3.68 g, 30.3 mmol).  Purification involved partitioning between a saturated aqueous 
solution of citric acid (75 mL) and EtOAc (2 x 50 mL).  Combined organic phases 
were washed with brine, dried with MgSO4, filtered, and concentrated in vacuum.  
The residue was distilled twice in a Kugelröhr apparatus (oven temperature 155 °C at 
0.2 torr) yielding 1.45 g (5.13 mmol, 51 %) of the compound as colorless oil.   
 
1H NMR (400.13 MHz, CDCl3) δ [7.46 - 7.15 (m), Σ5H], [4.18 (m) & 3.44 (br. s), 
Σ1H], [3.81 (m) & 3.64 (m), Σ1H], [3.21 (dd, J = 8.3 Hz, 5.1 Hz) & 2.75 (br. s), 
Σ1H], [1.85 (ps.t, J = 6.6 Hz) & 1.61 (ps.t, J = 5.6 Hz), Σ1H], [1.13 (t, J = 7.1 Hz) & 
1.08 (t, J = 7.3 Hz), Σ3H], [1.03 (br. s) & 0.88 (br. s), Σ3H], [0.88 (br.s) & 0.71 (ps. t, 
J = 5.6 Hz), Σ1H]; 13C NMR (100.61 MHz, CDCl3) δ 171.2, 169.1, 142.6, 141.6, 
129.5 (2C, +), 129.4 (2C, +), 128.4 (2C, +), 127.9 (2C, +), 127.6 (2C, +), 127.5 (2C, 
+), 46.6 (-), 45.9 (-), 29.8 (+), 28.2, 27.2 (+), 24.4, 24.2 (-), 23.4 (-), 19.9 (+), 12.8 
  
192 
(+); HRMS (TOF ES): found 202.1234, calculated for C13H16NO (M-Br) 202.1232 
(1.0 ppm). 
 
230w: This compound was prepared according to the protocol 
described above for amide 230t, starting from acylchloride 251 
(1.24 g, 6.25 mmol), N-ethyl-(4-nitroaniline) (0.99 g, 5.96 
mmol), and triethylamine (1.68 g, 14.9 mmol). Crude material was purified via short 
column chromatography on a silica gel (eluent Hexane:EtOAc 3:1, Rf = 0.39 and 
0.32).  
 
 
1H NMR (400.13 MHz, CDCl3) δ [8.34 (d, J = 8.8 Hz) & 8.31 (d, J = 8.8 Hz), Σ2H], 
[7.55 (d, J = 8.8 Hz) & 7.37 (d, J = 8.8 Hz), Σ2H], [4.22 (sextet, J = 7.1 Hz) & 3.93 
(sextet, J = 7.1 Hz), Σ1H], [3.74 (sextet, J = 7.1 Hz) & 3.66 (sextet, J = 7.1 Hz), 
Σ1H], [3.26 (dd, J = 8.3 Hz, 5.1 Hz) & 2.94 (dd, J = 7.3 Hz, 4.8 Hz), Σ1H], [1.96 (dd, 
J = 8.3 Hz, 6.6 Hz) & 1.80 (ps.-t, J = 6.3 Hz), Σ1H], [1.30 (dd, J = 7.6 Hz, 6.6 Hz) & 
0.83 (dd, J = 6.6 Hz, 5.3 Hz), Σ1H], [1.18 (t, J = 7.1 Hz) & 1.12 (t, J = 7.1 Hz), Σ3H], 
1.10 (s, 3H);  13C NMR (100.61 MHz, CDCl3) δ 178.9, 171.4, 147.5, 146.2, 128.4 (+, 
2C), 128.1 (+, 2C), 125.0 (+, 2C), 124.8 (+, 2C), 46.0 (-), 45.9 (-), 29.3 (+), 28.9 (+), 
26.8, 25.9, 23.6 (-), 23.2 (-), 21.6 (+), 19.6 (+), 13.4 (+), 13.0 (+);  HRMS (TOF ES): 
Found 327.0345, Calculated for C13H16BrN2O3 (M+H) 327.0344 (0.3 ppm). 
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230y: This compound was obtained according to procedure 
described above for 230t, starting from acyl chloride 251 (1.24 
g, 6.29 mmol), N-ethylanisidine (0.99 g, 6.47 mmol), and 
triethylamine (1.68 g, 14.9 mmol).  Acid-base extraction 
followed by Kugelröhr vacuum distillation (oven temperature 200 °C at 0.1 torr) 
afforded the title compound.  Yield 2.025 g (6.48 mmol, 99 %).   
 
1H NMR (400.13 MHz, CDCl3) δ [7.33 (d, J = 8.8 Hz) & 6.95 (d, J = 8.8 Hz), Σ2H], 
[7.07 (d, J = 8.8 Hz) & 6.97 (d, J = 9.1 Hz), Σ2H], [4.17 (m) & 3.79 (m), Σ1H], [3.87 
(s) & 3.85 (s), Σ3H], [3.60 (m) & 3.38 (m), Σ1H], [3.22 (dd, J = 8.3 Hz, 5.1 Hz) & 
2.75 (dd, J = 7.1 Hz, 4.8 Hz), Σ1H],  [1.85 (dd, J = 8.1 Hz, 6.6 Hz) & 1.66 (dd, J = 
6.3 Hz, 5.1 Hz), Σ1H], [ 1.14 (t, J = 7.1 Hz) & 1.08 (t, J = 7.1 Hz), Σ3H], [1.05 (br.s) 
& 0.89 (br.s), Σ3H], [0.95 (ps.t, J = 7.1 Hz) & 0.72 (br.s), Σ1H]  13C NMR (100.61 
MHz, CDCl3) δ 171.4, 169.2, 158.7 (2C), 135.3 (2C), 129.6 (2C, +), 129.2 (2C, +), 
114.6 (2C, +), 114.5 (2C, +), 55.5 (+), 55.4 (+), 46.5 (-), 45.9 (-), 29.7 (+), 28.2, 27.1 
(+), 26.2, 24.1 (-), 23.4 (-), 22.1 (+), 20.0 (+), 12.9 (+), 12.7 (+); HRMS (TOF ES): 
Found 312.0593, Calculated for C14H19BrNO2 (M+H) 312.0599 (1.9 ppm). 
 
252: A solution of 4.01 mL (3 eq., 30.4 mmol) of N-hexylamine 
in 10 mL of THF was added dropwise to a solution of acid 
chloride 251 (2 g, 10.13 mmol) in THF (7 mL).  After the amine 
O
N
Et
OMe
Br
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addition was complete, the mixture was allowed to stir at room temperature until 
GCMS analysis showed no remaining starting materials (1 hr).  The precipitate was 
filtered off through a fritted funnel, and the filtrate was washed with EtOAc (15 mL), 
then dissolved in water (10 mL) and extracted with EtOAc (2 x 15 mL).  The 
combined organic layers were washed with brine and dried with MgSO4.  All the 
organics phases were combined together and condensed under vacuum.  The residue 
was purified by Kugelröhr distillation (oven temp of 175 °C at 0.6 torr) to afford the 
mixture of diastereomers (~ 1:1) as a clear oil.  Yield 2.16 g (8.25 mmol, 81 %).  
 
 
1H NMR (500.13 MHz, CDCl3) δ [5.99 (s) & 5.87 (s), Σ1H], [3.59 (dd, J = 8.2 Hz, 
5.4 Hz) & 2.98 (dd, J = 7.6 Hz, 5.0 Hz), Σ1H], [3.44-3.31 (m) & 3.08 (m), Σ2H], 
[1.95 (dd, J = 7.6 Hz, 5.7 Hz) & 1.75 (ps.t, J = 5.7 Hz), Σ1H], 1.62 (m, 2H), [1.58 (s) 
& 1.48 (s), Σ3H], 1.39 (m, 6H), 1.27 (ps.t, J = 6.9 Hz, 1H), 0.98 (br. t, J = 5.7 Hz, 
3H); 13C NMR (125.77 MHz, CDCl3) δ 172.1, 169.9, 40.3 (-), 40.2 (-), 31.5 (-), 31.2 
(-), 29.7 (-), 29.6 (-), 29.2 (+), 27.9, 27.6 (-), 26.7 (-), 26.3 (-), 25.3 (+), 24.3 (-), 24.0, 
22.6 (-), 22.5 (-), 21.6 (+), 21.1 (+), 17.3 (+), 14.1 (+). 
 
230u: Flame-dried flask was charged with NaH (60 weight % 
suspension in mineral oil) (183 mg, 4.77 mmol, 2.5 eq) under 
nitrogen atmosphere.  This was suspended in 25 mL of anhydrous 
THF, and amide 252 (500.0 mg, 1.91 mmol) was added.  The mixture was stirred at 
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50 °C for 10 min before methyl iodide (325.0 mg, 143 µL, 2.29 mmol, 1.2 eq.) was 
added.  The reaction was complete after 4 hrs at 50 °C as shown by the disappearance 
of the starting material.  The reaction was quenched by pouring into brine, and 
extracting with EtOAc (3 x 15 mL).  The combined organic layers were washed with 
brine (~ 15 mL) and condensed under vacuum.  The crude product was purified via 
column chromatography on silica gel (eluting with hexane to remove the mineral oil, 
and then with Hexane:EtOAc (3:1)) to obtain a mixture of diastereomers (~ 2:1, Rf = 
0.34 and 0.27) as colorless oil.  Yield 328.9 mg (1.19 mmol, 62 %).   
 
1H NMR (500.13 MHz, CDCl3) δ [3.43 (m) & 3.30 (m), Σ2H], [3.18 (dd, J = 8.2 Hz, 
5.0 Hz) & 2.99 (dd, J = 7.6 Hz, 4.7 Hz), Σ1H], [3.15 (s) & 2.94 (s), Σ3H], 1.71 (ps.t, J 
= 7.3 Hz) & 1.59 (m), Σ1H], [1.59 (m) & 1.17 (dd, J = 14.9 Hz, 7.3 Hz), Σ1H], [1.47 
(s) & 1.39 (s), Σ3H], [1.30-0.88 m, 11H]; 13C NMR (125.77 MHz, CDCl3) δ 169.8, 
169.7, 49.8 (-), 48.2 (-), 47.8 (-), 47.7 (-), 35.6 (+), 35.3 (+), 32.8 (+), 31.6 (-), 31.5 
(-), 28.6 (-), 27.9, 26.7 (-), 26.5 (-), 25.9 (+), 22.6 (-), 22.5, 21.8 (-), 20.9 (+), 19.8 (-), 
18.9 (+), 14.0 (+), 13.9 (+); HRMS (TOF ES): Found 276.0960, Calculated for 
C12H23BrNO (M+H) 276.0963 (1.1 ppm). 
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3.5.7.  Synthesis of cyclopropenes DMSO Method 
 
Typical procedure: 
231f: Bromocyclopropane 8f (3.08 g, 12.5 mmol) was added dropwise to 
a stirred solution of tBuOK (1.68 g, 15 mmol) in anhydrous DMSO (20 
mL).  The resulting mixture was stirred at room temperature overnight, 
then quenched with water (150 mL) and extracted with ether (3 x 50 mL).  Combined 
organic phases were washed consecutively with water (3 x 50 mL) and brine (50 mL), 
dried with MgSO4, filtered, and concentrated.  Flash column chromatography of a 
residue217 (eluent - hexane) afforded cyclopropene 9f as colorless oil.  Yield 1.62 g 
(9.8 mmol, 79 %).  1H NMR (CDCl3, 400.13 MHz) δ 7.28 (d, J = 8.6 Hz, 2H), 7.28 
(s, 2H), 7.17 (d, J = 8.6 Hz, 2H), 1.65 (s, 3H); 13C NMR (CDCl3, 100.61 MHz) δ 
148.5, 130.7, 127.7 (+, 2C), 127.4 (+, 2C), 115.3 (+, 2C), 25.2 (+), 21.4; HRMS 
(TOF ES) Found 165.0480, Calculated for C10H1035Cl (M+H) 165.0471 (5.5 ppm). 
 
231b: 1H NMR (CDCl3, 400.13 MHz) δ 7.37 (s, 2H), 7.23 (s, 4H), 2.45 (s, 
3H), 1.75 (s, 3H); 13C NMR (CDCl3, 100.61 MHz) δ 146.9, 134.4, 128.5 
(+, 2C), 125.9 (+, 2C), 115.7 (+, 2C), 25.5 (+), 21.5, 20.8 (+); HRMS (TOF 
ES) Found 145.1023, Calculated for C11H13 (M+H) 145.1017 (4.1 ppm). 
 
231c: 1H NMR (CDCl3, 400.13 MHz) δ 7.31 (s, 2H), 7.26 (t, J = 7.6 Hz, 
1H), 7.11-7.09 (m, 2H), 7.05 (d, J = 7.6 Hz, 1H), 2.41 (s, 3H), 1.69 (s, 
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3H);  13C NMR (CDCl3, 100.61 MHz) δ 149.9, 137.3, 127.7 (+), 126.8 (+), 125.8 (+), 
123.1 (+), 115.5 (+, 2C), 25.5 (+), 21.7, 21.5 (+); HRMS (TOF ES) Found 143.0866, 
Calculated for C11H11 (M-H) 143.0861 (3.5 ppm). 
 
231d: 1H NMR (CDCl3, 400.13 MHz) δ 7.77 (s, 2H), 7.30-7.19 (m, 4H), 
2.56 (s, 3H), 1.57 (s, 3H);  13C NMR (CDCl3, 100.61 MHz) δ 147.6, 135.6, 
130.3 (+), 127.5 (+), 126.2 (+), 125.9 (+), 121.4 (+, 2C), 28.2 (+), 23.5, 19.1 (+); 
HRMS (TOF ES) Found 145.1019, Calculated for C11H13 (M+H) 145.1017 (1.4 
ppm). 
 
231e: 1H NMR (CDCl3, 400.13 MHz) δ 7.46 (d, J = 8.6 Hz, 2H), 7.36 (s, 
2H), 7.30 (d, J = 8.6 Hz, 2H), 1.76 (s, 3H), 1,45 (s, 9H);  13C NMR 
(CDCl3, 100.61 MHz) δ 147.7, 146.9, 125.7 (+, 2C), 124.7 (+, 2C), 115.5 
(+, 2C), 34.3, 31.4 (+, 3C), 25.4 (+), 21.4; HRMS (TOF ES) Found 159.1179, 
Calculated for C12H15 (M-Me) 159.1174 (3.1 ppm). 
 
231g: 1H NMR (CDCl3, 400.13 MHz) δ 7.70 (s, 2H), 7.34 (dd, J = 7.8 Hz, 
1.3 Hz, 1H), 7.30 (dd, J = 7.5 Hz, 1.8 Hz, 1H), 7.22 (td, J = 7.4 Hz, 1.3 
Hz, 1H), 7.15 (td, J = 7.8 Hz, 1.8 Hz, 1H), 1.54 (s, 3H);  13C NMR (CDCl3, 100.61 
MHz) δ 146.6, 133.6, 129.6 (+), 129.3 (+), 127.2 (+), 127.1 (+), 120.6 (+, 2C), 27.3 
(+), 23.7; HRMS (TOF ES) Found 165.0476, Calculated for C10H1035Cl (M+H) 
165.0471 (3.0 ppm). 
  
198 
 
231h: 1H NMR (CDCl3, 400.13 MHz) δ 7.56 (d, J = 8.3 Hz, 2H), 7.34 
(d, J = 8.3 Hz, 2H), 7.28 (s, 2H), 1.68 (s, 3H); 13C NMR (CDCl3, 100.61 
MHz) δ 154.1, 127.2 (q, 2JCF = 32.2 Hz), 126.3 (+, 2C), 124.7 (q, 3JCF = 
3.7 Hz, +, 2C), 124.5 (q, 1JCF = 271.5 Hz), 114.9 (+, 2C), 25.01 (+), 21.9; 19F NMR 
(376.50 MHz, CDCl3) δ major: -62.1; HRMS (TOF ES) Found 179.0677, Calculated 
for C11H9F2 (M-F) 179.0672 (2.8 ppm). 
 
231i: 1H NMR (CDCl3, 400.13 MHz) δ 8.47 (d, J = 8.6 Hz, 1H), 7.94 
(d, J = 8.1 Hz, 1H), 7.91 (s, 2H), 7.77 (d, J = 7.6 Hz, 1H), 7.63 (ps.-t, J 
= 7.8 Hz, 7.1 Hz, 1H), 7.56 (ps.-t, J = 7.6 Hz, 7.3 Hz, 1H), 7.50-7.44 (m, 2H), 1.72 (s, 
3H);  13C NMR (CDCl3, 100.61 MHz) δ 146.3, 134.0, 130.1, 128.8 (+), 126.4 (+), 
126.0 (+), 125.5 (+), 125.4 (+), 124.8 (+), 124.0 (+), 121.2 (+, 2C), 29.1 (+), 23.0; 
HRMS (TOF ES) Found 147.0609, Calculated for C10H8F (M-H) 147.0610 (0.7 
ppm). 
 
231j: 1H NMR (CDCl3, 400.13 MHz) δ 7.31 (s, 2H), 7.22 (dd, J = 8.8 Hz, 
4JHF = 5.3 Hz, 2H), 7.02 (ps.-t, J = 3JHF = 8.8 Hz, 2H), 1.68 (s, 3H);  13C 
NMR (CDCl3, 100.61 MHz) δ 160.8 (d, 1JCF = 243.0 Hz), 145.6 (d, 4JCF = 
2.9 Hz), 127.4 (d, 3JCF = 8.1 Hz, +, 2C), 115.7 (+, 2C), 114.4 (d, 2JCF = 21.2 Hz, +, 
2C), 25.5 (+), 21.4;  19F NMR (CDCl3, 376.50 MHz) δ -119.0; HRMS (TOF ES) 
Found 180.0931, Calculated for C14H12 (M+) 180.0939 (4.4 ppm). 
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231k:155  1H NMR (CDCl3, 400.13 MHz) δ 7.33 (s, 2H), 7.20 (d, J = 
8.8 Hz, 2H), 6.91 (d, J = 8.8 Hz, 2H), 3.85 (s, 3H), 1.69 (s, 3H);  13C 
NMR (CDCl3, 100.61 MHz) δ 157.2, 142.1, 126.9 (+, 2C), 116.0 (+, 
2C), 113.2 (+, 2C), 55.2 (+), 25.6 (+), 21.2; HRMS (TOF ES) Found 161.0968, 
Calculated for C11H13O (M+H) 161.0966 (1.2 ppm). 
 
231l: 1H NMR (CDCl3, 400.13 MHz) δ 7.70 (s, 2H), 7.22 (td, J = 8.1 
Hz, 2.0 Hz, 1H), 7.19 (dd, J = 7.1 Hz, 1.8 Hz, 1H), 6.94 (td, J = 7.3 HZ, 
1.0 HZ, 1H), 6.90 (d, J = 8.1 HZ, 1H), 3.93 (s, 3H), 1.56 (s, 3H); 13C NMR (CDCl3, 
100.61 MHz) δ 157.8, 137.6, 128.3 (+), 126.9 (+), 121.0 (+, 2C), 120.6 (+), 110.8 (+), 
55.2 (+), 27.7 (+), 21.3; HRMS (TOF ES) Found 161.0970, Calculated for C11H13O 
(M+H) 161.0966 (2.5 ppm). 
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3.5.8.  Preparation of Cyclopropenes 18-Crown-6 Method 
 
 
231p: (Typical procedure): An oven-dried 10 mL Wheaton vial equipped 
with a mininert cap was charged with tBuOK (160 mg, 1.43 mmol, 1.5 
eq), 18-crown-6 (25.2 mg 0.095 mmol, 0.1 eq), and dry THF (5 mL).  To this solution 
was added 2-bromo-N,N-diethyl-1-methylcyclopropanecarboxamide (5d) (250 mg, 
0.954 mmol) and the reaction mixture was stirred at 30 oC until the GCMS showed 
the disappearance of the starting materials (3 hours).  Then the reaction was quenched 
by pouring the mixture into brine (50 mL).  The aqueous layer was extracted with 
EtOAc (2 x 25 mL).  The combined organic phases were washed with brine (25 mL), 
dried with MgSO4, and concentrated under vacuum.  The residue was purified by 
Kugelröhr distillation (oven temperature of 60 °C at 0.2 torr) to afford the title 
cyclopropene as a colorless liquid, yield 146.7 mg (0.957 mmol, 90 %).  A scale-up 
synthesis was performed according to the same procedure starting from 
bromocyclopropane 5d (15.0 g, 61.7 mmol), tBuOK (10.38 g, 92.5 mmol), and 
18-crown-6 ether (1.63 g, 6.17 mmol, 10 mol%) in THF (290 mL) to afford 8.74 g 
(54.91 mmol, 89 %) of cyclopropene 231p.   
 
1H NMR (400.13 MHz, CDCl3) δ 7.28 (s, 2H), 3.54 (br. s, 2H), 3.29 (br. s, 2H), 1.31 
(s, 3H), 1.18 (br. s, 3H), 1.06 (br. s, 3H); 13C NMR (100.61 MHz, CDCl3) δ 175.5, 
115.8 (+, 2C), 41.3 (-), 38.7 (-), 23.9 (+), 23.2, 14.3 (+), 12.6 (+); HRMS (TOF ES): 
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Found 154.1231, Calculated for C9H16NO (M+H) 154.1232 (0.6 ppm). HRMS (TOF 
ES): m/z [M+H]+ calcd for C9H16NO 154.1232; found 154.1231.  
 
231a: This compound was obtained from bromocyclopropane 230a (10.00 
g, 47.18 mmol) according to the typical procedure.  The crude material was 
purified by Kugelröhr vacuum distillation (oven temperature 75 oC at 5 torr) to afford 
a clear oil, yield 5.22 g (40.1 mmol, 85 %).  All physical and spectral properties of 
this material were identical to those, described in literature.151 
 
 
231n: was prepared from bromocyclopropane 230n (250 mg, 0.95 
mmol) according to the typical procedure.  Purification by Kugelröhr 
vacuum distillation (oven temperature of 120 °C at 0.2 torr) afforded 
144.1 mg (0.80 mmol, 84 %) of a colorless oil.  
 
 
1H NMR (400.13 MHz, CDCl3) δ 7.80 (m, 3H), 7.46 (m, 3H), 7.38 (s, 2H), 7.35 
(dd, J = 8.6, 1.7, 1H), 1.78 (s) 3H; 13C NMR (100.61 MHz, CDCl3) δ 147.4, 133.4, 
131.5, 127.6 (+), 127.5 (+), 127.2 (+), 125.9 (+), 125.0 (+), 124.7 (+), 124.5 (+), 
115.8 (+, 2C), 25.6 (+), 22.2; HRMS (TOF ES): Found 179.0859, Calculated for 
C14H11 (M-H) 179.0861 (1.1 ppm).  
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231o: was obtained from bromocyclopropane 230o (250 mg, 1.09 
mmol), and purified via Kugelröhr vacuum distillation (oven temperature 
of 75 °C at 10 torr) to afford a clear oil, yield 120.9 mg (0.816 mmol, 75 %).   
 
1H NMR (400.13 MHz, CDCl3) δ 7.63 (s, 2H), 7.09 (m, 4H), 1.59 (s, 3H); 13C 
NMR (100.61 MHz, CDCl3) δ 162.9 (d, 1JCF = 245.9 Hz), 136.1 (d, 2JCF = 15.4 Hz), 
129.1 (d, 3JCF = 5.1 Hz, +), 127.4 (d, 3JCF = 8.1 Hz, +), 123.9 (d, 4JCF = 3.7 Hz, +), 
119.8 (+, 2C), 115.8 (d, 2JCF = 22.7 Hz, +), 27.6 (d, 4JCF = 2.2 Hz, +), 20.2; 19F NMR 
(376.50 MHz, CDCl3) δ -117.5;  HRMS (TOF ES) Found 129.0707, Calculated for 
C10H9 (M-F) 129.0704 (2.3 ppm).  
 
 
231q: was obtained according to the typical procedure from 
bromocyclopropane 230q (250 mg, 0.96 mmol) and was purified by 
Kugelröhr distillation (oven temperature of 55 °C at 0.2 torr) to afford a colorless 
liquid, yield 147.6 mg (0.81 mmol, 85 %).  
 
 
1H NMR (400.13 MHz, CDCl3) δ 7.31 (s, 2H), 4.57 (br. s, 1H), 3.30 (br. s, 1H), 
1.38 (br. s, 6H), 1.31 (s, 3H), 1.24 (br. s, 6H); 13C NMR (100.61 MHz, CDCl3) δ 
175.2, 115.6 (+, 2C), 48.9 (+), 45.3 (+), 28.0, 23.7 (+), 20.9 (+, 2C), 20.6 (+, 2C); 
HRMS (TOF ES): Found 182.1543, Calculated for C11H20NO (M+H) 182.1545 (1.1 
ppm). 
O
N
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231r: was obtained from cyclopropane 230r (250 mg, 1.01 mmol) 
using the same protocol as described above.  The reaction mixture was 
quenched by pouring into brine and extracting the aqueous layer with THF (2 x 25 
mL).  The combined organic layers were washed once with brine (15 mL), dried with 
MgSO4, concentrated in vacuum.  The residue was purified by Kugelröhr vacuum 
distillation (oven temperature of 95 °C at 0.2 torr) to afford cyclopropene as a clear 
liquid, yield 136.7 mg (0.82 mmol, 81 %).   
 
1H NMR (400.13 MHz, CDCl3) δ 7.32 (s, 2H), 3.62 (br. s, 8H), 1.35 (s, 3H); 13C 
NMR (100.61 MHz, CDCl3) δ 174.8, 115.4 (+, 2C), 66.9 (-, 2C), 23.6 (+), 22.49 (Due 
to the restricted rotation about the amide bond, the peak at 3.62 in the 1H is broad, and 
the CH2 groups alpha to the N are not observed in the 13C NMR);  HRMS (TOF ES): 
Found 168.1024, Calculated for C9H14NO2 (M+H) 168.1025 (0.6 ppm). 
 
 
231s: was obtained from cyclopropane 230s (250 mg, 1.02 mmol) 
using the same protocol as described above.  The product was isolated 
by Kugelröhr vacuum distillation (oven temperature of 75 °C at 0.2 torr) as a 
colorless oil, yield 142.7 mg (0.86 mmol, 85 %).  
 
1H NMR (400.13 MHz, CDCl3) δ 7.28 (s, 2H), 3.61 (br. s, 2H), 3.46 (br. s 2H), 1.61 
(br. s 2H), 1.53 (br. s 4H), 1.31 (s, 3H); 13C NMR (100.61 MHz, CDCl3) δ 174.5, 
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115.7 (+, 2C), 46.7 (-), 42.5 (-), 26.6 (-), 25.6 (-), 24.6 (-), 23.7 (+), 22.9; HRMS 
(TOF ES): Found 150.0917, Calculated for C9H12NO (M-Me) 150.0919 (1.3 ppm). 
  
 
231t: was obtained from bromocyclopropane 230t (250 mg, 0.96 
mmol) according to the typical procedure.  The product was isolated 
by Kugelröhr vacuum distillation (oven temperature of 85 °C at 0.2 torr) as a 
colorless oil, yield 128.0 mg (0.71 mmol, 75 %).   
 
1H NMR (400.13 MHz, CDCl3) δ 7.28 (s, 2H), 3.70 (br. s, 2H), 3.56 (br. s 2H), 2.39 
(br. s, 4H), 2.29 (s, 3H), 1.31 (s, 3H); 13C NMR (100.61 MHz, CDCl3) δ 174.6, 115.5 
(+, 2C), 55.3 (-), 54.6 (-), 46.0 (+), 45.5 (-), 41.3 (-), 23.7 (+), 22.7; HRMS (TOF ES): 
Found 181.1343, Calculated for C10H17N2O (M+H) 181.1341 (1.1 ppm).  
 
 
231u: Purified via column chromatography Hex: EtOAc 3:1 Rf = 0.31;   
 
1H NMR (500.13 MHz, C6D6) δ 7.27 (s, 2H), 3.35-3.25 (br.s, 2H), 2.76 (br.s, 3H), 
1.37 (s, 3H), 1.47-1.16 (m, 8H), 0.97 (t, J = 7.3 Hz, 3H);  13C NMR (125.67 MHz, 
C6D6) δ 174.8, 116.1 (+, 2C), 53.4 (-), 47.1 (+), 34.2, 31.9 (-), 26.7 (-, 2C), 23.2 (+), 
22.9 (-), 14.2 (+);  HRMS (TOF ES): Found 180.1388, Calculated for C11H18NO (M-
Me) 180.1388 (2.2 ppm). 
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231x: was obtained from bromocyclopropane 230x (250 mg, 0.89 
mmol) according to the typical procedure.  The product was isolated as a 
yellow oil by column chromatography on silica gel (eluent hexane-EtOAc 2:1, Rf = 
0.35).  Yield 51.9 mg (0.26 mmol, 30 %).   
 
1H NMR (400.13 MHz, CDCl3) δ 7.41 (m, 2H), 7.32 (m, 1H), 7.15 (m, 2H), 6.56 (s, 
2H) 3.70 (q, J = 14.1 Hz, 7.1 Hz, 2H), 1.14 (s, 3H), 1.08 (t, J = 7.3 Hz, 3H); 13C 
NMR (100.61 MHz, CDCl3) δ 176.4, 142.1, 129.1 (2C, +), 128.1 (2C, +), 127.2 (+), 
114.37 (2C, +), 44.9 (-), 24.0 (+), 23.9, 12.9 (+). HRMS (TOF ES): Found 202.1231, 
Calculated for C13H16NO (M+H) 202.1232 (0.5 ppm). 
 
 
231y: was obtained from bromocyclopropane 230y (110 mg, 
0.353 mmol) according to a typical procedure.  Purified via column 
chromatography on silica gel (eluent – hexane:EtOAc 2:1, Rf = 
0.32) to afford a yellow oil, yield 37.6 mg (0.187 mmol, 53 %).   
 
1H NMR (500.13 MHz, CDCl3) δ 7.05 (d, J = 8.8 Hz, 2H), 6.94 (d, J = 8.8 Hz, 2H), 
3.85 (s, 3H), 6.62 (s, 2H), 3.65 (q, J = 7.3 Hz, 2H), 1.15 (s, 3H), 1.07 (t, J = 6.9 Hz, 
3H). 13C NMR (125.67 MHz, CDCl3) δ 176.3, 158.5, 134.8, 129.2 (2C, +), 114.5 (2C, 
+), 114.2 (2C,+), 55.5 (+), 44.9 (-), 24.1 (+), 23.7, 12.8 (+); HRMS (TOF ES): Found 
230.1180, Calculated for C14H16NO2 (M-H) 230.1181 (0.4 ppm). 
O
N
Et
OMe
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3.5.9.  Rhodium-Catalyzed Hydroformylation of Cyclopropenes  
 
3.5.10. General Information  
 
See Chapter 1.4.1. for instrumentation details. 
 
Anhydrous toluene, diethyl ether, and tetrahydrofuran were obtained by 
passing degassed HPLC-grade commercially available solvents consecutively through 
two columns with activated alumina (Innovative Technology). Anhydrous 
dimethylsulfoxide was purchased form Acros Organics and used as received. The 
Rh(CO)2(acac) complex was purchased from Sigma-Aldrich, and phosphine ligands 
were obtained from Strem Chemicals. Starting materials: 3-methyl-3-
phenylcyclopropene (231a),151 ,178 1-chloro-4-(1-methylcycloprop-2-en-1-yl)benzene 
(231f),178 1-fluoro-4-(1-methylcycloprop-2-en-1-yl)-benzene (231j), 178 
[1-[(methoxymethoxy)methyl]-2-cyclopropen-1-yl]-benzene (231l),148a (1-
phenylcycloprop-2-en-1-yl)methyl acetate (231aa),148a methyl 1-phenylcycloprop-2-
ene-1-carboxylate (231ab),148b and 1-methylcycloprop-2-ene-1-carboxylate (231ac) 
148b, 161
 1,3-dimethyl-3-phenylcyclopropene (231ae),159 1-methyl-4-(1-
methylcycloprop-2-en-1-yl)benzene (231b)178 were prepared according to the 
published procedures. Preparative procedures for synthesis cyclopropene 231ac are 
provided below. Syngas (equimolar mixture of hydrogen and carbon monoxide, 
certified Standard Spec.) was purchased from Airgas and used as received. All other 
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chemicals were purchased from Sigma-Aldrich or Acros Organics, and used as 
received.  
 
3.5.11.  Special Equipment  
 
See Chapter 2.4.2. for this information.  
3.5.12.  Construction of the Synthesis Gas Manifold  
 
See Chapter 2.4.3. for this information 
 
3.5.13. Synthesis of a Cyclopropene Containing a Benzyl Protected Tertiary 
Alcohol 
 
 
 
230ac: To a stirred suspension of sodium hydride (suspension in 
mineral oil, 60 %) (979 mg, 24.47 mmol, 1.05 equiv.) in anhydrous 
THF (45 mL) was added 2-(2-bromo-1-methyl-cyclopropyl)propan-2-ol 218  (253) 
(4.50 g, 23.31 mmol) dropwise at room temperature. The mixture was stirred for 1 hr, 
then cooled to 0 °C and cannulated into a solution of benzyl bromide (4.78 g, 28.00 
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mmol, 1.2 equiv.) and tetrabutylammonium iodide (517 mg, 1.40 mmol, 6 mol %) in 
dry THF (25 mL). The resulting mixture was warmed up to room temperature and 
stirred overnight. Then, the mixture was quenched with water and partitioned 
between water and diethyl ether. Combined ethereal extracts were washed with brine, 
dried with MgSO4, filtered and concentrated to afford 7.54 g of crude material in a 
mixture with residual mineral oil. This was used in the following transformation 
without further purification.  
 
231ac: Crude bromocyclopropane 230ac (7.54 g) was added dropwise 
to a stirred solution of tBuOK (3.57 g, 31.8 mmol) in anhydrous 
DMSO (20 mL). The resulting mixture was stirred at room temperature for 5 hrs, 
when GC/MS analysis indicated full consumption of both diastereomeric 
bromocyclopropanes. Then the mixture was quenched with water (150 mL) and 
extracted with hexane (3 x 50 mL). Combined organic phases were washed 
consecutively with water (3 x 50 mL) and brine (50 mL), dried with Na2SO4, filtered, 
and concentrated. Flash column chromatography of the residue (eluent – 
hexane/EtOAc 7:1) afforded cyclopropene 231ac as colorless oil. Yield 3.42 g (16.9 
mmol, 73 % over two steps).  
 
1H NMR (CDCl3, 400.13 MHz) δ 7.42 (d, J = 7.6 Hz, 2H), 7.37 (ps.-t, J = 7.6 Hz, 7.3 
Hz, 2H), 7.32 (s, 2H), 7.28 (t, J = 7.3 Hz, 1H), 4.53 (s, 2H), 1.28 (s, 3H), 1.13 (s, 6H); 
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13C NMR (CDCl3, 100.61 MHz) δ 140.0, 128.2 (+, 2C), 127.4 (+, 2C), 127.0 (+), 
118.4 (+, 2C), 79.5, 64.1 (-), 25.7 (+, 2C), 25.5, 22.0 (+).  
 
3.5.14.  Optimization Procedure  
 
All loading operations were performed in a nitrogen-filled glovebox. To an oven-
dried 8 mL glass liners was added 2.91 µmol of chiral diphosphine ligand and 1.46 
µmol of the Rh source (29 µL of a 0.05 molar Rh(acac)(CO)2 stock solution in 
toluene) followed by 1.75 mL of dry toluene. 3-methyl-3-phenyl cyclopropene (250 
mg, 1.92 mmol) was then added to give a total vessel volume of ~ 2 mL and a 
substrate to catalyst ratio of 1500:1. Then the liner was placed in 10 mL stainless steel 
Parr reactor, which was sealed, removed from the glove box and placed in the RS10 
unit. The reaction mixture was stirred at 800 rpm and heated to 60 °C for 15 hours. A 
constant supply of syn gas (1:1 H2:CO) was provided at a pressure of 150 psi. Then 
the vessel was vented to a well ventilated fume-hood and opened (after this point all 
the operations were performed in air). The reaction mixture was transferred into 50 
mL round bottomed flask and concentrated in vacuum. The residual oil was dissolved 
in carbon tetrachloride (1 mL) and dibromomethane (77 µL) was added via 
microsyringe. Then the flask was capped, and the content was stirred for 10 minutes 
at room temperature. An aliquot (50 µL) of the mixture was placed in NMR tube and 
diluted with chloroform-d for measurement of 1H NMR spectra. An aliquot (30 µL) 
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of solution form NMR tube was dissolved in dichloromethane (1 mL) for GC/MS and 
chiral GC analysis. 
 
Table 20.  Optimization of diastereoselective hydroformylation of 3-methyl-3-
phenylcyclopropene 231a. 
 
 
 
# Ligand Yield of 247a, % (NMR) 247a:248a ratio 
1 None 0 N/D 
2 PPh3 0 N/D 
3 o-Tol3P 0 N/D 
4 TTMPP 0 N/D 
5 dppm 0 N/D 
6 dppe 50 21:1 
7 dppp 0 N/D 
8 dppb 0 N/D 
9 dppf 100 11:1 
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3.5.15.  Preparative Procedures  
 
247a: Typical procedure. All loading operations were performed in 
nitrogen-filled glovebox. To oven-dried 8 mL glass liners was added 
dppf (2.84 mg, 5.1 µmol, 0.13 mol %) and 0.05M solution of 
Rh(acac)(CO)2 in anhydrous toluene219 (51 µL, 2.56 µmol, 0.07 mol%) followed by 
3.08 mL of dry toluene. 3-methyl-3-phenylcyclopropene (5a) (500 mg, 3.84 mmol) 
was then added to give a total vessel volume of ~ 4 mL and a substrate to catalyst 
ratio of 1500:1. Then the reaction and the post-reaction work up were carried out as 
described in the previous section. The residue was purified by bulb-to-bulb 
distillation (oven temperature 70 °C at 0.4 torr). Yield 419 mg (3.23 mmol, 84 %). 
Alternatively, purification by flash column chromatography on silica gel can be 
performed, affording the same product (eluent hexane/EtOAc 10:1, Rf 0.40). Yield 
533 mg (3.33 mmol, 87 %). Relative configuration was assigned by comparison of 1H 
NMR spectra with known literature data.220 
 
1H NMR (400.13 MHz, CDCl3) δ 9.63 (d, J = 4.8 Hz, 1H), 7.38-7.32 (m, 4H), 7.29-
7.25 (m, 1H), 2.20 (ddd, J = 8.3 Hz, 5.8 Hz, 4.8 Hz, 1H), 1.74 (ps.-t, J = 5.8 Hz, 4.8 
Hz, 1H), 1.68 (dd, J = 8.3 Hz, 4.8 Hz, 1H), 1.63 (s, 3H); 13C NMR (100.67 MHz, 
CDCl3) δ 200.6 (+), 144.9, 128.5 (+, 2C), 127.1 (+, 2C), 126.7 (+), 36.7 (+), 33.9, 
21.9 (-), 20.9 (+); HRMS (TOF ES) Found 159.0813, Calculated for C11H11O (M-H) 
159.0810 (1.9 ppm).  
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247f: This compound was obtained in a similar manner starting 
from 250 mg (1.52 mmol) of cyclopropene 4b. A substrate to 
rhodium ratio of 1500:1 was employed. Isolation was performed 
using column chromatography on silica gel (eluent hexane/EtOAc 20:1. Rf 0.30). 
Yield 210 mg (1.08 mmol, 71 %). 
  
1H NMR (400.13 MHz, CDCl3) δ 9.61 (d, J = 4.8 Hz, 1H), 7.30 (d, J = 8.3 Hz, 2H), 
7.24 (d, J = 8.3 Hz, 2H), 2.14 (ddd, J = 8.4 Hz, 5.3 Hz, 4.8 Hz, 1H), 1.72 (ps.-t, J = 
5.3 Hz, 5.1 Hz, 1H), 1.62 (dd, J = 8.4 Hz, 5.1 Hz, 1H), 1.58 (s, 3H); 13C NMR 
(100.67 MHz, CDCl3) δ 200.2 (+), 143.5, 132.6, 128.6 (+, 4C), 36.6 (+), 33.3, 21.9 
(-), 20.7 (+); HRMS (TOF ES) Found 165.0468, Calculated for C10H10Cl (M-CHO) 
165.0471 (1.8 ppm).  
 
247jc: This compound was prepared in a similar manner, starting 
from 250 mg (1.69 mmol) of cyclopropene 4c. 4.36 mg (17 µmol) of 
Rh(acac)(CO)2 and 19 mg (34 µmol) of dppf were employed to 
maintain a substrate to rhodium ratio of 100:1. The reaction was carried out at 60 °C 
for 18 hrs. Isolation was performed using column chromatography on silica gel 
(eluent hexane/EtOAc 7:1, Rf 0.31). Yield 275 mg (1.54 mmol, 91 %).  
 
1H NMR (400.13 MHz, CDCl3) δ 9.60 (d, J = 5.1 Hz, 1H), 7.28 (dd, J = 8.8 Hz, 4JHF 
= 5.3 Hz, 2H), 7.02 (ps.-t, J = 3JHF = 8.8 Hz, 2H), 2.15 (ddd, J = 8.3 Hz, 5.6 Hz, 5.1 
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Hz,1H), 1.71 (dd, J = 5.6 Hz, 4.8 Hz, 1H), 1.62 (dd, J = 8.3 Hz, 4.8 Hz); 19F NMR 
(CDCl3, 376.50 MHz) δ -115.6; HRMS (TOF ES) Found 179.0877, Calculated for 
C11H12OF (M+H) 179.0872 (2.8 ppm).  
 
 
247z: This compound was prepared according to the typical 
procedure starting from 500 mg (2.63 mmol) of cyclopropene 
4f, maintaining a substrate to rhodium ratio of 1500:1. The 
reaction was carried out at 60 °C for 36 hrs. The product was isolated by column 
chromatography on silica gel (eluent hexane/EtOAc 10:1, Rf 0.26). Yield 414 mg 
(1.88 mmol, 72 %).  
 
1H NMR (400.13 MHz, CDCl3) δ 9.68 (d, J = 4.6 Hz, 1H), 7.41 (m, 2H), 7.33 (m, 
2H), 7.27 (m, 1H), 4.50 (s, 2H), 4.03 (d, J = 10.5 Hz, 1H), 3.74 (d, J = 10.5 Hz, 1H), 
3.19 (s, 3H), 2.31 (ddd, J = 8.1 Hz, 5.8 Hz, 4.6 Hz, 1H), 1.86 (ps.-t, J = 5.8 Hz, 4.8 
Hz , 1H), 1.59 (dd, J = 8.1 Hz, 4.8 Hz, 1H); 13C NMR (100.67 MHz, CDCl3) δ 199.4 
(+), 141.8, 128.6 (+, 2C), 128.3 (+, 2C), 127.2 (+), 96.1 (-), 69.6 (-), 55.2 (+), 38.2, 
34.6 (+), 19.1 (-); HRMS (TOF ES) Found 220.1093, Calculated for C13H16O3 (M+) 
220.1099 (2.7 ppm).  
 
247aa: This compound was prepared according to the typical 
procedure starting from 500 mg (2.66 mmol) of cyclopropene 4g, 
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maintaining a substrate to rhodium ratio of 1500:1. The reaction was carried out at 60 
°C for 36 hrs. The product was isolated by column chromatography on silica gel 
(eluent hexane/EtOAc 4:1, Rf 0.26). Yield 435 mg (1.99 mmol, 75 %).  
 
1H NMR (400.13 MHz, CDCl3) δ 9.70 (d, J = 4.3 Hz, 1H), 7.37-7.34 (m, 4H), 7.30 
(m, 1H), 4.64 (d, J = 11.9 Hz, 1H), 4.25 (d, J = 11.9 Hz, 1H), 2.37 (ddd, J = 8.1 Hz, 
5.8 Hz, 4.3 Hz, 1H), 1.98 (s, 3H), 1.88 (ps.-t, J = 5.8 Hz, 5.1 Hz , 1H), 1.59 (dd, J = 
8.1 Hz, 5.1 Hz, 1H); 13C NMR (100.67 MHz, CDCl3) δ 198.9 (+), 170.4, 140.9, 128.6 
(+, 2C), 128.5 (+, 2C), 127.5 (+), 66.3 (-), 37.1, 34.5 (+), 20.6 (+), 19.5 (-); HRMS 
(TOF ES) Found 189.0923, Calculated for C12H13O2 (M-CHO) 189.0916 (3.7 ppm).  
 
247ab+248ab: This compound was prepared according to the typical 
procedure starting from 250 mg (1.44 mmol) of cyclopropene 231ab, 
maintaining a substrate to rhodium ratio of 1500:1. The reaction was 
carried out at 60 °C for 18 hrs. The product was isolated by column chromatography 
on silica gel as mixture of diastereomers 1.12:1 (eluent hexane/EtOAc 7:1, Rf 0.37, 
0.28). Yield 262 mg (1.29 mmol, 90 %). The material was identical to the one 
described in literature.221 
 
(major): 1H NMR (400.13 MHz, CDCl3) δ 8.59 (d, J = 6.3 Hz, 1H), 7.40-7.32 (m, 
5H), 3.68 (s, 3H), 2.76 (ddd, J = 8.8 Hz, 6.3 Hz, 6.1 Hz, 1H), 2.17 (dd, J = 8.8 Hz, 4.8 
Hz, 1H), 2.10 (dd, J = 6.1 Hz, 4.8 Hz, 1H); HRMS (TOF ES) Found 205.0862, 
Calculated for C12H13O3 (M+H) 205.0865 (1.5 ppm).  
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(minor): 1H NMR (400.13 MHz, CDCl3) δ 9.48 (d, J = 5.8 Hz, 1H), 7.40-7.32 (m, 
5H), 3.69 (s, 3H), 2.45 (dd, J = 6.6 Hz, 4.8 Hz, 1H), 2.36 (ddd, J = 8.4 Hz, 6.6 Hz, 5.8 
Hz), 1.82 (dd, J = 8.4 Hz, 4.8 Hz, 1H).  
 
247ac: This compound was prepared according to the typical 
procedure starting from 250 mg (2.23 mmol) of cyclopropene 
231ac, maintaining a substrate to rhodium ratio of 1500:1. The reaction was carried 
out at 60 °C for 36 hrs. The product was purified by short filtration through silica gel 
(eluent Et2O). Yield 202 mg (1.42 mmol, 62 %). The material was identical to the one 
described in literature.222 
 
1H NMR (400.13 MHz, CDCl3) δ 9.57 (d, J = 4.3 Hz, 1H), 3.75 (s, 3H), 2.57 (ddd, J 
= 8.6 Hz, 6.6 Hz, 4.3 Hz, 1H), 2.39 (s, 3H), 1.76 (dd, J = 8.6 Hz, 4.6 Hz, 1H), 1.55 
(dd, J = 6.6 Hz, 4.6 Hz, 1H); HRMS (TOF ES) Found 141.0556, Calculated for 
C7H9O3 (M-H) 141.0552 (2.8 ppm).  
 
247ad: This compound was prepared according to the typical 
procedure starting from 500 mg (2.47 mmol) of cyclopropene 231ad, 
maintaining a substrate to rhodium ratio of 1500:1. The reaction was carried out at 
60 °C for 72 hrs. The product was purified by short filtration through silica gel 
(eluent EtOAc). Yield 524 mg (2.26 mmol, 91 %).  
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1H NMR (400.13 MHz, CDCl3) δ 9.50 (d, J = 5.3 Hz, 1H), 7.37-7.26 (m, 5H), 4.47 
(d, J = 11.4 Hz, 1H), 4.45 (d, J = 11.4 Hz, 1H), 2.26 (ddd, J = 8.3 Hz, 5.6 Hz, 5.3 Hz, 
1H), 1.56 (dd, J = 8.3 Hz, 4.6 Hz, 1H), 1.35 (s, 3H), 1.32 (s, 3H), 1.31 (s, 3H), 1.29 
(dd, J = 5.6 Hz, 4.6 Hz, 1H); 13C NMR (100.67 MHz, CDCl3) δ 202.4 (+), 139.3, 
128.2 (+, 2C), 127.1 (+), 126.9 (+, 2C), 75.6, 63.7 (-), 36.7, 31.8 (+), 22.6 (+), 22.2 
(+), 19.1 (-), 15.6 (+); HRMS (TOF ES) Found 233.1547, Calculated for C15H21O2 
(M+H) 233.1542 (2.1 ppm).  
 
247ae: This compound was prepared according to the typical 
procedure starting from 250 mg (1.73 mmol) of cyclopropene 231ae, 
maintaining a substrate to rhodium ratio of 100:1. The reaction was 
carried out at 60 °C for 18 hrs. The product was purified by short filtration through 
silica gel (eluent EtOAc). Yield 242 mg (1.39 mmol, 80 %).  
 
1H NMR (400.13 MHz, CDCl3) δ 9.60 (d, J = 5.3 Hz, 1H), 7.38-7.25 (m, 5H), 2.05-
1.95 (m, 2H), 1.59 (s, 3H), 0.95 (d, J = 6.1 Hz, 3H); 13C NMR (100.67 MHz, CDCl3) 
δ 201.3 (+), 142.2, 129.1 (+, 2C), 128.6 (+, 2C), 126.8 (+), 42.1 (+), 40.3, 29.4 (+), 
24.0 (+), 15.2 (+); HRMS (TOF ES) Found 145.1017, Calculated for C11H13 (M-
CHO) 145.1016 (0.7 ppm).  
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3.5.16.  Preparative Procedure for Asymmetric Hydroformylation  
 
 (-)-(R,R)-247a: All loading operations were performed in a nitrogen-
filled glovebox. To oven-dried 8 mL glass liners was added C3-
TunePHOS (3.04 mg, 2.56 µmol, 0.13 mol %) and 0.05M solution of Rh(acac)(CO)2 
in anhydrous toluene219 (51 µL, 2.56 µmol, 0.13 mol %) followed by 3.08 mL of dry 
toluene. 3-methyl-3-phenylcyclopropene (231a) (250 mg, 1.92 mmol) was then added 
to give a total vessel volume of ~ 4 mL and a substrate to catalyst ratio of 750:1. Then 
the liner was placed in 10 mL stainless steel Parr reactor, which was sealed, removed 
from the glove box and placed in the RS10 unit. The reaction mixture was stirred at 
800 rpm and heated to 60 °C for 18 hours. A constant supply of synthesis gas (1:1 
H2:CO) was provided at a pressure of 150 psi. Then the vessel was vented to a well 
ventilated fume-hood and opened. The reaction mixture was transferred into 50 mL 
round bottomed flask and concentrated in vacuum. The residue was purified by flash 
column chromatography on silica gel, affording the enantiomerically enriched 
aldehyde (R,R)-5a. Yield 265 mg (1.65 mmol, 86%). Enantiomeric excess223 74%; Rt: 
42.59 min - (S,S)-5a, minor; 43.07 min – (R,R)-5a, major. NMR spectra of this 
material were identical to spectra provided for the above racemic product. [α]D25 -
114.3° (c 1.42, CH2Cl2).  
 
(-)-(R,R)-247f: Was obtained in a similar manner starting from 
cyclopropene 231f (250 mg, 1.52 mmol). Yield 159 mg (0.82 
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mmol, 54 %). Enantiomeric excess223 83 %; Rt: 79.40 min - (S,S)-247f, minor; 81.16 
min – (R,R)-247f, major. NMR spectra of this material were identical to spectra 
provided for the above racemic product. [α]D25 -137.8° (c 0.64, CH2Cl2).  
 
(-)-(R,R)-247j: Was obtained in a similar manner starting from 
cyclopropene 231j (250 mg, 1.69 mmol). Yield 187 mg (1.05 
mmol, 62 %). Enantiomeric excess223 69 %; Rt: 45.62 min - (S,S)-
247j, minor; 46.25 min – (R,R)-247j, major. NMR spectra of this material were 
identical to spectra provided for the above racemic product. [α]D25 -137.8° (c 0.64, 
CH2Cl2).  
 
(-)-(R,R)-247ac: Was obtained in a similar manner starting from 
cyclopropene 231ac (250 mg, 2.23 mmol). Yield 198.2 mg (1.39 
mmol, 63 %). Enantiomeric excess223 74 %; Rt: 21.06 min - (S,S)-247ac, minor; 21.38 
min – (R,R)-231ac, major. NMR spectra of this material were identical to spectra 
provided for the above racemic product. [α]D25 -109.8° (c 1.17, CH2Cl2).  
 
(-)-(R,R)-247b: Was obtained in a similar manner starting from 
cyclopropene 231b (250 mg, 1.73 mmol). Yield 236 mg (1.35 
mmol, 78 %). Enantiomeric excess224  68 %; Rt: 38.98 min - 
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(S,S)-247b, minor; 39.41 min – (R,R)-247b, major. NMR spectra of this material were 
identical to spectra provided for the above racemic product. [α]D25 -137.8° (c 0.64, 
CH2Cl2). 
 
1H NMR (400.13 MHz, CDCl3) δ 9.61 (d, J = 5.1 Hz, 1H), 7.22 (d, J = 8.1 Hz, 2H), 
7.16 (d, J = 8.1 Hz, 2H), 2.36 (s, 3H), 2.17 (ddd, J = 8.3 Hz, 5.8 Hz, 5.1 Hz, 1H), 1.71 
(dd, J = 5.8 Hz, 4.8 Hz, 1H), 1.66 (dd, J = 8.3 Hz, 4.8 Hz, 1H), 1.61 (s, 3H); 13C 
NMR (100.67 MHz, CDCl3) δ 200.8 (+), 142.1, 136.5, 129.2 (+, 2C), 127.1 (+, 2C), 
36.9 (+), 33.7, 22.1 (-), 20.9 (+), 15.4 (+); HRMS (TOF ES) Found 175.1123, 
Calculated for C12H15O (M+H) 175.1123 (0.0 ppm).  
 
(-)-(R,R)-247ad: Was obtained in a similar manner starting from 
cyclopropene 231ad (250 mg, 1.73 mmol). Yield 236 mg (1.35 
mmol, 78 %). Enantiomeric excess 57 % (was determined as 
described below); NMR spectra of this material were identical to spectra provided for 
the above racemic product. αD25 -24.6° (c 1.25, CH2Cl2).  
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To determine optical purity the sample of compound 247ad was converted 
into primary alcohol 254ad. Aldehyde 247ad (100 mg, 0.43 mmol) was added to a 
stirred suspension of NaBH4 (33 mg, 0.86 mmol, 2 equiv) in methanol (1.0 mL). The 
mixture was stirred for 30 min at room temperature, then quenched with brine (10 
mL) and extracted with EtOAc (2 x 5 mL). Combined organic phases were washed 
with brine, dried with Na2SO4, filtered and concentrated. The residue was purified by 
preparative flash column chromatography on Silica gel (Rf 0.35, eluent hexane-
EtOAc 2:1). Yield 56 mg (0.24 mmol, 55 %).  
 
1H NMR (400.13 MHz, CDCl3) δ 7.41-7.33 (m, 4H), 7.29-7.26 (m, 1H), 4.50 (s, 2H), 
3.79 (dd, J = 11.4 Hz, 6.8 Hz, 1H), 3.61 (dd, J = 11.4 Hz, 8.3 Hz, 1H), 1.35-1.28 (m, 
1H), 1.26 (s, 3H), 1.24 (s, 3H), 1.22 (s, 3H), 0.96 (dd, J = 9.1 Hz, 4.8 Hz, 1H), 0.19 
(dd, J = 5.8 Hz, 4.8 Hz, 1H); 13C NMR (100.67 MHz, CDCl3) δ 139.8, 128.2 (+, 2C), 
127.1 (+, 2C), 127.0 (+), 76.6, 63.7 (-), 63.5 (-), 26.1, 23.1 (+), 22.5 (+), 21.6 (+), 
15.2 (-), 15.0 (+); [α]D25 -9.2° (c 0.62, CH2Cl2); HRMS (TOF ES) Found 217.1591, 
Calculated for C15H21O (M-OH) 217.1592 (0.5 ppm).  
 
Acylation of 254 with (S)-Mosher acid chloride produced a diastereomeric mixture of 
esters, which was analyzed by 19F NMR. 
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3.5.17.  Assignment of Absolute Configuration 
 
 
 
Assignment of absolute configuration for non-racemic compound 247a was 
performed by chemical transformation of this product into 2-methyl-2-
phenylcyclopropylmethanol 254a with known absolute configuration. To a stirred at 
0 °C solution of enantiomerically enriched sample of 247a (265 mg, 1.65 mmol) in 
ethanol (5 mL) was added dropwise a solution of sodium borohydride (75 mg, 1.99 
mmol, 1.2 equiv.) in ethanol (2 mL). The mixture was stirred for 10 min at 0 °C, and 
then quenched by 3N aqueous NaOH (10 mL) and stirred for 2.5 hrs at RT. The 
mixture was extracted by ether (3 x 15 mL), the combined organic phases were 
washed with brine, dried with Na2SO4, filtered, and concentrated. Purification of the 
crude residue by flash column chromatography on Silica gel afforded (-)-(R,R)-
alcohol 254a (253 mg, 1.56 mmol, 94%), which had 1H NMR spectra identical to 
those reported in literature.225  
 
1H NMR (400.13 MHz, CDCl3) δ 7.33-7.30 (m, 4H), 7.23-7.30 (m, 1H), 3.93 (dd, J = 
11.4 Hz, 6.3 Hz, 1H), 3.73 (dd, J = 11.4 Hz, 8.3 Hz, 1H), 1.49 (s, 3H), 1.45 (m, 1H), 
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1.17 (dd, J = 8.8 Hz, 4.6 Hz, 1H), 1.17 (dd, J = 6.6 Hz, 4.6 Hz, 1H); [α]D20 = -26.4° 
(c = 1.00, CH2Cl2);  
 
The sign of optical rotation found for the synthesized sample of alcohol 254a 
was opposite to that reported by Charette for (+)-(S,S)-254a, obtained in the 
asymmetric cyclopropanation of (2E)-3-phenyl-2-butene-1-ol in the presence of 
titanium (4R,5R)-TADDOLate.225  Based on this comparison, the absolute 
configuration of the obtained in our experiments levorotatory product 254a, and also 
the absolute configuration of the parent aldehyde 247a, was assigned as (1R,2R).  
The absolute configurations of compounds 247b,f,ac,ad were assigned by 
analogy with 247a using the following considerations. The difference between 
cyclopropenes 231b,f,ac,ad  employed in the asymmetric hydroformylation is the 
large substituent “L”, which is turned outward in the trigonal bipyramidal rhodium 
complex I1 (Figure 22). Analysis of the corresponding stereomodels suggests the 
nature of the large substituent “L” should not dramatically affect the mode of 
enantioinduction. Accordingly, we assigned the configurations of products 
247b,f,ac,ad to be the same as that for aldehyde 247a.  
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Appendix Crystallographic Studies on Pd-Ligand Complexes 
 
A.1.  Preparation of Palladium Complexes and Single Crystal X-Ray Studies 
 
 
A mixture of (MeCN)2PdCl2 (30 mg, 0.116 mmol) and L1 (40 mg, 0.116 
mmol) in degassed methylene chloride (3 mL) was stirred in a 10 mL round-bottomed 
flask in a nitrogen-filled glove box for 30 min at room temperature.  Then, degassed 
hexane was added (ca. 4 mL); the flask was closed with a cotton ball to allow slow 
evaporation of the solvent, and left overnight.  The obtained yellow crystalline 
material was analyzed using single crystal X-ray crystallography.  Analogously, a 
sample of the palladium complex (L4)PdCl2 was obtained from (MeCN)2PdCl2 (40 
mg, 0.154 mmol) and L4 (54 mg, 0.156 mmol).  It should be mentioned that 
crystallization of (L4)PdCl2 complex produced a crystallosolvate with water and 
dichloromethane.  We failed to obtain suitable quality crystals by crystallization from 
anhydrous solvents, which suggested that incorporation of solvent was essential for 
efficient packing of molecules in the crystalline lattice.  
 
A.2.  Single Crystal X-ray Studies for (L4)PdCl2٠0.25 CH2Cl2 ٠0.50 H2O and 
(L1)PdCl2.   
 
 
Crystals of (L4)PdCl2٠0.25 CH2Cl2 ٠0.50 H2O, (1) were analyzed at 100(2) 
K, orthorhombic, space group P212121 – D24 (No. 19)] (1)226 with a = 17.117(1) b = 
17.473(1) Å, c = 33.072(2) Å, V = 9891(1) Å3 and Z =  16 formula units {dcalcd = 
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1.485 g/cm3; µa(MoKα) = 1.100 mm-1}.  Crystals of (L4)PdCl2 (2), were analyzed at 
100(2) K, monoclinic, space group P21 – C22 (No. 4) (1) with a = 7.2466(4), b = 
19.576(1) Å, c = 7.9997(4) Å, β = 104.296(1)°, V = 1110(1) Å3 and Z =  2 molecules 
{dcalcd = 1.579 g/cm3; µa(MoKα) = 1.171 mm-1} .   Full hemispheres of diffracted 
intensities (1850 10-second frames with a ω scan width of 0.30°) were measured for 
single-domain specimens of both compounds using graphite-monochromated MoKα 
radiation (λ= 0.71073 Å) on a Bruker SMART APEX CCD Single Crystal 
Diffraction System227 .   X-rays were provided by a fine-focus sealed x-ray tube 
operated at 50kV and 30mA.  Lattice constants were determined with the Bruker 
SAINT software package using peak centers for 9554 (1) and  8994 (2) reflections.  
Totals of 117245 (1) and 13156 (2) integrated reflection intensities having 
2θ(MoKα)< 61.15 (1) or 61.02º (2) were produced using the Bruker program 
SAINT;228 29017 (1) and 6415 (2) of these were unique and gave Rint = 0.092 (1) and 
Rint = 0.036 (2) with a coverage that was at least 98.4% complete for both 
compounds. The data were corrected empirically229 for variable absorption effects 
using equivalent reflections; the relative transmission factors ranged from 0.742 to 
1.000 for 1 and 0.803 to 1.000 for 2.  The Bruker software package SHELXTL was 
used to solve both structures using “direct methods” techniques.  All stages of 
weighted full-matrix least-squares refinement were conducted using Fo2 data with the 
SHELXTL Version 6.10 software package.229 
 All methyl groups in both compounds were incorporated into the structural 
model as rigid groups (using idealized sp3-hybridized geometry and a C-H bond 
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length of 0.98 Å) which were allowed to rotate about their C-C bonds in least-squares 
refinement cycles.  Hydrogen atoms for the water molecules of crystallization present 
in 1 were not included in the structural model.  The remaining hydrogen atoms were 
incorporated into the structural model as idealized atoms (assuming sp2- or sp3-
hybridization of the carbon atoms and C-H bond lengths of 0.95 – 1.00 Å).  The 
isotropic thermal parameters of all included hydrogen atoms were fixed at values 1.2 
(nonmethyl) or 1.5 (methyl) times the equivalent isotropic thermal parameter of the 
carbon atom to which they are covalently bonded.    
 The CH2Cl2 solvent molecule and one of the two crystallographically-
independent water molecules in 1 adopt three different arrangements in the crystal.  
Dichloromethane chlorine atom Cl(1) and the oxygen atom of the first water molecule 
[O(1w)], both share the same two sites in the crystal part of the time.  The first site is 
80 % Cl(1) and 20 % O(1w׳) and the second site is 80 % O(1w) and 20 % Cl(1׳).   
The other dichloromethane chlorine atom [Cl(2)] has two alternate positions [Cl(2) 
occupied 80 % of the time and Cl(2׳) occupied 20 % of the time] separated by 1.44 Å.  
The dichloromethane methylene group is disordered with three orientations in the 
crystal.  The methylene carbon occupies three different sites with the following 
occupancy factors:  0.45, 0.35 and 0.20 for C(1s), C(1s׳) and C(1s״), respectively.   
The first orientation of the dichloromethane molecule is occupied 45 % of the time 
and specified by atoms Cl(1), C(1s) and Cl(2).  The second orientation is occupied 
35 % of the time and specified by atoms Cl(1), C(1s׳) and Cl(2) and the third 
orientation is occupied 20 % of the time and specified by atoms Cl(1׳), C(1s״) and 
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Cl(2׳).  A free variable representing the length of a C-Cl single bond was included in 
the refinement to restrain the disordered dichloromethane molecule.  The values of all 
C-Cl bond lengths and tetrahedral Cl-C-Cl angles for the three different orientations 
of this disordered molecule were restrained by requiring pairs of non-hydrogen atoms 
to have separations near idealized multiples of this free variable.  This free variable 
refined to a final value of 1.623(6) Å.   
 The final structural model for both compounds incorporated anisotropic 
thermal parameters for all ordered non-hydrogen atoms and isotropic thermal 
parameters for all included hydrogen atoms and the remaining non-hydrogen atoms.   
 A total of 1049 parameters were refined for 1 using 8 restraints, 29017 data 
and weights of w = 1/ [σ2(F2) + (0.0557 P)2+ (21.277 P)], where P = [Fo2 + 2Fc2] / 3.  
Final agreement factors at convergence are:  R1(unweighted, based on F) = 0.075 for 
24699 independent absorption-corrected “observed” reflections having 2θ(MoKα)<  
61.15° and I>2σ(I);  R1(unweighted, based on F) = 0.090 and wR2(weighted, based 
on F2) = 0.155 for all 29017 independent absorption-corrected reflections having 
2θ(MoKα)< 61.15°.  The largest shift/s.u. was 0.001 in the final refinement cycle.  
The final difference Fourier had maxima and minima of 1.90 e-/Å3 and –2.01 e-/Å3, 
respectively, that were within 1.02 Å of a Pd or disordered Cl atom.  The absolute 
configuration was established experimentally for 1 using anomalous dispersion of the 
X-rays; the Flack “absolute structure parameter” refined to a final value of 0.06(3).   
 A total of 251 parameters were refined for 2 using 1 restraint, 6415 data and 
weights of w = 1/ [σ2(F2) + (0.0273 P)2], where P = [Fo2 + 2Fc2] / 3.  Final agreement 
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factors at convergence are:  R1(unweighted, based on F) = 0.025 for 6226 
independent absorption-corrected “observed” reflections having 2θ(MoKα)<  61.02° 
and I>2σ(I);  R1(unweighted, based on F) = 0.025 and wR2(weighted, based on F2) = 
0.058 for all 6415 independent absorption-corrected reflections having 2θ(MoKα)< 
61.02°.  The largest shift/s.u. was 0.000 in the final refinement cycle.  The final 
difference Fourier had maxima and minima of 1.33 e-/Å3 and –0.40 e-/Å3, 
respectively, that were within 1.27Å of the Pd atom.  The absolute configuration was 
established experimentally for 2 using anomalous dispersion of the X-rays; the Flack 
“absolute structure parameter” refined to a final value of -0.03(2). 
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A.3.  Crystallographic Data 
 
 
 
 
Figure 23. ORTEP drawing of (L1)PdCl2 complex, showing the atom-numbering 
scheme; 50 % probability amplitude displacement ellipsoids are shown. 
 
Figure 24. Packing of (L1)PdCl2 complex in the crystalline lattice cell. 
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Table 21. Crystal data and structure refinement for (L1)PdCl2. 
 
Identification code  k13f 
Empirical formula  C21H32Cl2NOPPd 
Formula weight  522.75 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21 
Unit cell dimensions a = 7.2466(4) Å α= 90°. 
 b = 19.5763(10) Å β= 104.2960(10)°. 
 c = 7.9997(4) Å γ = 90°. 
Volume 1099.71(10) Å3 
Z 2 
Density (calculated) 1.579 g/cm3 
Absorption coefficient 1.171 mm-1 
F(000) 536 
Crystal size 0.36 x 0.24 x 0.10 mm3 
Theta range for data collection 2.63 to 30.51°. 
Index ranges -10 ≤ h ≤ 10, -27 ≤ k ≤ 27, -11 ≤ l ≤ 11 
Reflections collected 13156 
Independent reflections 6415 [R(int) = 0.0358] 
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Table 21. Continued 
Completeness to theta = 30.51° 98.4 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.803 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 6415 / 1 / 251 
Goodness-of-fit on F2 1.011 
Final R indices [I>2sigma(I)] R1 = 0.0246, ωR2 = 0.0573 
R indices (all data) R1 = 0.0254, ωR2 = 0.0576 
Absolute structure parameter -0.027(16) 
Largest diff. peak and hole 1.327 and -0.403 eÅ-3 
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Table 22. Atomic coordinates (x 104) and isotropic displacement parameters 
(Å2 x 103) for (L1)PdCl2 
__________________________________________________________________________________  
 x y z U(eq) 
_____________________________________________________________________   
Pd 4010(1) 1153(1) 1177(1) 12(1) 
Cl(1) 6319(1) 1561(1) 3616(1) 19(1) 
Cl(2) 5693(1) 153(1) 1449(1) 19(1) 
P 1784(1) 724(1) -1095(1) 12(1) 
O 1350(2) 2999(1) -743(2) 16(1) 
N 2856(3) 2115(1) 772(2) 14(1) 
C(1) -389(3) 1215(1) -1391(3) 14(1) 
C(2) -1063(3) 1455(1) 147(3) 16(1) 
C(3) -463(3) 1977(1) -1010(3) 14(1) 
C(4) 1333(3) 2338(1) -293(3) 14(1) 
C(5) 3325(3) 3218(1) -88(3) 17(1) 
C(6) 4024(3) 2732(1) 1427(3) 15(1) 
C(7) 3568(3) 3011(1) 3053(3) 16(1) 
C(8) 1825(4) 2916(1) 3425(3) 19(1) 
C(9) 1369(4) 3275(1) 4784(3) 22(1) 
C(10) 2649(4) 3727(1) 5759(3) 24(1) 
C(11) 4426(4) 3805(1) 5436(3) 27(1) 
C(12) 4900(4) 3451(1) 4097(3) 21(1) 
C(13) -2000(3) 2392(1) -2217(3) 19(1) 
  
232 
Table 22. Continued 
C(14) 898(3) -167(1) -801(3) 16(1) 
C(15) 883(3) -251(1) 1107(3) 19(1) 
C(16) 2146(4) -724(1) -1309(3) 21(1) 
C(17) -1158(3) -259(1) -1881(3) 20(1) 
C(18) 2472(3) 832(1) -3190(3) 15(1) 
C(19) 2609(4) 1602(1) -3504(3) 22(1) 
C(20) 1014(4) 528(1) -4744(3) 23(1) 
C(21) 4424(3) 517(1) -3071(3) 19(1) 
____________________________________________________________________ 
U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor.  
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Table 23. Bond lengths [Å] and angles [°] for (L1)PdCl2. 
 
Pd-N  2.0538(19) 
Pd-P  2.2728(6) 
Pd-Cl(2)  2.2885(6) 
Pd-Cl(1)  2.3730(6) 
P-C(1)  1.810(2) 
P-C(18)  1.874(2) 
P-C(14)  1.892(3) 
O-C(4)  1.344(3) 
O-C(5)  1.462(3) 
N-C(4)  1.292(3) 
N-C(6)  1.493(3) 
C(1)-C(2)  1.506(3) 
C(1)-C(3)  1.526(3) 
C(2)-C(3)  1.513(3) 
C(3)-C(4)  1.467(3) 
C(4)-O-C(5) 105.07(17) 
C(4)-N-C(6) 106.08(18) 
C(4)-N-Pd 131.39(16) 
C(6)-N-Pd 120.84(14) 
C(2)-C(1)-C(3) 59.86(15) 
C(2)-C(1)-P 120.41(15) 
C(3)-C(1)-P 124.46(16) 
C(1)-C(2)-C(3) 60.72(16) 
C(4)-C(3)-C(2) 116.57(19) 
C(4)-C(3)-C(13) 115.6(2) 
C(2)-C(3)-C(13) 118.33(19) 
C(4)-C(3)-C(1) 118.49(19) 
C(2)-C(3)-C(1) 59.42(14) 
C(13)-C(3)-C(1) 116.95(19) 
N-C(4)-O 116.0(2) 
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Table 23. Continued 
C(3)-C(13) 1.518(3) 
C(5)-C(6)  1.526(3) 
C(6)-C(7)  1.521(3) 
C(7)-C(8)  1.380(3) 
C(7)-C(12)  1.404(3) 
C(8)-C(9)  1.400(3) 
C(9)-C(10)  1.376(4) 
C(10)-C(11)  1.383(4) 
C(11)-C(12)  1.389(4) 
C(14)-C(16)  1.534(3) 
C(14)-C(17)  1.537(3) 
C(14)-C(15)  1.538(3) 
C(18)-C(21)  1.524(3) 
C(18)-C(19)  1.536(3) 
C(18)-C(20)  1.538(3) 
 
N-C(4)-C(3) 128.8(2) 
O-C(4)-C(3) 115.1(2) 
O-C(5)-C(6) 101.81(17) 
N-C(6)-C(7) 111.50(18) 
N-C(6)-C(5) 100.25(17) 
C(7)-C(6)-C(5) 110.81(19) 
C(8)-C(7)-C(12) 119.1(2) 
C(8)-C(7)-C(6) 122.7(2) 
C(12)-C(7)-C(6) 117.8(2) 
C(7)-C(8)-C(9) 120.3(2) 
C(10)-C(9)-C(8) 120.5(2) 
C(9)-C(10)-C(11) 119.6(2) 
C(10)-C(11)-C(12) 120.5(3) 
C(11)-C(12)-C(7) 120.0(3) 
C(16)-C(14)-C(17) 108.7(2) 
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Table 23. Continued 
N-Pd-P 91.84(5) 
N-Pd-Cl(2) 170.53(5) 
P-Pd-Cl(2) 90.92(2) 
N-Pd-Cl(1) 89.91(5) 
P-Pd-Cl(1) 177.60(2) 
Cl(2)-Pd-Cl(1) 87.61(2) 
C(1)-P-C(18) 103.80(10) 
C(1)-P-C(14) 101.25(11) 
C(18)-P-C(14) 112.84(11) 
C(1)-P-Pd 109.31(8) 
C(18)-P-Pd 112.34(8) 
C(14)-P-Pd 115.90(8) 
 
 
C(16)-C(14)-C(15) 109.6(2) 
C(17)-C(14)-C(15) 107.58(19) 
C(16)-C(14)-P 112.43(17) 
C(17)-C(14)-P 110.44(17) 
C(15)-C(14)-P 107.97(16) 
C(21)-C(18)-C(19) 108.1(2) 
C(21)-C(18)-C(20) 109.6(2) 
C(19)-C(18)-C(20) 107.8(2) 
C(21)-C(18)-P 110.28(17) 
C(19)-C(18)-P 107.40(16) 
C(20)-C(18)-P 113.44(17) 
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Table 24. Anisotropic displacement parameters  (Å2 x 103) for (L1)PdCl2 complex.  
The anisotropic displacement factor exponent takes the form:  -2p2[h2 a*2U11 + ...  
+ 2 h k a* b* U12 ] 
___________________________________________________________________________ 
 U11 U22  U33 U23 U13 U12 
_______________________________________________________________ 
Pd 14(1)  12(1) 10(1)  1(1) 2(1)  1(1) 
Cl(1) 19(1)  20(1) 14(1)  -1(1) -1(1)  1(1) 
Cl(2) 20(1)  14(1) 22(1)  3(1) 3(1)  4(1) 
P 14(1)  11(1) 12(1)  -1(1) 3(1)  1(1) 
O 18(1)  13(1) 16(1)  2(1) 2(1)  -1(1) 
N 16(1)  11(1) 14(1)  -2(1) 2(1)  -3(1) 
C(1) 15(1)  13(1) 14(1)  -3(1) 3(1)  1(1) 
C(2) 18(1)  13(1) 19(1)  0(1) 6(1)  -1(1) 
C(3) 16(1)  12(1) 14(1)  0(1) 3(1)  1(1) 
C(4) 18(1)  11(1) 13(1)  -2(1) 6(1)  0(1) 
C(5) 17(1)  17(1) 16(1)  1(1) 3(1)  -3(1) 
C(6) 17(1)  11(1) 17(1)  -1(1) 3(1)  -3(1) 
C(7) 23(1)  11(1) 12(1)  2(1) 0(1)  1(1) 
C(8) 27(1)  15(1) 15(1)  1(1) 4(1)  0(1) 
C(9) 34(1)  18(1) 17(1)  4(1) 10(1)  4(1) 
C(10) 43(2)  18(1) 12(1)  2(1) 7(1)  5(1) 
C(11) 42(2)  19(1) 14(1)  -3(1) -5(1)  -4(1) 
C(12) 26(1)  18(1) 16(1)  -1(1) 2(1)  -3(1) 
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Table 24. Continued 
C(13) 19(1)  16(1) 21(1)  0(1) 1(1)  3(1) 
C(14) 18(1)  13(1) 19(1)  -1(1) 7(1)  0(1) 
C(15) 24(1)  16(1) 19(1)  2(1) 7(1)  -3(1) 
C(16) 25(1)  13(1) 25(1)  -2(1) 5(1)  5(1) 
C(17) 21(1)  14(1) 24(1)  -4(1) 4(1)  -2(1) 
C(18) 15(1)  17(1) 13(1)  2(1) 5(1)  2(1) 
C(19) 30(1)  19(1) 19(1)  5(1) 12(1)  5(1) 
C(20) 26(1)  29(1) 13(1)  -4(1) 5(1)  2(1) 
C(21) 20(1)  21(1) 18(1)  0(1) 7(1)  2(1) 
______________________________________________________________________________ 
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Table 25. Hydrogen coordinates ( x 104) and isotropic displacement parameters 
(Å2 x 103) for (L1)PdCl2 complex. 
____________________________________________________________________________ 
 x  y  z  U(eq) 
_______________________________________________________________ 
  
H(1) -1437 1056 -2376 16 
H(2A) -209 1380 1305 20 
H(2B) -2438 1415 91 20 
H(5A) 3400 3700 299 20 
H(5B) 4063 3163 -969 20 
H(6) 5415 2635 1616 18 
H(8) 930 2607 2756 23 
H(9) 168 3205 5035 27 
H(10) 2313 3983 6648 29 
H(11) 5330 4104 6137 33 
H(12) 6126 3506 3887 25 
H(13A) -2288 2799 -1613 29 
H(13B) -3152 2114 -2594 29 
H(13C) -1551 2533 -3225 29 
H(15A) 484 -717 1303 29 
H(15B) -8 77 1400 29 
H(15C) 2165 -168 1834 29 
H(16A) 1768 -1171 -955 32 
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Table 25. Continued 
H(16B) 3485 -637 -735 32 
H(16C) 1983 -718 -2562 32 
H(17A) -1511 -742 -1893 29 
H(17B) -1251 -104 -3064 29 
H(17C) -2021 12 -1375 29 
H(19A) 3160 1676 -4491 33 
H(19B) 3419 1817 -2476 33 
H(19C) 1333 1804 -3747 33 
H(20A) 1407 629 -5805 34 
H(20B) -241 730 -4814 34 
H(20C) 946 32 -4603 34 
H(21A) 4846 632 -4110 29 
H(21B) 4343 19 -2973 29 
H(21C) 5339 697 -2053 29 
_____________________________________________________________________
___________ 
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Table 26. Torsion angles [°] for (L1)PdCl2 complex. 
 
N-Pd-P-C(1) -28.89(10) 
Cl(2)-Pd-P-C(1) 160.17(8) 
Cl(1)-Pd-P-C(1) 108.0(5) 
N-Pd-P-C(18) 85.77(10) 
Cl(2)-Pd-P-C(18) -85.17(9) 
Cl(1)-Pd-P-C(18) -137.3(5) 
N-Pd-P-C(14) -142.47(10) 
Cl(2)-Pd-P-C(14) 46.59(8) 
Cl(1)-Pd-P-C(14) -5.6(6) 
P-Pd-N-C(4) 5.6(2) 
Cl(2)-Pd-N-C(4) 112.4(3) 
Cl(1)-Pd-N-C(4) -172.8(2) 
P-Pd-N-C(6) -157.38(15) 
Cl(2)-Pd-N-C(6) -50.5(4) 
Cl(1)-Pd-N-C(6) 24.26(15) 
C(13)-C(3)-C(4)-O 2.8(3) 
C(1)-C(3)-C(4)-O 149.01(19) 
C(4)-O-C(5)-C(6) -26.8(2) 
C(4)-N-C(6)-C(7) 90.7(2) 
Pd-N-C(6)-C(7) -102.51(18) 
C(4)-N-C(6)-C(5) -26.6(2) 
Pd-N-C(6)-C(5) 140.15(15) 
O-C(5)-C(6)-N 31.6(2) 
O-C(5)-C(6)-C(7) -86.2(2) 
N-C(6)-C(7)-C(8) -26.5(3) 
C(5)-C(6)-C(7)-C(8) 84.2(3) 
N-C(6)-C(7)-C(12) 161.4(2) 
C(5)-C(6)-C(7)-C(12) -87.8(2) 
C(12)-C(7)-C(8)-C(9) 2.4(3) 
C(6)-C(7)-C(8)-C(9) -169.6(2) 
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Table 26. Continued 
C(18)-P-C(1)-C(2) -159.73(19) 
C(14)-P-C(1)-C(2) 83.1(2) 
Pd-P-C(1)-C(2) -39.7(2) 
C(18)-P-C(1)-C(3) -87.40(19) 
C(14)-P-C(1)-C(3) 155.45(18) 
Pd-P-C(1)-C(3) 32.65(19) 
P-C(1)-C(2)-C(3) 114.7(2) 
C(1)-C(2)-C(3)-C(4) -108.9(2) 
C(1)-C(2)-C(3)-C(13) 106.2(2) 
C(2)-C(1)-C(3)-C(4) 105.7(2) 
P-C(1)-C(3)-C(4) -2.5(3) 
P-C(1)-C(3)-C(2) -108.15(19) 
C(2)-C(1)-C(3)-C(13) -108.5(2) 
P-C(1)-C(3)-C(13) 143.31(18) 
C(6)-N-C(4)-O 11.0(3) 
 
C(7)-C(8)-C(9)-C(10) 0.3(4) 
C(8)-C(9)-C(10)-C(11) -2.7(4) 
C(9)-C(10)-C(11)-C(12) 2.4(4) 
C(10)-C(11)-C(12)-C(7) 0.2(4) 
C(8)-C(7)-C(12)-C(11) -2.7(4) 
C(6)-C(7)-C(12)-C(11) 169.7(2) 
C(1)-P-C(14)-C(16) 154.65(17) 
C(18)-P-C(14)-C(16) 44.3(2) 
Pd-P-C(14)-C(16) -87.22(17) 
C(1)-P-C(14)-C(17) 33.06(18) 
C(18)-P-C(14)-C(17) -77.29(19) 
Pd-P-C(14)-C(17) 151.18(14) 
C(1)-P-C(14)-C(15) -84.31(16) 
C(18)-P-C(14)-C(15) 165.34(15) 
Pd-P-C(14)-C(15) 33.82(17) 
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Table 26. Continued 
Pd-N-C(4)-O -153.81(16) 
C(6)-N-C(4)-C(3) -165.2(2) 
Pd-N-C(4)-C(3) 30.0(4) 
C(5)-O-C(4)-N 10.8(3) 
C(5)-O-C(4)-C(3) -172.42(18) 
C(2)-C(3)-C(4)-N 33.2(3) 
C(13)-C(3)-C(4)-N 179.0(2) 
C(1)-C(3)-C(4)-N -34.8(3) 
C(2)-C(3)-C(4)-O -143.1(2) 
 
 
C(1)-P-C(18)-C(21) 173.03(17) 
C(14)-P-C(18)-C(21) -78.21(19) 
Pd-P-C(18)-C(21) 55.06(18) 
C(1)-P-C(18)-C(19) 55.5(2) 
C(14)-P-C(18)-C(19) 164.22(18) 
Pd-P-C(18)-C(19) -62.51(19) 
C(1)-P-C(18)-C(20) -63.5(2) 
C(14)-P-C(18)-C(20) 45.2(2) 
Pd-P-C(18)-C(20) 178.48(15) 
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Figure 25.  ORTEP drawing of complex (L4)PdCl2 · 0.25 CH2Cl2 · 0.50 H2O, (the 
first (A) of four crystallographically-independent molecules), showing the atom-
numbering scheme; 50 % probability amplitude displacement ellipsoids are shown. 
 
 
Four crystallographically-independent (L4)PdCl2 molecules in a crystalline complex 
(L4)PdCl2 · 0.25 CH2Cl2 · 0.50 H2O have nearly identical molecular conformations.  
27 Non-hydrogen atoms for the second (B), third (C), and fourth (D) molecules can 
be superimposed with the corresponding non-hydrogen atoms of the first molecule 
(A) with a maximum rms deviation of 0.29 Å for any molecular pair.  Furthermore, 
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the maximum deviation for any pair of atoms for these superimposed molecules is 
0.90 Å.    
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Figure 26.  Packing of (L4)PdCl2 complex in the crystalline lattice cell, showing four 
sets of crystallographically-independent molecules, colored by symmetry 
equivalence.  Molecule A is shown in green, molecule B – in blue, molecule C – in 
red, molecule D – in yellow.  Disordered water and dichloromethane molecules are 
shown in purple, violet, gray, and turquoise.  
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Table 27. Crystal data and structure refinement for (L4)PdCl2. 
 
Identification code  k12f 
Empirical formula  C21.25H33.50Cl2.50NO1.50PPd 
Formula weight  552.99 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 17.1172(12) Å α= 90°. 
 b = 17.4726(12) Å β= 90°. 
 c = 33.072(2) Å γ = 90°. 
Volume 9891.1(12) Å3 
Z 16 
Density (calculated) 1.485 g/cm3 
Absorption coefficient 1.100 mm-1 
F(000) 4536 
Crystal size 0.40 x 0.30 x 0.09 mm3 
Theta range for data collection 1.67 to 30.57° 
Index ranges -23 ≤ h ≤ 24, -24 ≤ k ≤ 24, -46 ≤ l ≤ 46 
Reflections collected 117245 
Independent reflections 29017 [R(int) = 0.0918] 
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Table 27. Continued 
Completeness to theta = 30.57° 98.5 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 1.000 and 0.742 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 29017 / 8 / 1049 
Goodness-of-fit on F2 1.121 
Final R indices [I>2sigma(I)] R1 = 0.0745, ωR2 = 0.1490 
R indices (all data) R1 = 0.0898, ωR2 = 0.1549 
Absolute structure parameter 0.06(3) 
Largest diff. peak and hole 1.901 and -2.012 eÅ -3 
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Table 28. Atomic coordinates (x 104) and equivalent  isotropic displacement 
parameters (Å2 x 103) for (L4)PdCl2.  U(eq) is defined as one third of  the trace of the 
orthogonalized Uij tensor. 
_____________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________ 
Pd(1A) 7573(1) 308(1) 614(1) 14(1) 
Cl(1A) 7757(1) 1170(1) 55(1) 20(1) 
Cl(2A) 7318(1) -622(1) 148(1) 26(1) 
P(1A) 7459(1) -524(1) 1135(1) 16(1) 
O(1A) 8079(3) 1958(3) 1515(1) 25(1) 
N(1A) 7706(3) 1193(3) 1005(2) 15(1) 
C(1A) 8020(4) -170(4) 1560(2) 18(1) 
C(2A) 8841(4) 78(4) 1496(2) 25(2) 
C(3A) 8246(4) 640(4) 1646(2) 22(1) 
C(4A) 7998(4) 1251(4) 1361(2) 17(1) 
C(5A) 7932(5) 2463(4) 1171(2) 30(2) 
C(6A) 7412(5) 1980(4) 897(2) 25(2) 
C(7A) 6559(4) 2019(4) 949(2) 23(2) 
C(8A) 6205(5) 2287(5) 1292(2) 40(2) 
C(9A) 5413(6) 2222(7) 1347(3) 54(3) 
C(10A) 4948(5) 1960(7) 1053(3) 49(3) 
C(11A) 5278(5) 1651(5) 704(2) 37(2) 
C(12A) 6076(5) 1707(4) 649(2) 27(2) 
C(13A) 8267(5) 877(5) 2086(2) 33(2) 
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Table 28. Continued 
C(14A) 7879(4) -1509(4) 1068(2) 19(1) 
C(15A) 8653(4) -1438(4) 811(2) 25(2) 
C(16A) 7329(5) -2043(4) 847(2) 31(2) 
C(17A) 8106(5) -1866(4) 1482(2) 27(2) 
C(18A) 6425(4) -563(4) 1319(2) 25(2) 
C(19A) 6245(5) 214(5) 1515(2) 36(2) 
C(20A) 6288(4) -1179(5) 1646(2) 28(2) 
C(21A) 5866(4) -663(5) 954(2) 31(2) 
Pd(1B) 7498(1) 5099(1) 2067(1) 18(1) 
Cl(1B) 7803(1) 5739(1) 1448(1) 27(1) 
Cl(2B) 7196(2) 4055(1) 1687(1) 42(1) 
P(1B) 7329(1) 4445(1) 2650(1) 17(1) 
O(1B) 7933(3) 7002(3) 2817(1) 29(1) 
N(1B) 7627(3) 6098(3) 2375(2) 18(1) 
C(1B) 7894(4) 4902(4) 3043(2) 18(1) 
C(2B) 8714(4) 5150(4) 2959(2) 24(2) 
C(3B) 8116(4) 5745(4) 3060(2) 23(2) 
C(4B) 7881(4) 6255(4) 2732(2) 20(1) 
C(5B) 7825(5) 7406(4) 2434(2) 32(2) 
C(6B) 7367(4) 6826(4) 2178(2) 22(1) 
C(7B) 6498(4) 6886(4) 2179(2) 22(2) 
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Table 28. Continued 
C(8B) 6064(6) 7254(5) 2474(3) 45(2) 
C(9B) 5275(6) 7249(6) 2472(3) 49(3) 
C(10B) 4864(6) 6879(6) 2185(3) 49(3) 
C(11B) 5274(6) 6510(7) 1887(4) 62(3) 
C(12B) 6077(6) 6527(6) 1877(3) 45(2) 
C(13B) 8123(6) 6111(5) 3479(2) 42(2) 
C(14B) 7757(5) 3450(4) 2667(2) 29(2) 
C(15B) 8519(5) 3453(5) 2426(2) 37(2) 
C(16B) 7197(6) 2853(4) 2490(2) 38(2) 
C(17B) 7954(5) 3216(4) 3107(2) 30(2) 
C(18B) 6299(4) 4484(4) 2818(2) 25(2) 
C(19B) 6126(5) 5318(5) 2952(3) 36(2) 
C(20B) 6119(5) 3970(5) 3179(2) 37(2) 
C(21B) 5749(5) 4286(5) 2470(3) 44(2) 
Pd(1C) 1720(1) 4391(1) 1931(1) 17(1) 
Cl(1C) 927(1) 4022(1) 2495(1) 23(1) 
Cl(2C) 2763(1) 4399(1) 2366(1) 27(1) 
P(1C) 2522(1) 4600(1) 1398(1) 19(1) 
O(1C) -122(3) 4427(3) 1070(1) 23(1) 
N(1C) 752(3) 4499(3) 1571(2) 17(1) 
C(1C) 2047(4) 4305(4) 935(2) 18(1) 
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Table 28. Continued 
C(2C) 1670(4) 3528(4) 908(2) 20(1) 
C(3C) 1178(4) 4231(4) 863(2) 16(1) 
C(4C) 628(4) 4384(4) 1195(2) 18(1) 
C(5C) -605(4) 4457(4) 1444(2) 24(1) 
C(6C) -17(4) 4745(5) 1757(2) 25(2) 
C(7C) -14(4) 5602(4) 1830(2) 24(2) 
C(8C) -118(4) 6113(5) 1504(2) 29(2) 
C(9C) -140(5) 6892(6) 1566(3) 41(2) 
C(10C) -47(5) 7190(5) 1960(3) 37(2) 
C(11C) 36(6) 6697(6) 2282(3) 44(2) 
C(12C) 56(4) 5894(5) 2214(2) 26(2) 
C(13C) 896(4) 4462(4) 446(2) 24(2) 
C(14C) 3451(4) 4009(4) 1383(2) 23(2) 
C(15C) 3248(5) 3207(5) 1549(2) 34(2) 
C(16C) 4118(5) 4373(6) 1624(2) 39(2) 
C(17C) 3723(4) 3901(4) 939(2) 23(2) 
C(18C) 2694(4) 5653(5) 1319(2) 26(2) 
C(19C) 1897(5) 6000(5) 1229(3) 32(2) 
C(20C) 3253(5) 5811(5) 965(2) 34(2) 
C(21C) 3027(5) 6021(5) 1715(2) 32(2) 
Pd(1D) 6689(1) 5314(1) -511(1) 19(1) 
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Table 28. Continued 
Cl(1D) 5871(1) 5758(1) -1047(1) 27(1) 
Cl(2D) 7725(1) 5434(1) -942(1) 34(1) 
P(1D) 7517(1) 4986(1) -11(1) 23(1) 
O(1D) 4896(3) 5061(3) 363(1) 24(1) 
N(1D) 5731(3) 5111(3) -154(2) 18(1) 
C(1D) 7069(4) 5204(4) 468(2) 21(1) 
C(2D) 6693(4) 5960(4) 534(2) 25(2) 
C(3D) 6187(4) 5261(4) 556(2) 22(1) 
C(4D) 5630(4) 5151(4) 224(2) 23(1) 
C(5D) 4395(4) 5065(4) 7(2) 22(1) 
C(6D) 4968(4) 4889(4) -343(2) 22(1) 
C(7D) 4966(4) 4059(4) -460(2) 23(1) 
C(8D) 4853(5) 3467(5) -179(2) 35(2) 
C(9D) 4843(6) 2725(5) -288(3) 39(2) 
C(10D) 4968(5) 2521(5) -688(3) 39(2) 
C(11D) 5103(5) 3094(5) -977(3) 39(2) 
C(12D) 5111(4) 3859(5) -864(2) 26(2) 
C(13D) 5930(4) 4997(5) 976(2) 28(2) 
C(14D) 8463(4) 5556(5) 34(2) 28(2) 
C(15D) 8292(5) 6375(5) -88(2) 37(2) 
C(16D) 9120(5) 5212(7) -233(2) 43(2) 
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Table 28. Continued 
C(17D) 8756(5) 5559(6) 477(2) 42(2) 
C(18D) 7673(5) 3929(5) 3(2) 31(2) 
C(19D) 6900(5) 3562(5) 91(3) 35(2) 
C(20D) 8262(6) 3675(5) 331(3) 42(2) 
C(21D) 7972(6) 3637(5) -411(3) 41(2) 
Cl(1) 6738(5) 7557(4) -354(2) 174(3) 
O(1W') 6738(5) 7557(4) -354(2) 174(3) 
Cl(2) 5346(5) 8154(6) -510(3) 219(4) 
Cl(2') 5663(18) 7420(20) -407(8) 188(15) 
C(1S) 6044(5) 8098(7) -180(3) 13(3) 
C(1S') 5961(8) 7487(11) -633(6) 41(6) 
C(1S") 4783(13) 7340(40) -230(9) 76(19) 
O(1W) 4817(7) 6990(5) 225(4) 164(5) 
Cl(1') 4817(7) 6990(5) 225(4) 164(5) 
O(2W) 4876(13) 7391(8) 1022(3) 231(11) 
________________________________________________________________________________  
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Table 29. Bond lengths [Å] and angles [°] for (L4)PdCl2. 
 
Pd(1A)-N(1A)  2.029(5) 
Pd(1A)-P(1A)  2.2610(16) 
Pd(1A)-Cl(2A)  2.2818(17) 
Pd(1A)-Cl(1A)  2.4059(16) 
P(1A)-C(1A)  1.812(6) 
P(1A)-C(18A)  1.873(7) 
P(1A)-C(14A)  1.878(7) 
O(1A)-C(4A)  1.343(8) 
O(1A)-C(5A)  1.462(8) 
N(1A)-C(4A)  1.283(8) 
N(1A)-C(6A)  1.508(8) 
C(1A)-C(2A)  1.488(10) 
C(1A)-C(3A)  1.494(9) 
C(2A)-C(3A)  1.501(10) 
C(3A)-C(4A)  1.487(9) 
C(14B)-C(15B)  1.529(12) 
C(14B)-C(16B)  1.532(11) 
C(14B)-C(17B)  1.548(10) 
C(18B)-C(20B)  1.525(10) 
C(18B)-C(21B)  1.528(11) 
C(18B)-C(19B)  1.552(11) 
Pd(1C)-N(1C)  2.049(5) 
Pd(1C)-P(1C)  2.2643(17) 
Pd(1C)-Cl(2C)  2.2921(17) 
Pd(1C)-Cl(1C)  2.3963(17) 
P(1C)-C(1C)  1.809(7) 
P(1C)-C(18C)  1.882(8) 
P(1C)-C(14C)  1.896(7) 
O(1C)-C(4C)  1.350(8) 
O(1C)-C(5C)  1.487(8) 
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Table 29. Continued 
C(3A)-C(13A)  1.511(9) 
C(5A)-C(6A)  1.525(10) 
C(6A)-C(7A)  1.472(11) 
C(7A)-C(8A)  1.370(10) 
C(7A)-C(12A)  1.402(10) 
C(8A)-C(9A)  1.372(13) 
C(9A)-C(10A)  1.337(13) 
C(10A)-C(11A)  1.395(12) 
C(11A)-C(12A)  1.381(12) 
C(14A)-C(16A)  1.513(10) 
C(14A)-C(17A)  1.554(9) 
C(14A)-C(15A)  1.579(10) 
C(18A)-C(19A)  1.536(11) 
C(18A)-C(20A)  1.544(10) 
C(18A)-C(21A)  1.550(10) 
 
N(1C)-C(4C)  1.280(8) 
N(1C)-C(6C)  1.514(8) 
C(1C)-C(2C)  1.506(10) 
C(1C)-C(3C)  1.512(9) 
C(2C)-C(3C)  1.496(9) 
C(3C)-C(4C)  1.469(9) 
C(3C)-C(13C)  1.517(9) 
C(5C)-C(6C)  1.531(10) 
C(6C)-C(7C)  1.516(11) 
C(7C)-C(12C)  1.372(9) 
C(7C)-C(8C)  1.413(10) 
C(8C)-C(9C)  1.379(12) 
C(9C)-C(10C)  1.412(12) 
C(10C)-C(11C)  1.375(13) 
C(11C)-C(12C)  1.422(12) 
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Table 29. Continued 
Pd(1B)-N(1B)  2.032(5) 
Pd(1B)-P(1B)  2.2583(16) 
Pd(1B)-Cl(2B)  2.2753(19) 
Pd(1B)-Cl(1B)  2.3912(17) 
P(1B)-C(1B)  1.807(7) 
P(1B)-C(18B)  1.851(7) 
P(1B)-C(14B)  1.888(7) 
O(1B)-C(4B)  1.337(8) 
O(1B)-C(5B)  1.462(8) 
N(1B)-C(4B)  1.290(8) 
N(1B)-C(6B)  1.498(8) 
C(1B)-C(2B)  1.496(10) 
C(1B)-C(3B)  1.523(9) 
C(2B)-C(3B)  1.497(10) 
C(3B)-C(4B)  1.458(9) 
 
C(14C)-C(16C)  1.531(11) 
C(14C)-C(15C)  1.545(11) 
C(14C)-C(17C)  1.551(9) 
C(18C)-C(19C)  1.523(10) 
C(18C)-C(20C)  1.537(10) 
C(18C)-C(21C)  1.567(10) 
Pd(1D)-N(1D)  2.053(6) 
Pd(1D)-P(1D)  2.2514(18) 
Pd(1D)-Cl(2D)  2.2844(18) 
Pd(1D)-Cl(1D)  2.3889(17) 
P(1D)-C(1D)  1.800(6) 
P(1D)-C(18D)  1.868(8) 
P(1D)-C(14D)  1.906(7) 
O(1D)-C(4D)  1.348(8) 
O(1D)-C(5D)  1.455(7) 
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Table 29. Continued 
C(3B)-C(13B)  1.527(10) 
C(5B)-C(6B)  1.537(9) 
C(6B)-C(7B)  1.490(11) 
C(7B)-C(12B)  1.382(11) 
C(7B)-C(8B)  1.384(11) 
C(8B)-C(9B)  1.351(13) 
C(9B)-C(10B)  1.346(14) 
C(10B)-C(11B)  1.372(13) 
C(11B)-C(12B)  1.376(13) 
C(7D)-C(12D)  1.401(10) 
C(7D)-C(8D)  1.404(10) 
C(8D)-C(9D)  1.345(12) 
C(9D)-C(10D)  1.388(13) 
C(10D)-C(11D)  1.402(13) 
C(11D)-C(12D)  1.387(11) 
 
N(1D)-C(4D)  1.263(8) 
N(1D)-C(6D)  1.498(9) 
C(1D)-C(2D)  1.486(10) 
C(1D)-C(3D)  1.542(9) 
C(2D)-C(3D)  1.499(10) 
C(3D)-C(4D)  1.467(9) 
C(3D)-C(13D)  1.528(9) 
C(5D)-C(6D)  1.550(9) 
C(6D)-C(7D)  1.501(10) 
C(18D)-C(21D)  1.549(11) 
Cl(1)-C(1S)  1.623(6) 
Cl(1)-Cl(2')  1.86(3) 
Cl(2)-Cl(2')  1.44(4) 
Cl(2)-C(1S)  1.623(6) 
Cl(2)-C(1S')  1.623(6) 
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C(14D)-C(15D)  1.514(12) 
C(14D)-C(16D)  1.550(11) 
C(14D)-C(17D)  1.550(9) 
C(18D)-C(19D)  1.499(12) 
C(18D)-C(20D)  1.547(11) 
N(1A)-Pd(1A)-P(1A) 90.83(15) 
N(1A)-Pd(1A)-Cl(2A) 174.26(16) 
P(1A)-Pd(1A)-Cl(2A) 92.28(6) 
N(1A)-Pd(1A)-Cl(1A) 89.91(15) 
P(1A)-Pd(1A)-Cl(1A) 177.18(7) 
Cl(2A)-Pd(1A)-Cl(1A) 87.21(6) 
C(1A)-P(1A)-C(18A) 105.1(3) 
C(1A)-P(1A)-C(14A) 101.6(3) 
C(18A)-P(1A)-C(14A) 111.5(3) 
C(1A)-P(1A)-Pd(1A) 109.1(2) 
 
Cl(2)-C(1S")  1.95(4) 
Cl(2')-C(1S')  0.91(3) 
Cl(2')-C(1S)  1.55(4) 
Cl(2')-C(1S")  1.623(6) 
C(16A)-C(14A)-C(17A) 109.5(5) 
C(16A)-C(14A)-C(15A) 108.0(6) 
C(17A)-C(14A)-C(15A) 107.3(6) 
C(16A)-C(14A)-P(1A) 112.5(5) 
C(17A)-C(14A)-P(1A) 111.2(5) 
C(15A)-C(14A)-P(1A) 108.1(4) 
C(19A)-C(18A)-C(20A) 106.8(6) 
C(19A)-C(18A)-C(21A) 107.7(6) 
C(20A)-C(18A)-C(21A) 111.9(6) 
C(19A)-C(18A)-P(1A) 107.2(5) 
C(20A)-C(18A)-P(1A) 113.3(5) 
  
259 
Table 29. Continued 
C(18A)-P(1A)-Pd(1A) 110.6(2) 
C(14A)-P(1A)-Pd(1A) 117.9(2) 
C(4A)-O(1A)-C(5A) 104.0(5) 
C(4A)-N(1A)-C(6A) 106.0(5) 
C(4A)-N(1A)-Pd(1A) 133.6(4) 
C(6A)-N(1A)-Pd(1A) 120.4(4) 
C(2A)-C(1A)-C(3A) 60.4(5) 
C(2A)-C(1A)-P(1A) 119.2(5) 
C(3A)-C(1A)-P(1A) 127.4(5) 
C(1A)-C(2A)-C(3A) 60.0(5) 
C(4A)-C(3A)-C(1A) 119.1(5) 
C(4A)-C(3A)-C(2A) 117.0(6) 
C(1A)-C(3A)-C(2A) 59.6(5) 
C(4A)-C(3A)-C(13A) 114.7(6) 
C(1A)-C(3A)-C(13A) 116.7(6) 
 
C(21A)-C(18A)-P(1A) 109.6(5) 
N(1B)-Pd(1B)-P(1B) 91.22(15) 
N(1B)-Pd(1B)-Cl(2B) 171.86(16) 
P(1B)-Pd(1B)-Cl(2B) 92.14(7) 
N(1B)-Pd(1B)-Cl(1B) 90.20(15) 
P(1B)-Pd(1B)-Cl(1B) 174.34(7) 
Cl(2B)-Pd(1B)-Cl(1B) 87.18(7) 
C(1B)-P(1B)-C(18B) 106.0(3) 
C(1B)-P(1B)-C(14B) 100.2(3) 
C(18B)-P(1B)-C(14B) 113.2(4) 
C(1B)-P(1B)-Pd(1B) 108.8(2) 
C(18B)-P(1B)-Pd(1B) 111.1(2) 
C(14B)-P(1B)-Pd(1B) 116.3(2) 
C(4B)-O(1B)-C(5B) 106.4(5) 
C(4B)-N(1B)-C(6B) 108.5(5) 
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C(2A)-C(3A)-C(13A) 118.8(6) 
N(1A)-C(4A)-O(1A) 117.5(6) 
N(1A)-C(4A)-C(3A) 129.4(6) 
O(1A)-C(4A)-C(3A) 113.0(5) 
O(1A)-C(5A)-C(6A) 103.2(6) 
C(7A)-C(6A)-N(1A) 110.3(6) 
C(7A)-C(6A)-C(5A) 118.9(6) 
N(1A)-C(6A)-C(5A) 99.7(5) 
C(8A)-C(7A)-C(12A) 117.4(7) 
C(8A)-C(7A)-C(6A) 123.4(7) 
C(12A)-C(7A)-C(6A) 119.0(6) 
C(7A)-C(8A)-C(9A) 121.2(8) 
C(10A)-C(9A)-C(8A) 121.3(8) 
C(9A)-C(10A)-C(11A) 119.6(9) 
C(12A)-C(11A)-C(10A) 118.8(8) 
 
C(4B)-N(1B)-Pd(1B) 132.8(5) 
C(6B)-N(1B)-Pd(1B) 118.7(4) 
C(2B)-C(1B)-C(3B) 59.5(5) 
C(2B)-C(1B)-P(1B) 119.7(5) 
C(3B)-C(1B)-P(1B) 125.9(5) 
C(1B)-C(2B)-C(3B) 61.2(5) 
C(4B)-C(3B)-C(2B) 116.7(6) 
C(4B)-C(3B)-C(1B) 119.8(6) 
C(2B)-C(3B)-C(1B) 59.4(4) 
C(4B)-C(3B)-C(13B) 114.8(6) 
C(2B)-C(3B)-C(13B) 119.1(6) 
C(1B)-C(3B)-C(13B) 116.0(6) 
N(1B)-C(4B)-O(1B) 115.0(6) 
N(1B)-C(4B)-C(3B) 130.0(6) 
O(1B)-C(4B)-C(3B) 115.0(6) 
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C(11A)-C(12A)-C(7A) 121.1(7) 
O(1B)-C(5B)-C(6B) 102.9(5) 
C(7B)-C(6B)-N(1B) 110.8(5) 
C(7B)-C(6B)-C(5B) 117.6(6) 
N(1B)-C(6B)-C(5B) 99.7(5) 
C(12B)-C(7B)-C(8B) 116.1(8) 
C(12B)-C(7B)-C(6B) 119.1(7) 
C(8B)-C(7B)-C(6B) 124.7(7) 
C(9B)-C(8B)-C(7B) 122.0(8) 
C(10B)-C(9B)-C(8B) 122.0(8) 
C(9B)-C(10B)-C(11B) 117.7(9) 
C(10B)-C(11B)-C(12B) 121.2(9) 
C(11B)-C(12B)-C(7B) 121.0(9) 
C(15B)-C(14B)-C(16B) 109.7(7) 
C(15B)-C(14B)-C(17B) 107.7(6) 
 
N(1C)-C(6C)-C(7C) 110.0(6) 
N(1C)-C(6C)-C(5C) 101.7(5) 
C(7C)-C(6C)-C(5C) 115.8(6) 
C(12C)-C(7C)-C(8C) 118.8(7) 
C(12C)-C(7C)-C(6C) 121.0(7) 
C(8C)-C(7C)-C(6C) 120.1(6) 
C(9C)-C(8C)-C(7C) 120.9(7) 
C(8C)-C(9C)-C(10C) 119.9(8) 
C(11C)-C(10C)-C(9C) 119.7(8) 
C(10C)-C(11C)-C(12C) 119.9(8) 
C(7C)-C(12C)-C(11C) 120.7(8) 
C(16C)-C(14C)-C(15C) 111.1(6) 
C(16C)-C(14C)-C(17C) 108.6(6) 
C(15C)-C(14C)-C(17C) 107.1(6) 
C(16C)-C(14C)-P(1C) 112.7(6) 
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C(16B)-C(14B)-C(17B) 108.5(6) 
C(15B)-C(14B)-P(1B) 108.1(5) 
C(16B)-C(14B)-P(1B) 111.8(6) 
C(17B)-C(14B)-P(1B) 110.9(5) 
C(20B)-C(18B)-C(21B) 109.4(6) 
C(20B)-C(18B)-C(19B) 107.0(6) 
C(21B)-C(18B)-C(19B) 108.0(7) 
C(20B)-C(18B)-P(1B) 114.0(5) 
C(21B)-C(18B)-P(1B) 110.6(6) 
C(19B)-C(18B)-P(1B) 107.6(5) 
N(1C)-Pd(1C)-P(1C) 91.31(15) 
N(1C)-Pd(1C)-Cl(2C) 173.48(16) 
P(1C)-Pd(1C)-Cl(2C) 90.91(6) 
N(1C)-Pd(1C)-Cl(1C) 91.07(15) 
P(1C)-Pd(1C)-Cl(1C) 173.43(7) 
 
C(15C)-C(14C)-P(1C) 107.2(5) 
C(17C)-C(14C)-P(1C) 110.0(4) 
C(19C)-C(18C)-C(20C) 109.7(6) 
C(19C)-C(18C)-C(21C) 109.0(6) 
C(20C)-C(18C)-C(21C) 109.6(6) 
C(19C)-C(18C)-P(1C) 106.0(5) 
C(20C)-C(18C)-P(1C) 112.3(5) 
C(21C)-C(18C)-P(1C) 110.1(5) 
N(1D)-Pd(1D)-P(1D) 92.08(15) 
N(1D)-Pd(1D)-Cl(2D) 174.46(17) 
P(1D)-Pd(1D)-Cl(2D) 89.65(7) 
N(1D)-Pd(1D)-Cl(1D) 90.80(15) 
P(1D)-Pd(1D)-Cl(1D) 175.21(7) 
Cl(2D)-Pd(1D)-Cl(1D) 87.84(7) 
C(1D)-P(1D)-C(18D) 104.4(3) 
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Cl(2C)-Pd(1C)-Cl(1C) 87.39(6) 
C(1C)-P(1C)-C(18C) 103.4(3) 
C(1C)-P(1C)-C(14C) 101.6(3) 
C(18C)-P(1C)-C(14C) 113.4(3) 
C(1C)-P(1C)-Pd(1C) 110.0(2) 
C(18C)-P(1C)-Pd(1C) 111.1(2) 
C(14C)-P(1C)-Pd(1C) 116.1(2) 
C(4C)-O(1C)-C(5C) 106.1(5) 
C(4C)-N(1C)-C(6C) 107.2(5) 
C(4C)-N(1C)-Pd(1C) 133.2(5) 
C(6C)-N(1C)-Pd(1C) 119.5(4) 
C(2C)-C(1C)-C(3C) 59.4(4) 
C(2C)-C(1C)-P(1C) 120.0(5) 
C(3C)-C(1C)-P(1C) 126.8(4) 
C(3C)-C(2C)-C(1C) 60.5(4) 
 
C(1D)-P(1D)-C(14D) 100.5(3) 
C(18D)-P(1D)-C(14D) 113.1(4) 
C(1D)-P(1D)-Pd(1D) 109.0(2) 
C(18D)-P(1D)-Pd(1D) 111.0(3) 
C(14D)-P(1D)-Pd(1D) 117.3(2) 
C(4D)-O(1D)-C(5D) 105.9(5) 
C(4D)-N(1D)-C(6D) 108.0(6) 
C(4D)-N(1D)-Pd(1D) 132.0(5) 
C(6D)-N(1D)-Pd(1D) 120.0(4) 
C(2D)-C(1D)-C(3D) 59.3(5) 
C(2D)-C(1D)-P(1D) 120.1(5) 
C(3D)-C(1D)-P(1D) 126.7(4) 
C(1D)-C(2D)-C(3D) 62.2(5) 
C(4D)-C(3D)-C(2D) 116.5(6) 
C(4D)-C(3D)-C(13D) 117.0(6) 
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C(4C)-C(3C)-C(2C) 115.9(6) 
C(4C)-C(3C)-C(1C) 119.9(5) 
C(2C)-C(3C)-C(1C) 60.1(4) 
C(4C)-C(3C)-C(13C) 115.2(5) 
C(2C)-C(3C)-C(13C) 119.2(5) 
C(1C)-C(3C)-C(13C) 115.6(6) 
N(1C)-C(4C)-O(1C) 116.4(6) 
N(1C)-C(4C)-C(3C) 130.5(6) 
O(1C)-C(4C)-C(3C) 113.1(5) 
O(1C)-C(5C)-C(6C) 102.0(5) 
N(1D)-C(6D)-C(5D) 100.8(5) 
C(7D)-C(6D)-C(5D) 112.6(6) 
C(12D)-C(7D)-C(8D) 118.1(7) 
C(12D)-C(7D)-C(6D) 119.1(6) 
C(8D)-C(7D)-C(6D) 122.8(7) 
 
C(2D)-C(3D)-C(13D) 117.2(6) 
C(4D)-C(3D)-C(1D) 119.1(5) 
C(2D)-C(3D)-C(1D) 58.5(5) 
C(13D)-C(3D)-C(1D) 115.7(6) 
N(1D)-C(4D)-O(1D) 117.3(6) 
N(1D)-C(4D)-C(3D) 131.3(7) 
O(1D)-C(4D)-C(3D) 111.4(6) 
O(1D)-C(5D)-C(6D) 103.3(5) 
N(1D)-C(6D)-C(7D) 111.1(5) 
C(1S)-Cl(1)-Cl(2') 52.3(12) 
Cl(2')-Cl(2)-C(1S) 60.5(16) 
Cl(2')-Cl(2)-C(1S') 34.0(12) 
C(1S)-Cl(2)-C(1S') 69.3(3) 
Cl(2')-Cl(2)-C(1S") 54.7(12) 
C(1S)-Cl(2)-C(1S") 89.9(10) 
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C(9D)-C(8D)-C(7D) 122.4(8) 
C(8D)-C(9D)-C(10D) 120.0(8) 
C(9D)-C(10D)-C(11D) 119.4(8) 
C(12D)-C(11D)-C(10D) 120.4(8) 
C(11D)-C(12D)-C(7D) 119.7(8) 
C(15D)-C(14D)-C(16D) 110.8(7) 
C(15D)-C(14D)-C(17D) 108.0(7) 
C(16D)-C(14D)-C(17D) 107.7(6) 
C(15D)-C(14D)-P(1D) 108.0(5) 
C(16D)-C(14D)-P(1D) 111.8(6) 
C(17D)-C(14D)-P(1D) 110.5(5) 
C(19D)-C(18D)-C(20D) 108.5(7) 
C(19D)-C(18D)-C(21D) 108.9(7) 
C(20D)-C(18D)-C(21D) 108.1(7) 
C(19D)-C(18D)-P(1D) 107.5(5) 
 
C(1S')-Cl(2)-C(1S") 85.1(18) 
C(1S')-Cl(2')-Cl(2) 84(3) 
C(1S')-Cl(2')-C(1S) 94(3) 
Cl(2)-Cl(2')-C(1S) 65.7(17) 
C(1S')-Cl(2')-C(1S") 146(3) 
Cl(2)-Cl(2')-C(1S") 79(2) 
C(1S)-Cl(2')-C(1S") 106(3) 
C(1S')-Cl(2')-Cl(1) 60.6(18) 
Cl(2)-Cl(2')-Cl(1) 106(2) 
C(1S)-Cl(2')-Cl(1) 55.9(12) 
C(1S")-Cl(2')-Cl(1) 153(2) 
Cl(2')-C(1S)-Cl(1) 71.9(12) 
Cl(2')-C(1S)-Cl(2) 53.8(13) 
Cl(1)-C(1S)-Cl(2) 109.55(9) 
Cl(2')-C(1S')-Cl(2) 62(2) 
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C(20D)-C(18D)-P(1D) 113.2(6) 
C(21D)-C(18D)-P(1D) 110.6(6) 
 
 
Cl(2')-C(1S")-Cl(2) 46.2(17) 
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Table 30. Anisotropic displacement parameters  (Å2 x 103) for (L4)PdCl2 complex.  
The anisotropic displacement factor exponent takes the form:  -2p2[ h2 a*2U11 + ...  
+ 2 h k a* b* U12 ] 
___________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
_______________________________________________________________ 
Pd(1A) 20(1)  14(1) 9(1)  -2(1) 1(1)  1(1) 
Cl(1A) 27(1)  20(1) 12(1)  2(1) 1(1)  1(1) 
Cl(2A) 41(1)  23(1) 15(1)  -4(1) -3(1)  -2(1) 
P(1A) 19(1)  17(1) 13(1)  2(1) 2(1)  0(1) 
O(1A) 42(3)  16(2) 18(2)  -1(2) -11(2)  0(2) 
N(1A) 22(3)  12(2) 12(2)  -1(2) 1(2)  6(2) 
C(1A) 22(3)  18(3) 15(3)  6(2) -2(2)  -5(3) 
C(2A) 23(3)  30(4) 22(3)  3(3) -5(3)  0(3) 
C(3A) 27(3)  22(3) 16(3)  3(3) -8(3)  -3(3) 
C(4A) 26(3)  11(3) 14(3)  -1(2) 3(2)  3(2) 
C(5A) 49(5)  19(4) 21(3)  5(3) -14(3)  7(3) 
C(6A) 40(4)  18(3) 17(3)  -4(2) -10(3)  8(3) 
C(7A) 28(4)  19(3) 20(3)  -4(3) -4(3)  11(3) 
C(8A) 43(5)  49(5) 28(4)  -27(4) -5(4)  16(4) 
C(9A) 45(6)  86(8) 32(5)  -27(5) 1(4)  21(5) 
C(10A) 26(4)  78(8) 43(5)  -17(5) -1(4)  19(5) 
C(11A) 40(5)  45(5) 26(4)  -1(4) -5(4)  7(4) 
C(12A) 33(4)  31(4) 19(3)  -1(3) -4(3)  1(3) 
C(13A) 50(5)  31(4) 17(3)  -5(3) -13(4)  3(4) 
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C(14A) 26(3)  9(3) 22(3)  7(2) 1(3)  -3(2) 
C(15A) 35(4)  18(3) 21(3)  -1(3) 8(3)  3(3) 
C(16A) 45(5)  16(3) 32(4)  2(3) 6(3)  -7(3) 
C(17A) 38(5)  23(4) 22(3)  5(3) 3(3)  2(3) 
C(18A) 22(3)  24(4) 28(4)  1(3) 2(3)  6(3) 
C(19A) 26(4)  56(6) 26(4)  3(4) 12(3)  7(4) 
C(20A) 23(4)  39(5) 22(3)  7(3) 2(3)  -6(3) 
C(21A) 27(4)  40(5) 25(4)  7(3) 4(3)  -2(3) 
Pd(1B) 22(1)  20(1) 10(1)  -3(1) 0(1)  6(1) 
Cl(1B) 26(1)  45(1) 11(1)  3(1) 2(1)  6(1) 
Cl(2B) 78(2)  26(1) 21(1)  -11(1) -15(1)  15(1) 
P(1B) 22(1)  14(1) 14(1)  -2(1) 1(1)  -1(1) 
O(1B) 52(4)  16(2) 19(2)  4(2) -15(2)  -11(2) 
N(1B) 18(3)  20(3) 16(2)  3(2) -1(2)  3(2) 
C(1B) 28(3)  12(3) 14(3)  1(2) -4(2)  4(3) 
C(2B) 28(4)  18(3) 26(3)  8(3) -7(3)  -5(3) 
C(3B) 30(4)  23(4) 16(3)  2(3) -6(3)  -7(3) 
C(4B) 31(4)  12(3) 16(3)  7(2) -6(3)  -7(3) 
C(5B) 51(5)  19(4) 26(4)  2(3) -25(4)  -8(3) 
C(6B) 33(4)  14(3) 17(3)  5(2) -8(3)  -2(3) 
C(7B) 35(4)  14(3) 17(3)  1(2) -8(3)  -1(3) 
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C(8B) 51(6)  46(5) 37(5)  -22(4) -15(4)  27(4) 
C(9B) 45(6)  57(6) 46(5)  -18(5) 3(5)  30(5) 
C(10B) 32(5)  60(7) 54(6)  -20(5) 0(4)  19(5) 
C(11B) 31(5)  68(7) 87(8)  -42(7) -23(5)  5(5) 
C(12B) 45(6)  61(6) 31(5)  -19(4) -7(4)  12(5) 
C(13B) 84(7)  24(4) 18(3)  0(3) -28(4)  -7(4) 
C(14B) 40(5)  22(4) 24(4)  -4(3) -4(3)  8(3) 
C(15B) 57(6)  26(4) 30(4)  -5(3) -1(4)  19(4) 
C(16B) 67(6)  15(4) 32(4)  -3(3) -11(4)  2(4) 
C(17B) 48(5)  16(3) 24(4)  7(3) -4(3)  3(3) 
C(18B) 24(3)  30(4) 22(3)  7(3) 1(3)  -3(3) 
C(19B) 34(4)  35(5) 38(4)  -2(4) 10(3)  12(4) 
C(20B) 29(4)  48(5) 33(4)  15(4) -2(3)  -10(4) 
C(21B) 33(5)  39(5) 60(6)  18(5) -8(4)  -10(4) 
Pd(1C) 19(1)  24(1) 9(1)  -2(1) 1(1)  2(1) 
Cl(1C) 27(1)  27(1) 15(1)  1(1) 4(1)  2(1) 
Cl(2C) 26(1)  43(1) 12(1)  -1(1) -3(1)  1(1) 
P(1C) 19(1)  27(1) 11(1)  -2(1) 1(1)  4(1) 
O(1C) 21(2)  24(3) 24(2)  -6(2) 3(2)  4(2) 
N(1C) 22(3)  16(3) 12(2)  -1(2) 3(2)  4(2) 
C(1C) 14(3)  26(4) 13(3)  1(3) 2(2)  12(3) 
  
270 
Table 30. Continued 
C(2C) 29(4)  20(3) 11(3)  -5(2) 3(3)  10(3) 
C(3C) 18(3)  10(3) 18(3)  -3(2) -3(2)  7(2) 
C(4C) 15(3)  20(3) 19(3)  2(3) -3(2)  2(3) 
C(5C) 20(3)  29(4) 22(3)  -7(3) 4(3)  1(3) 
C(6C) 16(3)  34(4) 26(3)  -4(3) 5(3)  11(3) 
C(7C) 24(3)  28(4) 20(3)  -5(3) 2(3)  9(3) 
C(8C) 23(4)  31(4) 32(4)  0(3) -1(3)  11(3) 
C(9C) 32(5)  56(6) 34(5)  6(4) -9(4)  17(4) 
C(10C) 30(4)  28(4) 54(5)  -19(4) -10(4)  10(3) 
C(11C) 36(5)  55(6) 40(5)  -17(5) 0(4)  -4(4) 
C(12C) 20(3)  33(4) 23(4)  -8(3) 1(3)  -2(3) 
C(13C) 20(3)  35(4) 16(3)  0(3) 0(3)  2(3) 
C(14C) 19(3)  38(4) 12(3)  2(3) -3(2)  9(3) 
C(15C) 37(4)  46(5) 19(3)  4(3) 9(3)  12(4) 
C(16C) 31(4)  68(6) 18(3)  -3(4) -6(3)  8(4) 
C(17C) 24(4)  33(4) 12(3)  -1(3) 1(3)  -1(3) 
C(18C) 22(4)  36(4) 21(3)  -1(3) 1(3)  3(3) 
C(19C) 30(4)  24(4) 42(5)  0(3) -5(3)  0(3) 
C(20C) 33(4)  41(5) 28(4)  5(3) -1(3)  -7(4) 
C(21C) 43(5)  33(4) 20(4)  0(3) -2(3)  -8(4) 
Pd(1D) 22(1)  26(1) 8(1)  1(1) -1(1)  2(1) 
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Cl(1D) 29(1)  40(1) 12(1)  6(1) -2(1)  4(1) 
Cl(2D) 29(1)  64(1) 9(1)  -1(1) 3(1)  -4(1) 
P(1D) 21(1)  36(1) 11(1)  0(1) 1(1)  6(1) 
O(1D) 22(2)  37(3) 13(2)  3(2) -1(2)  -3(2) 
N(1D) 29(3)  15(3) 12(2)  3(2) -5(2)  5(2) 
C(1D) 17(3)  37(4) 9(3)  3(3) -3(2)  2(3) 
C(2D) 29(4)  31(4) 17(3)  2(3) -4(3)  -11(3) 
C(3D) 19(3)  31(4) 14(3)  -3(3) 3(2)  2(3) 
C(4D) 31(4)  21(4) 17(3)  2(3) -1(3)  -3(3) 
C(5D) 21(3)  34(4) 11(3)  -2(3) -8(2)  1(3) 
C(6D) 19(3)  33(4) 16(3)  8(3) 1(2)  5(3) 
C(7D) 25(3)  21(3) 22(3)  5(3) -3(3)  6(3) 
C(8D) 47(5)  30(4) 28(4)  12(3) -12(4)  -5(4) 
C(9D) 45(5)  26(4) 47(5)  8(4) -1(4)  -1(4) 
C(10D) 26(4)  27(4) 63(6)  0(4) 2(4)  -1(3) 
C(11D) 37(5)  32(5) 47(5)  -15(4) -4(4)  1(4) 
C(12D) 18(3)  29(4) 31(4)  -1(3) -1(3)  7(3) 
C(13D) 24(3)  47(5) 13(3)  6(3) 0(3)  -9(3) 
C(14D) 18(3)  47(5) 19(3)  -3(3) -8(3)  -6(3) 
C(15D) 34(4)  52(5) 26(4)  -8(4) 9(4)  -17(4) 
C(16D) 25(4)  92(8) 12(3)  9(4) 0(3)  10(5) 
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C(17D) 22(4)  88(8) 16(3)  -10(4) 3(3)  -3(4) 
C(18D) 33(4)  36(4) 24(3)  -2(3) -1(3)  18(3) 
C(19D) 38(5)  33(4) 34(4)  3(3) 1(4)  16(4) 
C(20D) 43(5)  44(5) 40(5)  14(4) -12(4)  8(4) 
C(21D) 59(6)  34(5) 31(4)  4(4) 5(4)  14(4) 
Cl(1) 206(8)  170(6) 146(6)  35(5) -62(6)  -31(6) 
O(1W') 206(8)  170(6) 146(6)  35(5) -62(6)  -31(6) 
O(1W) 199(11)  74(6) 218(12)  7(7) -55(9)  90(7) 
Cl(1') 199(11)  74(6) 218(12)  7(7) -55(9)  90(7) 
O(2W) 440(30)  176(13) 75(8)  -16(8) 46(12)  -254(17) 
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Table 31. Hydrogen coordinates ( x 104) and isotropic  displacement parameters 
(Å2 x 103) for (L4)PdCl2 complex. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1AA) 7949 -484 1811 22 
H(2AA) 9026 133 1213 30 
H(2AB) 9241 -105 1689 30 
H(5AA) 8425 2603 1033 36 
H(5AB) 7660 2936 1257 36 
H(6AA) 7545 2091 608 30 
H(8AA) 6513 2522 1496 48 
H(9AA) 5190 2366 1599 65 
H(10A) 4397 1985 1081 59 
H(11A) 4960 1405 507 45 
H(12A) 6301 1532 403 33 
H(13A) 7743 1034 2171 49 
H(13B) 8629 1307 2119 49 
H(13C) 8442 445 2251 49 
H(15A) 8936 -1925 818 37 
H(15B) 8983 -1033 925 37 
H(15C) 8520 -1310 531 37 
H(16A) 7574 -2548 820 46 
H(16B) 7217 -1836 578 46 
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H(16C) 6842 -2091 1000 46 
H(17A) 8301 -2388 1441 41 
H(17B) 7645 -1881 1658 41 
H(17C) 8514 -1555 1610 41 
H(19A) 5691 235 1589 54 
H(19B) 6362 626 1322 54 
H(19C) 6566 278 1758 54 
H(20A) 5746 -1153 1740 42 
H(20B) 6642 -1088 1874 42 
H(20C) 6391 -1686 1532 42 
H(21A) 5329 -722 1052 46 
H(21B) 6016 -1120 800 46 
H(21C) 5898 -212 779 46 
H(1BA) 7823 4663 3316 22 
H(2BA) 8901 5122 2676 29 
H(2BB) 9115 5034 3166 29 
H(5BA) 8334 7531 2308 38 
H(5BB) 7524 7884 2473 38 
H(6BA) 7561 6841 1893 26 
H(8BA) 6330 7519 2684 54 
H(9BA) 5002 7514 2679 59 
  
275 
Table 31. Continued 
H(10B) 4309 6874 2189 58 
H(11B) 4998 6237 1683 74 
H(12B) 6347 6288 1660 55 
H(13D) 8461 6564 3476 63 
H(13E) 8321 5741 3677 63 
H(13F) 7590 6263 3553 63 
H(15D) 8739 2935 2421 56 
H(15E) 8892 3803 2554 56 
H(15F) 8415 3623 2149 56 
H(16D) 7380 2339 2560 57 
H(16E) 7181 2907 2195 57 
H(16F) 6673 2933 2601 57 
H(17D) 8141 2685 3111 44 
H(17E) 7485 3260 3275 44 
H(17F) 8363 3554 3213 44 
H(19D) 5567 5373 3010 53 
H(19E) 6273 5671 2735 53 
H(19F) 6428 5438 3196 53 
H(20D) 5628 4133 3305 55 
H(20E) 6543 4008 3377 55 
H(20F) 6070 3439 3088 55 
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H(21D) 5206 4354 2558 66 
H(21E) 5831 3753 2388 66 
H(21F) 5856 4625 2240 66 
H(1CA) 2345 4448 686 22 
H(2CA) 1771 3219 662 24 
H(2CB) 1617 3229 1160 24 
H(5CA) -808 3945 1516 28 
H(5CB) -1048 4817 1413 28 
H(6CA) -98 4470 2019 30 
H(8CA) -173 5916 1237 34 
H(9CA) -218 7229 1344 49 
H(10C) -42 7727 2003 45 
H(11C) 81 6893 2548 52 
H(12C) 117 5555 2436 31 
H(13G) 416 4183 381 36 
H(13H) 1299 4340 245 36 
H(13I) 791 5013 442 36 
H(15G) 3721 2891 1556 51 
H(15H) 2859 2965 1373 51 
H(15I) 3035 3255 1823 51 
H(16G) 4569 4027 1625 58 
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H(16H) 3946 4464 1903 58 
H(16I) 4266 4860 1499 58 
H(17G) 4228 3637 936 34 
H(17H) 3777 4403 810 34 
H(17I) 3336 3596 792 34 
H(19G) 1944 6558 1212 48 
H(19H) 1532 5866 1446 48 
H(19I) 1701 5800 971 48 
H(20G) 3309 6365 928 51 
H(20H) 3042 5583 717 51 
H(20I) 3765 5587 1024 51 
H(21G) 3195 6547 1659 48 
H(21H) 3475 5722 1810 48 
H(21I) 2621 6026 1924 48 
H(1DA) 7382 5023 705 25 
H(2DA) 6630 6299 296 30 
H(2DB) 6810 6229 790 30 
H(5DA) 4143 5570 -30 26 
H(5DB) 3985 4667 28 26 
H(6DA) 4853 5219 -583 27 
H(8DA) 4782 3595 97 42 
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H(9DA) 4749 2341 -91 47 
H(10D) 4963 1997 -766 46 
H(11D) 5190 2958 -1251 47 
H(12D) 5213 4245 -1059 31 
H(13J) 5524 5341 1078 42 
H(13K) 6379 5005 1159 42 
H(13L) 5722 4475 959 42 
H(15J) 8766 6684 -56 56 
H(15K) 7878 6581 85 56 
H(15L) 8124 6388 -371 56 
H(16J) 9600 5511 -197 65 
H(16K) 8962 5228 -517 65 
H(16L) 9215 4681 -152 65 
H(17J) 9261 5822 491 63 
H(17K) 8816 5031 572 63 
H(17L) 8377 5826 648 63 
H(19J) 6978 3018 150 52 
H(19K) 6556 3616 -144 52 
H(19L) 6660 3813 325 52 
H(20J) 8263 3116 351 64 
H(20K) 8111 3896 592 64 
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H(20L) 8786 3854 258 64 
H(21J) 7996 3077 -408 62 
H(21K) 8495 3845 -463 62 
H(21L) 7615 3805 -625 62 
H(1SA) 6254 8596 -124 16 
H(1SB) 5849 7892 70 16 
H(1SC) 5702 7047 -522 50 
H(1SD) 6029 7392 -917 50 
H(1SE) 4570 6966 -412 91 
H(1SF) 4467 7792 -245 91 
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Table 32. Torsion angles [°] for (L4)PdCl2 complex. 
 
N(1A)-Pd(1A)-P(1A)-C(1A) 
Cl(2A)-Pd(1A)-P(1A)-C(1A) 
Cl(1A)-Pd(1A)-P(1A)-C(1A) 
N(1A)-Pd(1A)-P(1A)-C(18A) 
Cl(2A)-Pd(1A)-P(1A)-C(18A) 
Cl(1A)-Pd(1A)-P(1A)-C(18A) 
N(1A)-Pd(1A)-P(1A)-C(14A) 
Cl(2A)-Pd(1A)-P(1A)-C(14A) 
Cl(1A)-Pd(1A)-P(1A)-C(14A) 
P(1A)-Pd(1A)-N(1A)-C(4A) 
Cl(2A)-Pd(1A)-N(1A)-C(4A) 
Cl(1A)-Pd(1A)-N(1A)-C(4A) 
P(1A)-Pd(1A)-N(1A)-C(6A) 
Cl(2A)-Pd(1A)-N(1A)-C(6A) 
Cl(1A)-Pd(1A)-N(1A)-C(6A) 
C(7A)-C(8A)-C(9A)-C(10A) -6.3(17) 
C(8A)-C(9A)-C(10A)-C(11A) 8.7(18) 
C(9A)-C(10A)-C(11A)-C(12A) -7.9(16) 
C(10A)-C(11A)-C(12A)-C(7A) 4.6(13) 
C(8A)-C(7A)-C(12A)-C(11A) -2.1(12) 
C(6A)-C(7A)-C(12A)-C(11A) 172.5(7) 
C(1A)-P(1A)-C(14A)-C(16A) 157.8(5) 
C(18A)-P(1A)-C(14A)-C(16A) 46.3(6) 
Pd(1A)-P(1A)-C(14A)-C(16A) -83.2(5) 
C(1A)-P(1A)-C(14A)-C(17A) 34.6(5) 
C(18A)-P(1A)-C(14A)-C(17A) -76.9(6) 
Pd(1A)-P(1A)-C(14A)-C(17A) 153.6(4) 
C(1A)-P(1A)-C(14A)-C(15A) -83.0(5) 
C(18A)-P(1A)-C(14A)-C(15A) 165.6(5) 
Pd(1A)-P(1A)-C(14A)-C(15A) 36.1(5) 
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C(18A)-P(1A)-C(1A)-C(2A) 
C(14A)-P(1A)-C(1A)-C(2A) 
Pd(1A)-P(1A)-C(1A)-C(2A) 
C(18A)-P(1A)-C(1A)-C(3A) 
C(14A)-P(1A)-C(1A)-C(3A) 
Pd(1A)-P(1A)-C(1A)-C(3A) 
P(1A)-C(1A)-C(2A)-C(3A) 118.9(6) 
C(2A)-C(1A)-C(3A)-C(4A) 106.0(7) 
P(1A)-C(1A)-C(3A)-C(4A) 0.2(10) 
P(1A)-C(1A)-C(3A)-C(2A) -105.8(7) 
C(2A)-C(1A)-C(3A)-C(13A) 
P(1A)-C(1A)-C(3A)-C(13A) 
C(1A)-C(2A)-C(3A)-C(4A) -109.5(7) 
C(1A)-C(2A)-C(3A)-C(13A) 
C(6A)-N(1A)-C(4A)-O(1A) 
 
C(1A)-P(1A)-C(18A)-C(19A) 49.5(6) 
C(14A)-P(1A)-C(18A)-C(19A) 158.7(5) 
Pd(1A)-P(1A)-C(18A)-C(19A) -68.1(5) 
C(1A)-P(1A)-C(18A)-C(20A) -68.1(6) 
C(14A)-P(1A)-C(18A)-C(20A) 41.1(6) 
Pd(1A)-P(1A)-C(18A)-C(20A) 174.3(5) 
C(1A)-P(1A)-C(18A)-C(21A) 166.1(5) 
C(14A)-P(1A)-C(18A)-C(21A) -84.7(6) 
Pd(1A)-P(1A)-C(18A)-C(21A) 48.5(6) 
N(1B)-Pd(1B)-P(1B)-C(1B) -31.7(3) 
Cl(2B)-Pd(1B)-P(1B)-C(1B) 155.7(2) 
Cl(1B)-Pd(1B)-P(1B)-C(1B) 72.7(7) 
N(1B)-Pd(1B)-P(1B)-C(18B) 84.7(3) 
Cl(2B)-Pd(1B)-P(1B)-C(18B) -87.9(3) 
Cl(1B)-Pd(1B)-P(1B)-C(18B) -170.9(7) 
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Pd(1A)-N(1A)-C(4A)-O(1A) 
C(6A)-N(1A)-C(4A)-C(3A) 
Pd(1A)-N(1A)-C(4A)-C(3A) 
C(5A)-O(1A)-C(4A)-N(1A) 
C(5A)-O(1A)-C(4A)-C(3A) 
C(1A)-C(3A)-C(4A)-N(1A) 
C(2A)-C(3A)-C(4A)-N(1A) 
C(13A)-C(3A)-C(4A)-N(1A) 
C(1A)-C(3A)-C(4A)-O(1A) 
C(2A)-C(3A)-C(4A)-O(1A) 
C(13A)-C(3A)-C(4A)-O(1A) 
C(4A)-O(1A)-C(5A)-C(6A) 
C(4A)-N(1A)-C(6A)-C(7A) 
Pd(1A)-N(1A)-C(6A)-C(7A) 
C(4A)-N(1A)-C(6A)-C(5A) 
 
N(1B)-Pd(1B)-P(1B)-C(14B) -143.9(3) 
Cl(2B)-Pd(1B)-P(1B)-C(14B) 43.5(3) 
Cl(1B)-Pd(1B)-P(1B)-C(14B) -39.5(8) 
P(1B)-Pd(1B)-N(1B)-C(4B) 28.5(7) 
Cl(2B)-Pd(1B)-N(1B)-C(4B) 142.8(10) 
Cl(1B)-Pd(1B)-N(1B)-C(4B) -146.0(7) 
P(1B)-Pd(1B)-N(1B)-C(6B) -149.1(5) 
Cl(2B)-Pd(1B)-N(1B)-C(6B) -34.8(15) 
Cl(1B)-Pd(1B)-N(1B)-C(6B) 36.4(5) 
C(18B)-P(1B)-C(1B)-C(2B) -164.2(5) 
C(14B)-P(1B)-C(1B)-C(2B) 77.9(6) 
Pd(1B)-P(1B)-C(1B)-C(2B) -44.6(5) 
C(18B)-P(1B)-C(1B)-C(3B) -92.2(6) 
C(14B)-P(1B)-C(1B)-C(3B) 149.9(6) 
Pd(1B)-P(1B)-C(1B)-C(3B) 27.4(7) 
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Pd(1A)-N(1A)-C(6A)-C(5A) 
O(1A)-C(5A)-C(6A)-C(7A) 
O(1A)-C(5A)-C(6A)-N(1A) 
N(1A)-C(6A)-C(7A)-C(8A) 
C(5A)-C(6A)-C(7A)-C(8A) -18.9(11) 
N(1A)-C(6A)-C(7A)-C(12A) 
C(5A)-C(6A)-C(7A)-C(12A) 
C(12A)-C(7A)-C(8A)-C(9A) 
C(6A)-C(7A)-C(8A)-C(9A) -171.6(9) 
Pd(1B)-N(1B)-C(4B)-O(1B) 
C(6B)-N(1B)-C(4B)-C(3B) 172.3(7) 
Pd(1B)-N(1B)-C(4B)-C(3B) 
C(5B)-O(1B)-C(4B)-N(1B) -11.4(9) 
C(5B)-O(1B)-C(4B)-C(3B) 169.1(6) 
C(2B)-C(3B)-C(4B)-N(1B) 53.3(11) 
 
P(1B)-C(1B)-C(2B)-C(3B) 116.6(6) 
C(1B)-C(2B)-C(3B)-C(4B) -110.4(7) 
C(1B)-C(2B)-C(3B)-C(13B) 104.7(7) 
C(2B)-C(1B)-C(3B)-C(4B) 105.2(7) 
P(1B)-C(1B)-C(3B)-C(4B) -1.3(10) 
P(1B)-C(1B)-C(3B)-C(2B) -106.5(6) 
C(2B)-C(1B)-C(3B)-C(13B) -109.9(8) 
P(1B)-C(1B)-C(3B)-C(13B) 143.6(6) 
C(6B)-N(1B)-C(4B)-O(1B)       -7.1(8) 
N(1C)-Pd(1C)-P(1C)-C(14C) -141.6(3) 
Cl(2C)-Pd(1C)-P(1C)-C(14C) 44.5(3) 
Cl(1C)-Pd(1C)-P(1C)-C(14C) -30.4(7) 
P(1C)-Pd(1C)-N(1C)-C(4C) 27.1(7) 
Cl(2C)-Pd(1C)-N(1C)-C(4C) 137.0(12) 
Cl(1C)-Pd(1C)-N(1C)-C(4C) -146.7(7) 
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C(1B)-C(3B)-C(4B)-N(1B) -15.0(12) 
C(13B)-C(3B)-C(4B)-N(1B) 
C(2B)-C(3B)-C(4B)-O(1B) -127.2(7) 
C(1B)-C(3B)-C(4B)-O(1B) 164.5(6) 
C(13B)-C(3B)-C(4B)-O(1B) 
C(4B)-O(1B)-C(5B)-C(6B) 23.8(8) 
C(4B)-N(1B)-C(6B)-C(7B) -103.6(6) 
Pd(1B)-N(1B)-C(6B)-C(7B) 
C(4B)-N(1B)-C(6B)-C(5B) 21.0(7) 
Pd(1B)-N(1B)-C(6B)-C(5B) 
O(1B)-C(5B)-C(6B)-C(7B) 93.7(7) 
O(1B)-C(5B)-C(6B)-N(1B) -26.1(7) 
N(1B)-C(6B)-C(7B)-C(12B) 
C(5B)-C(6B)-C(7B)-C(12B) 
N(1B)-C(6B)-C(7B)-C(8B) 93.4(9) 
 
P(1C)-Pd(1C)-N(1C)-C(6C) -154.6(5) 
Cl(2C)-Pd(1C)-N(1C)-C(6C) -44.7(17) 
Cl(1C)-Pd(1C)-N(1C)-C(6C) 31.5(5) 
C(18C)-P(1C)-C(1C)-C(2C) -168.2(5) 
C(14C)-P(1C)-C(1C)-C(2C) 74.1(5) 
Pd(1C)-P(1C)-C(1C)-C(2C) -49.4(5) 
C(18C)-P(1C)-C(1C)-C(3C) -95.8(6) 
C(14C)-P(1C)-C(1C)-C(3C) 146.5(6) 
Pd(1C)-P(1C)-C(1C)-C(3C) 23.0(7) 
P(1C)-C(1C)-C(2C)-C(3C) 117.6(5) 
C(1C)-C(2C)-C(3C)-C(4C) -111.0(6) 
C(1C)-C(2C)-C(3C)-C(13C) 104.5(7) 
C(2C)-C(1C)-C(3C)-C(4C) 104.5(7) 
P(1C)-C(1C)-C(3C)-C(4C) -1.9(9) 
P(1C)-C(1C)-C(3C)-C(2C) -106.4(6) 
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C(5B)-C(6B)-C(7B)-C(8B) -20.4(10) 
C(12B)-C(7B)-C(8B)-C(9B) 
C(6B)-C(7B)-C(8B)-C(9B) -175.7(9) 
C(7B)-C(8B)-C(9B)-C(10B) 
C(8B)-C(9B)-C(10B)-C(11B) 
C(9B)-C(10B)-C(11B)-C(12B) 
C(10B)-C(11B)-C(12B)-C(7B) 
C(8B)-C(7B)-C(12B)-C(11B) 
C(6B)-C(7B)-C(12B)-C(11B) 
C(1B)-P(1B)-C(14B)-C(15B) 
C(18B)-P(1B)-C(14B)-C(15B) 
Pd(1B)-P(1B)-C(14B)-C(15B) 
C(1B)-P(1B)-C(14B)-C(16B) 
C(18B)-P(1B)-C(14B)-C(16B) 
Pd(1B)-P(1B)-C(14B)-C(16B) 
 
C(2C)-C(1C)-C(3C)-C(13C) -110.3(6) 
P(1C)-C(1C)-C(3C)-C(13C) 143.3(5) 
C(6C)-N(1C)-C(4C)-O(1C) -6.4(8) 
Pd(1C)-N(1C)-C(4C)-O(1C) 171.9(4) 
C(6C)-N(1C)-C(4C)-C(3C) 171.6(7) 
Pd(1C)-N(1C)-C(4C)-C(3C) -10.0(12) 
C(5C)-O(1C)-C(4C)-N(1C) -10.5(8) 
C(5C)-O(1C)-C(4C)-C(3C) 171.2(6) 
C(2C)-C(3C)-C(4C)-N(1C) 59.9(10) 
C(1C)-C(3C)-C(4C)-N(1C) -9.0(11) 
C(13C)-C(3C)-C(4C)-N(1C) -154.3(7) 
C(2C)-C(3C)-C(4C)-O(1C) -122.0(6) 
C(1C)-C(3C)-C(4C)-O(1C) 169.1(6) 
C(13C)-C(3C)-C(4C)-O(1C) 23.8(8) 
C(4C)-O(1C)-C(5C)-C(6C) 21.8(7) 
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C(1B)-P(1B)-C(14B)-C(17B) 
C(18B)-P(1B)-C(14B)-C(17B) 
Pd(1B)-P(1B)-C(14B)-C(17B) 
C(1B)-P(1B)-C(18B)-C(20B) 
C(14B)-P(1B)-C(18B)-C(20B) 
Pd(1B)-P(1B)-C(18B)-C(20B) 
C(1B)-P(1B)-C(18B)-C(21B) 
C(14B)-P(1B)-C(18B)-C(21B) 
Pd(1B)-P(1B)-C(18B)-C(21B) 
C(1B)-P(1B)-C(18B)-C(19B) 
C(14B)-P(1B)-C(18B)-C(19B) 
Pd(1B)-P(1B)-C(18B)-C(19B) 
N(1C)-Pd(1C)-P(1C)-C(1C) 
Cl(2C)-Pd(1C)-P(1C)-C(1C) 
Cl(1C)-Pd(1C)-P(1C)-C(1C) 
 
C(4C)-N(1C)-C(6C)-C(7C) -103.5(7) 
Pd(1C)-N(1C)-C(6C)-C(7C) 77.8(6) 
C(4C)-N(1C)-C(6C)-C(5C) 19.7(7) 
Pd(1C)-N(1C)-C(6C)-C(5C) -158.9(4) 
O(1C)-C(5C)-C(6C)-N(1C) -24.3(7) 
O(1C)-C(5C)-C(6C)-C(7C) 94.9(7) 
N(1C)-C(6C)-C(7C)-C(12C) -106.5(7) 
C(5C)-C(6C)-C(7C)-C(12C) 138.9(7) 
N(1C)-C(6C)-C(7C)-C(8C) 76.2(8) 
C(5C)-C(6C)-C(7C)-C(8C) -38.4(9) 
C(12C)-C(7C)-C(8C)-C(9C) 0.8(11) 
C(6C)-C(7C)-C(8C)-C(9C) 178.1(7) 
C(7C)-C(8C)-C(9C)-C(10C) 0.9(13) 
C(8C)-C(9C)-C(10C)-C(11C) -2.4(13) 
C(9C)-C(10C)-C(11C)-C(12C) 2.2(13) 
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Table 32. Continued 
N(1C)-Pd(1C)-P(1C)-C(18C) 
Cl(2C)-Pd(1C)-P(1C)-C(18C) 
Cl(1C)-Pd(1C)-P(1C)-C(18C) 
C(1C)-P(1C)-C(14C)-C(16C) 
C(18C)-P(1C)-C(14C)-C(16C) 
Pd(1C)-P(1C)-C(14C)-C(16C) 
C(1C)-P(1C)-C(14C)-C(15C) 
C(18C)-P(1C)-C(14C)-C(15C) 
Pd(1C)-P(1C)-C(14C)-C(15C) 
C(1C)-P(1C)-C(14C)-C(17C) 
C(18C)-P(1C)-C(14C)-C(17C) 
Pd(1C)-P(1C)-C(14C)-C(17C) 
C(1C)-P(1C)-C(18C)-C(19C) 
C(14C)-P(1C)-C(18C)-C(19C) 
Pd(1C)-P(1C)-C(18C)-C(19C) 
 
C(8C)-C(7C)-C(12C)-C(11C) -1.0(11) 
C(6C)-C(7C)-C(12C)-C(11C)     -178.3(7) 
C(10C)-C(11C)-C(12C)-C(7C)     -0.5(13) 
C(13D)-C(3D)-C(4D)-N(1D) -158.2(8) 
C(1D)-C(3D)-C(4D)-N(1D) -11.0(12) 
C(2D)-C(3D)-C(4D)-O(1D) -125.8(7) 
C(13D)-C(3D)-C(4D)-O(1D) 20.0(9) 
C(1D)-C(3D)-C(4D)-O(1D) 167.2(6) 
C(4D)-O(1D)-C(5D)-C(6D) 18.8(7) 
C(4D)-N(1D)-C(6D)-C(7D) -102.8(7) 
Pd(1D)-N(1D)-C(6D)-C(7D) 78.5(6) 
C(4D)-N(1D)-C(6D)-C(5D) 16.7(7) 
Pd(1D)-N(1D)-C(6D)-C(5D) -162.0(4) 
O(1D)-C(5D)-C(6D)-N(1D) -21.0(6) 
O(1D)-C(5D)-C(6D)-C(7D) 97.5(6) 
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Table 32. Continued 
C(1C)-P(1C)-C(18C)-C(20C) 
C(14C)-P(1C)-C(18C)-C(20C) 
Pd(1C)-P(1C)-C(18C)-C(20C) 
C(1C)-P(1C)-C(18C)-C(21C) 
C(14C)-P(1C)-C(18C)-C(21C) 
Pd(1C)-P(1C)-C(18C)-C(21C) 
N(1D)-Pd(1D)-P(1D)-C(1D) 
Cl(2D)-Pd(1D)-P(1D)-C(1D) 
Cl(1D)-Pd(1D)-P(1D)-C(1D) 
N(1D)-Pd(1D)-P(1D)-C(18D) 
Cl(2D)-Pd(1D)-P(1D)-C(18D) 
Cl(1D)-Pd(1D)-P(1D)-C(18D) 
N(1D)-Pd(1D)-P(1D)-C(14D) 
Cl(2D)-Pd(1D)-P(1D)-C(14D) 
Cl(1D)-Pd(1D)-P(1D)-C(14D) 
 
N(1D)-C(6D)-C(7D)-C(12D) -99.4(7) 
C(5D)-C(6D)-C(7D)-C(12D) 148.3(6) 
N(1D)-C(6D)-C(7D)-C(8D) 78.2(9) 
C(5D)-C(6D)-C(7D)-C(8D) -34.0(9) 
C(12D)-C(7D)-C(8D)-C(9D) -3.2(13) 
C(6D)-C(7D)-C(8D)-C(9D) 179.1(8) 
C(7D)-C(8D)-C(9D)-C(10D) 1.9(15) 
C(8D)-C(9D)-C(10D)-C(11D) -0.2(14) 
C(9D)-C(10D)-C(11D)-C(12D) -0.1(13) 
C(10D)-C(11D)-C(12D)-C(7D) -1.3(12) 
C(8D)-C(7D)-C(12D)-C(11D) 2.9(11) 
C(6D)-C(7D)-C(12D)-C(11D) -179.4(7) 
C(1D)-P(1D)-C(14D)-C(15D) -83.6(5) 
C(18D)-P(1D)-C(14D)-C(15D) 165.7(5) 
Pd(1D)-P(1D)-C(14D)-C(15D) 34.4(6) 
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P(1D)-Pd(1D)-N(1D)-C(4D) 
Cl(2D)-Pd(1D)-N(1D)-C(4D) 
Cl(1D)-Pd(1D)-N(1D)-C(4D) 
P(1D)-Pd(1D)-N(1D)-C(6D) 
Cl(2D)-Pd(1D)-N(1D)-C(6D) 
Cl(1D)-Pd(1D)-N(1D)-C(6D) 
C(18D)-P(1D)-C(1D)-C(2D) 
C(14D)-P(1D)-C(1D)-C(2D) 
Pd(1D)-P(1D)-C(1D)-C(2D) 
C(18D)-P(1D)-C(1D)-C(3D) 
C(14D)-P(1D)-C(1D)-C(3D) 
Pd(1D)-P(1D)-C(1D)-C(3D) 
P(1D)-C(1D)-C(2D)-C(3D) 117.3(6) 
C(1D)-C(2D)-C(3D)-C(4D) -109.3(6) 
C(1D)-C(2D)-C(3D)-C(13D) 
 
C(1D)-P(1D)-C(14D)-C(16D) 154.3(5) 
C(18D)-P(1D)-C(14D)-C(16D) 43.6(6) 
Pd(1D)-P(1D)-C(14D)-C(16D) -87.7(6) 
C(1D)-P(1D)-C(14D)-C(17D) 34.4(7) 
C(18D)-P(1D)-C(14D)-C(17D) -76.3(6) 
Pd(1D)-P(1D)-C(14D)-C(17D) 152.4(5) 
C(1D)-P(1D)-C(18D)-C(19D) 54.8(6) 
C(14D)-P(1D)-C(18D)-C(19D) 163.2(5) 
Pd(1D)-P(1D)-C(18D)-C(19D) -62.5(5) 
C(1D)-P(1D)-C(18D)-C(20D) -65.0(6) 
C(14D)-P(1D)-C(18D)-C(20D) 43.4(7) 
Pd(1D)-P(1D)-C(18D)-C(20D) 177.8(5) 
C(1D)-P(1D)-C(18D)-C(21D) 173.6(6) 
C(14D)-P(1D)-C(18D)-C(21D) -78.0(6) 
Pd(1D)-P(1D)-C(18D)-C(21D) 56.4(6) 
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Table 32. Continued 
C(2D)-C(1D)-C(3D)-C(4D) 105.0(7) 
P(1D)-C(1D)-C(3D)-C(4D) -1.6(11) 
P(1D)-C(1D)-C(3D)-C(2D) -106.6(7) 
C(2D)-C(1D)-C(3D)-C(13D) 
P(1D)-C(1D)-C(3D)-C(13D) 
C(6D)-N(1D)-C(4D)-O(1D) 
Pd(1D)-N(1D)-C(4D)-O(1D) 
C(6D)-N(1D)-C(4D)-C(3D) 
Pd(1D)-N(1D)-C(4D)-C(3D) 
C(5D)-O(1D)-C(4D)-N(1D) 
C(5D)-O(1D)-C(4D)-C(3D) 
C(2D)-C(3D)-C(4D)-N(1D) 
C(1S')-Cl(2')-C(1S)-Cl(1) -50(2) 
Cl(2)-Cl(2')-C(1S)-Cl(1) -132.5(9) 
C(1S")-Cl(2')-C(1S)-Cl(1) 157.8(18) 
 
C(1S)-Cl(2)-Cl(2')-C(1S') -97(2) 
C(1S")-Cl(2)-Cl(2')-C(1S') 150(4) 
C(1S')-Cl(2)-Cl(2')-C(1S) 97(2) 
C(1S")-Cl(2)-Cl(2')-C(1S) -114(2) 
C(1S)-Cl(2)-Cl(2')-C(1S") 114(2) 
C(1S')-Cl(2)-Cl(2')-C(1S") -150(4) 
C(1S)-Cl(2)-Cl(2')-Cl(1) -39.4(12) 
C(1S')-Cl(2)-Cl(2')-Cl(1) 57.1(15) 
C(1S")-Cl(2)-Cl(2')-Cl(1) -153(3) 
C(1S)-Cl(1)-Cl(2')-C(1S') 118(3) 
C(1S)-Cl(1)-Cl(2')-Cl(2)           44.4(14) 
C(1S)-Cl(1)-Cl(2')-C(1S")            -54(7) 
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Table 32. Continued 
C(1S')-Cl(2')-C(1S)-Cl(2) 82(2) 
C(1S")-Cl(2')-C(1S)-Cl(2) -69.7(18) 
Cl(1)-Cl(2')-C(1S)-Cl(2) 132.5(9) 
Cl(2')-Cl(1)-C(1S)-Cl(2) -39.1(12) 
C(1S')-Cl(2)-C(1S)-Cl(2') -36.4(13) 
C(1S")-Cl(2)-C(1S)-Cl(2') 48.4(19) 
Cl(2')-Cl(2)-C(1S)-Cl(1) 48.0(11) 
C(1S')-Cl(2)-C(1S)-Cl(1) 11.6(13) 
C(1S")-Cl(2)-C(1S)-Cl(1) 96(2) 
C(1S)-Cl(2')-C(1S')-Cl(2) -65.1(16) 
C(1S")-Cl(2')-C(1S')-Cl(2) 61(8) 
Cl(1)-Cl(2')-C(1S')-Cl(2) -112.2(14) 
C(1S)-Cl(2)-C(1S')-Cl(2') 68(3) 
C(1S")-Cl(2)-C(1S')-Cl(2') -24(3) 
C(1S')-Cl(2')-C(1S")-Cl(2) -62(8) 
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Table 32. Continued 
C(1S)-Cl(2')-C(1S")-Cl(2) 60.5(17) 
Cl(1)-Cl(2')-C(1S")-Cl(2) 104(7) 
C(1S)-Cl(2)-C(1S")-Cl(2') -53(2) 
C(1S')-Cl(2)-C(1S")-Cl(2') 16.3(19) 
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